id	sid	tid	token	lemma	pos
easat-3872	1	1	edelweiss	edelweiss	PROPN
easat-3872	1	2	applied	apply	VERB
easat-3872	1	3	science	science	NOUN
easat-3872	1	4	and	and	CCONJ
easat-3872	1	5	technology	technology	NOUN
easat-3872	1	6	issn	issn	PROPN
easat-3872	1	7	:	:	PUNCT
easat-3872	1	8	2576	2576	NUM
easat-3872	1	9	-	-	SYM
easat-3872	1	10	8484	8484	NUM
easat-3872	1	11	vol	vol	NOUN
easat-3872	1	12	.	.	PROPN
easat-3872	1	13	8	8	NUM
easat-3872	1	14	,	,	PUNCT
easat-3872	1	15	no	no	INTJ
easat-3872	1	16	.	.	NOUN
easat-3872	1	17	6	6	NUM
easat-3872	1	18	,	,	PUNCT
easat-3872	1	19	8752	8752	NUM
easat-3872	1	20	-	-	SYM
easat-3872	1	21	8758	8758	NUM
easat-3872	1	22	2024	2024	NUM
easat-3872	1	23	publisher	publisher	NOUN
easat-3872	1	24	:	:	PUNCT
easat-3872	1	25	learning	learn	VERB
easat-3872	1	26	gate	gate	NOUN
easat-3872	1	27	doi	doi	PROPN
easat-3872	1	28	:	:	PUNCT
easat-3872	1	29	10.55214/25768484.v8i6.3872	10.55214/25768484.v8i6.3872	NUM
easat-3872	1	30	©	©	ADP
easat-3872	1	31	2024	2024	NUM
easat-3872	1	32	by	by	ADP
easat-3872	1	33	the	the	DET
easat-3872	1	34	authors	author	NOUN
easat-3872	1	35	;	;	PUNCT
easat-3872	1	36	licensee	licensee	PROPN
easat-3872	1	37	learning	learning	NOUN
easat-3872	1	38	gate	gate	NOUN
easat-3872	1	39	©	©	PROPN
easat-3872	1	40	2024	2024	NUM
easat-3872	1	41	by	by	ADP
easat-3872	1	42	the	the	DET
easat-3872	1	43	authors	author	NOUN
easat-3872	1	44	;	;	PUNCT
easat-3872	1	45	licensee	licensee	PROPN
easat-3872	1	46	learning	learn	VERB
easat-3872	1	47	gate	gate	NOUN
easat-3872	1	48	*	*	PUNCT
easat-3872	1	49	correspondence	correspondence	NOUN
easat-3872	1	50	:	:	PUNCT
easat-3872	1	51	nur-r@fk.unair.ac.id	nur-r@fk.unair.ac.id	NUM
easat-3872	1	52	alternative	alternative	ADJ
easat-3872	1	53	management	management	NOUN
easat-3872	1	54	of	of	ADP
easat-3872	1	55	persistent	persistent	ADJ
easat-3872	1	56	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	1	57	hypoglycemia	hypoglycemia	NOUN
easat-3872	1	58	in	in	ADP
easat-3872	1	59	a	a	DET
easat-3872	1	60	neonate	neonate	NOUN
easat-3872	1	61	:	:	PUNCT
easat-3872	1	62	a	a	DET
easat-3872	1	63	case	case	NOUN
easat-3872	1	64	report	report	NOUN
easat-3872	1	65	on	on	ADP
easat-3872	1	66	octreotide	octreotide	NOUN
easat-3872	1	67	and	and	CCONJ
easat-3872	1	68	nifedipine	nifedipine	PROPN
easat-3872	1	69	therapy	therapy	NOUN
easat-3872	1	70	iva	iva	PROPN
easat-3872	1	71	nur	nur	VERB
easat-3872	1	72	annia1	annia1	PROPN
easat-3872	1	73	,	,	PUNCT
easat-3872	1	74	muhammad	muhammad	PROPN
easat-3872	1	75	faizi2	faizi2	PROPN
easat-3872	1	76	,	,	PUNCT
easat-3872	1	77	nur	nur	VERB
easat-3872	1	78	rochmah3	rochmah3	NOUN
easat-3872	1	79	*	*	PROPN
easat-3872	1	80	,	,	PUNCT
easat-3872	1	81	yuni	yuni	PROPN
easat-3872	1	82	hisbiyah4	hisbiyah4	PROPN
easat-3872	1	83	,	,	PUNCT
easat-3872	1	84	rayi	rayi	VERB
easat-3872	1	85	kurnia	kurnia	PROPN
easat-3872	1	86	perwitasari5	perwitasari5	PROPN
easat-3872	1	87	1,2,3,4,5department	1,2,3,4,5department	NUM
easat-3872	1	88	of	of	ADP
easat-3872	1	89	child	child	NOUN
easat-3872	1	90	health	health	NOUN
easat-3872	1	91	,	,	PUNCT
easat-3872	1	92	faculty	faculty	NOUN
easat-3872	1	93	of	of	ADP
easat-3872	1	94	medicine	medicine	NOUN
easat-3872	1	95	universitas	universita	NOUN
easat-3872	1	96	airlangga	airlangga	PROPN
easat-3872	1	97	,	,	PUNCT
easat-3872	1	98	dr	dr	PROPN
easat-3872	1	99	.	.	PROPN
easat-3872	1	100	soetomo	soetomo	PROPN
easat-3872	1	101	general	general	PROPN
easat-3872	1	102	hospital	hospital	PROPN
easat-3872	1	103	,	,	PUNCT
easat-3872	1	104	surabaya	surabaya	PROPN
easat-3872	1	105	,	,	PUNCT
easat-3872	1	106	indonesia	indonesia	PROPN
easat-3872	1	107	,	,	PUNCT
easat-3872	1	108	60286	60286	NUM
easat-3872	1	109	;	;	PUNCT
easat-3872	1	110	hamidabdul.mr@gmail.com	hamidabdul.mr@gmail.com	PROPN
easat-3872	1	111	(	(	PUNCT
easat-3872	1	112	i.n.a	i.n.a	NOUN
easat-3872	1	113	.	.	PUNCT
easat-3872	1	114	)	)	PUNCT
easat-3872	1	115	muhammad.faizi@fk.unair.ac.id	muhammad.faizi@fk.unair.ac.id	X
easat-3872	2	1	(	(	PUNCT
easat-3872	2	2	m.f	m.f	NOUN
easat-3872	2	3	.	.	PUNCT
easat-3872	2	4	)	)	PUNCT
easat-3872	3	1	nur-r@fk.unair.ac.id	nur-r@fk.unair.ac.id	PROPN
easat-3872	3	2	(	(	PUNCT
easat-3872	3	3	n.r	n.r	PROPN
easat-3872	3	4	.	.	PROPN
easat-3872	3	5	)	)	PUNCT
easat-3872	4	1	yuni.hisbiyah@gmail.com	yuni.hisbiyah@gmail.com	X
easat-3872	4	2	(	(	PUNCT
easat-3872	4	3	y.h	y.h	PROPN
easat-3872	4	4	.	.	PROPN
easat-3872	4	5	)	)	PUNCT
easat-3872	5	1	rayi.kurnia.p@gmail.com	rayi.kurnia.p@gmail.com	X
easat-3872	5	2	(	(	PUNCT
easat-3872	5	3	r.k.p	r.k.p	NOUN
easat-3872	5	4	.	.	PUNCT
easat-3872	5	5	)	)	PUNCT
easat-3872	5	6	.	.	PUNCT
easat-3872	6	1	abstract	abstract	ADV
easat-3872	6	2	:	:	PUNCT
easat-3872	6	3	this	this	DET
easat-3872	6	4	case	case	NOUN
easat-3872	6	5	report	report	NOUN
easat-3872	6	6	highlights	highlight	VERB
easat-3872	6	7	the	the	DET
easat-3872	6	8	successful	successful	ADJ
easat-3872	6	9	management	management	NOUN
easat-3872	6	10	of	of	ADP
easat-3872	6	11	persistent	persistent	ADJ
easat-3872	6	12	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	6	13	hypoglycemia	hypoglycemia	NOUN
easat-3872	6	14	in	in	ADP
easat-3872	6	15	infancy	infancy	NOUN
easat-3872	6	16	(	(	PUNCT
easat-3872	6	17	phhi	phhi	NOUN
easat-3872	6	18	)	)	PUNCT
easat-3872	6	19	using	use	VERB
easat-3872	6	20	alternative	alternative	ADJ
easat-3872	6	21	therapies	therapy	NOUN
easat-3872	6	22	,	,	PUNCT
easat-3872	6	23	demonstrating	demonstrate	VERB
easat-3872	6	24	their	their	PRON
easat-3872	6	25	efficacy	efficacy	NOUN
easat-3872	6	26	and	and	CCONJ
easat-3872	6	27	practical	practical	ADJ
easat-3872	6	28	implications	implication	NOUN
easat-3872	6	29	in	in	ADP
easat-3872	6	30	resource	resource	NOUN
easat-3872	6	31	-	-	PUNCT
easat-3872	6	32	limited	limit	VERB
easat-3872	6	33	settings	setting	NOUN
easat-3872	6	34	.	.	PUNCT
easat-3872	7	1	a	a	DET
easat-3872	7	2	48	48	NUM
easat-3872	7	3	-	-	PUNCT
easat-3872	7	4	hour	hour	NOUN
easat-3872	7	5	-	-	PUNCT
easat-3872	7	6	old	old	ADJ
easat-3872	7	7	neonate	neonate	NOUN
easat-3872	7	8	presented	present	VERB
easat-3872	7	9	with	with	ADP
easat-3872	7	10	severe	severe	ADJ
easat-3872	7	11	hypoglycemia	hypoglycemia	NOUN
easat-3872	7	12	unresponsive	unresponsive	ADJ
easat-3872	7	13	to	to	ADP
easat-3872	7	14	high	high	ADJ
easat-3872	7	15	-	-	PUNCT
easat-3872	7	16	dose	dose	NOUN
easat-3872	7	17	glucose	glucose	NOUN
easat-3872	7	18	infusion	infusion	NOUN
easat-3872	7	19	.	.	PUNCT
easat-3872	8	1	laboratory	laboratory	NOUN
easat-3872	8	2	investigations	investigation	NOUN
easat-3872	8	3	confirmed	confirm	VERB
easat-3872	8	4	phhi	phhi	NOUN
easat-3872	8	5	with	with	ADP
easat-3872	8	6	elevated	elevated	ADJ
easat-3872	8	7	insulin	insulin	NOUN
easat-3872	8	8	and	and	CCONJ
easat-3872	8	9	c	c	NOUN
easat-3872	8	10	-	-	PUNCT
easat-3872	8	11	peptide	peptide	NOUN
easat-3872	8	12	levels	level	NOUN
easat-3872	8	13	.	.	PUNCT
easat-3872	9	1	due	due	ADP
easat-3872	9	2	to	to	ADP
easat-3872	9	3	the	the	DET
easat-3872	9	4	unavailability	unavailability	NOUN
easat-3872	9	5	of	of	ADP
easat-3872	9	6	diazoxide	diazoxide	NOUN
easat-3872	9	7	,	,	PUNCT
easat-3872	9	8	treatment	treatment	NOUN
easat-3872	9	9	involved	involve	VERB
easat-3872	9	10	subcutaneous	subcutaneous	ADJ
easat-3872	9	11	octreotide	octreotide	NOUN
easat-3872	9	12	and	and	CCONJ
easat-3872	9	13	oral	oral	ADJ
easat-3872	9	14	nifedipine	nifedipine	NOUN
easat-3872	9	15	.	.	PUNCT
easat-3872	10	1	the	the	DET
easat-3872	10	2	clinical	clinical	ADJ
easat-3872	10	3	course	course	NOUN
easat-3872	10	4	was	be	AUX
easat-3872	10	5	managed	manage	VERB
easat-3872	10	6	and	and	CCONJ
easat-3872	10	7	monitored	monitor	VERB
easat-3872	10	8	according	accord	VERB
easat-3872	10	9	to	to	ADP
easat-3872	10	10	international	international	ADJ
easat-3872	10	11	guidelines	guideline	NOUN
easat-3872	10	12	for	for	ADP
easat-3872	10	13	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	10	14	hypoglycemia	hypoglycemia	NOUN
easat-3872	10	15	.	.	PUNCT
easat-3872	11	1	the	the	DET
easat-3872	11	2	combination	combination	NOUN
easat-3872	11	3	therapy	therapy	NOUN
easat-3872	11	4	successfully	successfully	ADV
easat-3872	11	5	stabilized	stabilize	VERB
easat-3872	11	6	blood	blood	NOUN
easat-3872	11	7	glucose	glucose	NOUN
easat-3872	11	8	levels	level	NOUN
easat-3872	11	9	,	,	PUNCT
easat-3872	11	10	enabling	enable	VERB
easat-3872	11	11	cessation	cessation	NOUN
easat-3872	11	12	of	of	ADP
easat-3872	11	13	intravenous	intravenous	ADJ
easat-3872	11	14	glucose	glucose	NOUN
easat-3872	11	15	infusion	infusion	NOUN
easat-3872	11	16	by	by	ADP
easat-3872	11	17	day	day	NOUN
easat-3872	11	18	10	10	NUM
easat-3872	11	19	.	.	PUNCT
easat-3872	12	1	the	the	DET
easat-3872	12	2	patient	patient	NOUN
easat-3872	12	3	also	also	ADV
easat-3872	12	4	recovered	recover	VERB
easat-3872	12	5	fully	fully	ADV
easat-3872	12	6	from	from	ADP
easat-3872	12	7	hospital	hospital	NOUN
easat-3872	12	8	-	-	PUNCT
easat-3872	12	9	acquired	acquire	VERB
easat-3872	12	10	pneumonia	pneumonia	NOUN
easat-3872	12	11	with	with	ADP
easat-3872	12	12	antibiotic	antibiotic	ADJ
easat-3872	12	13	treatment	treatment	NOUN
easat-3872	12	14	.	.	PUNCT
easat-3872	13	1	these	these	DET
easat-3872	13	2	outcomes	outcome	NOUN
easat-3872	13	3	underscore	underscore	VERB
easat-3872	13	4	the	the	DET
easat-3872	13	5	potential	potential	ADJ
easat-3872	13	6	efficacy	efficacy	NOUN
easat-3872	13	7	of	of	ADP
easat-3872	13	8	nifedipine	nifedipine	NOUN
easat-3872	13	9	as	as	ADP
easat-3872	13	10	a	a	DET
easat-3872	13	11	viable	viable	ADJ
easat-3872	13	12	second	second	ADJ
easat-3872	13	13	-	-	PUNCT
easat-3872	13	14	line	line	NOUN
easat-3872	13	15	therapy	therapy	NOUN
easat-3872	13	16	for	for	ADP
easat-3872	13	17	phhi	phhi	NOUN
easat-3872	13	18	in	in	ADP
easat-3872	13	19	contexts	context	NOUN
easat-3872	13	20	where	where	SCONJ
easat-3872	13	21	standard	standard	ADJ
easat-3872	13	22	treatments	treatment	NOUN
easat-3872	13	23	are	be	AUX
easat-3872	13	24	inaccessible	inaccessible	ADJ
easat-3872	13	25	.	.	PUNCT
easat-3872	14	1	this	this	DET
easat-3872	14	2	case	case	NOUN
easat-3872	14	3	underscores	underscore	VERB
easat-3872	14	4	the	the	DET
easat-3872	14	5	importance	importance	NOUN
easat-3872	14	6	of	of	ADP
easat-3872	14	7	flexible	flexible	ADJ
easat-3872	14	8	,	,	PUNCT
easat-3872	14	9	evidencebased	evidencebased	ADJ
easat-3872	14	10	therapeutic	therapeutic	ADJ
easat-3872	14	11	approaches	approach	NOUN
easat-3872	14	12	tailored	tailor	VERB
easat-3872	14	13	to	to	ADP
easat-3872	14	14	individual	individual	ADJ
easat-3872	14	15	patient	patient	NOUN
easat-3872	14	16	needs	need	NOUN
easat-3872	14	17	,	,	PUNCT
easat-3872	14	18	especially	especially	ADV
easat-3872	14	19	in	in	ADP
easat-3872	14	20	resource	resource	NOUN
easat-3872	14	21	-	-	PUNCT
easat-3872	14	22	constrained	constrain	VERB
easat-3872	14	23	environments	environment	NOUN
easat-3872	14	24	.	.	PUNCT
easat-3872	15	1	the	the	DET
easat-3872	15	2	findings	finding	NOUN
easat-3872	15	3	highlight	highlight	VERB
easat-3872	15	4	nifedipine	nifedipine	PROPN
easat-3872	15	5	’s	’s	PART
easat-3872	15	6	clinical	clinical	ADJ
easat-3872	15	7	utility	utility	NOUN
easat-3872	15	8	in	in	ADP
easat-3872	15	9	phhi	phhi	NOUN
easat-3872	15	10	management	management	NOUN
easat-3872	15	11	and	and	CCONJ
easat-3872	15	12	emphasize	emphasize	VERB
easat-3872	15	13	the	the	DET
easat-3872	15	14	need	need	NOUN
easat-3872	15	15	for	for	ADP
easat-3872	15	16	further	further	ADJ
easat-3872	15	17	research	research	NOUN
easat-3872	15	18	,	,	PUNCT
easat-3872	15	19	including	include	VERB
easat-3872	15	20	large	large	ADJ
easat-3872	15	21	-	-	PUNCT
easat-3872	15	22	scale	scale	NOUN
easat-3872	15	23	studies	study	NOUN
easat-3872	15	24	,	,	PUNCT
easat-3872	15	25	to	to	PART
easat-3872	15	26	establish	establish	VERB
easat-3872	15	27	standardized	standardized	ADJ
easat-3872	15	28	treatment	treatment	NOUN
easat-3872	15	29	protocols	protocol	NOUN
easat-3872	15	30	and	and	CCONJ
easat-3872	15	31	expand	expand	VERB
easat-3872	15	32	access	access	NOUN
easat-3872	15	33	to	to	ADP
easat-3872	15	34	effective	effective	ADJ
easat-3872	15	35	therapies	therapy	NOUN
easat-3872	15	36	globally	globally	ADV
easat-3872	15	37	.	.	PUNCT
easat-3872	16	1	keywords	keyword	NOUN
easat-3872	16	2	:	:	PUNCT
easat-3872	17	1	hyperinsulinism	hyperinsulinism	NOUN
easat-3872	17	2	,	,	PUNCT
easat-3872	17	3	hypoglycemia	hypoglycemia	NOUN
easat-3872	17	4	,	,	PUNCT
easat-3872	17	5	neonate	neonate	NOUN
easat-3872	17	6	,	,	PUNCT
easat-3872	17	7	nifedipine	nifedipine	NOUN
easat-3872	17	8	,	,	PUNCT
easat-3872	17	9	octreotide	octreotide	NOUN
easat-3872	17	10	.	.	PUNCT
easat-3872	18	1	1	1	X
easat-3872	18	2	.	.	X
easat-3872	18	3	introduction	introduction	NOUN
easat-3872	18	4	persistent	persistent	ADJ
easat-3872	18	5	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	18	6	hypoglycemia	hypoglycemia	NOUN
easat-3872	18	7	in	in	ADP
easat-3872	18	8	infancy	infancy	NOUN
easat-3872	18	9	(	(	PUNCT
easat-3872	18	10	phhi	phhi	NOUN
easat-3872	18	11	)	)	PUNCT
easat-3872	18	12	is	be	AUX
easat-3872	18	13	a	a	DET
easat-3872	18	14	rare	rare	ADJ
easat-3872	18	15	but	but	CCONJ
easat-3872	18	16	critical	critical	ADJ
easat-3872	18	17	metabolic	metabolic	NOUN
easat-3872	18	18	disorder	disorder	NOUN
easat-3872	18	19	characterized	characterize	VERB
easat-3872	18	20	by	by	ADP
easat-3872	18	21	unregulated	unregulated	ADJ
easat-3872	18	22	insulin	insulin	NOUN
easat-3872	18	23	secretion	secretion	NOUN
easat-3872	18	24	despite	despite	SCONJ
easat-3872	18	25	hypoglycemia	hypoglycemia	NOUN
easat-3872	18	26	.	.	PUNCT
easat-3872	19	1	as	as	ADP
easat-3872	19	2	the	the	DET
easat-3872	19	3	leading	lead	VERB
easat-3872	19	4	cause	cause	NOUN
easat-3872	19	5	of	of	ADP
easat-3872	19	6	severe	severe	ADJ
easat-3872	19	7	and	and	CCONJ
easat-3872	19	8	persistent	persistent	ADJ
easat-3872	19	9	neonatal	neonatal	ADJ
easat-3872	19	10	hypoglycemia	hypoglycemia	NOUN
easat-3872	19	11	,	,	PUNCT
easat-3872	19	12	it	it	PRON
easat-3872	19	13	poses	pose	VERB
easat-3872	19	14	significant	significant	ADJ
easat-3872	19	15	risks	risk	NOUN
easat-3872	19	16	for	for	ADP
easat-3872	19	17	neurological	neurological	ADJ
easat-3872	19	18	damage	damage	NOUN
easat-3872	19	19	,	,	PUNCT
easat-3872	19	20	including	include	VERB
easat-3872	19	21	seizures	seizure	NOUN
easat-3872	19	22	and	and	CCONJ
easat-3872	19	23	developmental	developmental	ADJ
easat-3872	19	24	delays	delay	NOUN
easat-3872	19	25	,	,	PUNCT
easat-3872	19	26	if	if	SCONJ
easat-3872	19	27	not	not	PART
easat-3872	19	28	promptly	promptly	ADV
easat-3872	19	29	treated	treat	VERB
easat-3872	19	30	.	.	PUNCT
easat-3872	20	1	while	while	SCONJ
easat-3872	20	2	its	its	PRON
easat-3872	20	3	incidence	incidence	NOUN
easat-3872	20	4	is	be	AUX
easat-3872	20	5	low	low	ADJ
easat-3872	20	6	globally	globally	ADV
easat-3872	20	7	,	,	PUNCT
easat-3872	20	8	phhi	phhi	NOUN
easat-3872	20	9	is	be	AUX
easat-3872	20	10	more	more	ADV
easat-3872	20	11	prevalent	prevalent	ADJ
easat-3872	20	12	in	in	ADP
easat-3872	20	13	consanguineous	consanguineous	ADJ
easat-3872	20	14	populations	population	NOUN
easat-3872	20	15	,	,	PUNCT
easat-3872	20	16	reflecting	reflect	VERB
easat-3872	20	17	its	its	PRON
easat-3872	20	18	genetic	genetic	ADJ
easat-3872	20	19	basis	basis	NOUN
easat-3872	20	20	[	[	X
easat-3872	20	21	1	1	NUM
easat-3872	20	22	]	]	PUNCT
easat-3872	20	23	.	.	PUNCT
easat-3872	21	1	globally	globally	ADV
easat-3872	21	2	,	,	PUNCT
easat-3872	21	3	its	its	PRON
easat-3872	21	4	incidence	incidence	NOUN
easat-3872	21	5	is	be	AUX
easat-3872	21	6	estimated	estimate	VERB
easat-3872	21	7	at	at	ADP
easat-3872	21	8	1	1	NUM
easat-3872	21	9	in	in	ADP
easat-3872	21	10	50,000	50,000	NUM
easat-3872	21	11	live	live	ADJ
easat-3872	21	12	births	birth	NOUN
easat-3872	21	13	,	,	PUNCT
easat-3872	21	14	but	but	CCONJ
easat-3872	21	15	this	this	PRON
easat-3872	21	16	increases	increase	VERB
easat-3872	21	17	significantly	significantly	ADV
easat-3872	21	18	in	in	ADP
easat-3872	21	19	consanguineous	consanguineous	ADJ
easat-3872	21	20	populations	population	NOUN
easat-3872	21	21	due	due	ADP
easat-3872	21	22	to	to	ADP
easat-3872	21	23	the	the	DET
easat-3872	21	24	genetic	genetic	ADJ
easat-3872	21	25	basis	basis	NOUN
easat-3872	21	26	of	of	ADP
easat-3872	21	27	the	the	DET
easat-3872	21	28	condition	condition	NOUN
easat-3872	21	29	.	.	PUNCT
easat-3872	22	1	the	the	DET
easat-3872	22	2	2023	2023	NUM
easat-3872	22	3	international	international	ADJ
easat-3872	22	4	guidelines	guideline	NOUN
easat-3872	22	5	for	for	ADP
easat-3872	22	6	the	the	DET
easat-3872	22	7	diagnosis	diagnosis	NOUN
easat-3872	22	8	and	and	CCONJ
easat-3872	22	9	management	management	NOUN
easat-3872	22	10	of	of	ADP
easat-3872	22	11	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	22	12	hypoglycemia	hypoglycemia	NOUN
easat-3872	22	13	emphasize	emphasize	VERB
easat-3872	22	14	diazoxide	diazoxide	ADV
easat-3872	22	15	as	as	ADP
easat-3872	22	16	the	the	DET
easat-3872	22	17	first	first	ADJ
easat-3872	22	18	-	-	PUNCT
easat-3872	22	19	line	line	NOUN
easat-3872	22	20	therapy	therapy	NOUN
easat-3872	22	21	for	for	ADP
easat-3872	22	22	phhi	phhi	NOUN
easat-3872	22	23	due	due	ADP
easat-3872	22	24	to	to	ADP
easat-3872	22	25	its	its	PRON
easat-3872	22	26	effectiveness	effectiveness	NOUN
easat-3872	22	27	in	in	ADP
easat-3872	22	28	suppressing	suppress	VERB
easat-3872	22	29	insulin	insulin	NOUN
easat-3872	22	30	secretion	secretion	NOUN
easat-3872	22	31	through	through	ADP
easat-3872	22	32	katp	katp	PROPN
easat-3872	22	33	channel	channel	NOUN
easat-3872	22	34	modulation	modulation	NOUN
easat-3872	22	35	.	.	PUNCT
easat-3872	23	1	however	however	ADV
easat-3872	23	2	,	,	PUNCT
easat-3872	23	3	in	in	ADP
easat-3872	23	4	many	many	ADJ
easat-3872	23	5	lowand	lowand	ADJ
easat-3872	23	6	middleincome	middleincome	PROPN
easat-3872	23	7	countries	country	NOUN
easat-3872	23	8	(	(	PUNCT
easat-3872	23	9	lmics	lmic	NOUN
easat-3872	23	10	)	)	PUNCT
easat-3872	23	11	,	,	PUNCT
easat-3872	23	12	access	access	NOUN
easat-3872	23	13	to	to	ADP
easat-3872	23	14	diazoxide	diazoxide	NOUN
easat-3872	23	15	is	be	AUX
easat-3872	23	16	often	often	ADV
easat-3872	23	17	limited	limit	VERB
easat-3872	23	18	due	due	ADP
easat-3872	23	19	to	to	ADP
easat-3872	23	20	high	high	ADJ
easat-3872	23	21	costs	cost	NOUN
easat-3872	23	22	,	,	PUNCT
easat-3872	23	23	supply	supply	NOUN
easat-3872	23	24	chain	chain	NOUN
easat-3872	23	25	issues	issue	NOUN
easat-3872	23	26	,	,	PUNCT
easat-3872	23	27	and	and	CCONJ
easat-3872	23	28	regulatory	regulatory	ADJ
easat-3872	23	29	barriers	barrier	NOUN
easat-3872	23	30	[	[	X
easat-3872	23	31	2	2	NUM
easat-3872	23	32	]	]	PUNCT
easat-3872	23	33	.	.	PUNCT
easat-3872	24	1	octreotide	octreotide	NOUN
easat-3872	24	2	,	,	PUNCT
easat-3872	24	3	a	a	DET
easat-3872	24	4	somatostatin	somatostatin	NOUN
easat-3872	24	5	analog	analog	NOUN
easat-3872	24	6	,	,	PUNCT
easat-3872	24	7	and	and	CCONJ
easat-3872	24	8	nifedipine	nifedipine	NOUN
easat-3872	24	9	,	,	PUNCT
easat-3872	24	10	a	a	DET
easat-3872	24	11	calcium	calcium	NOUN
easat-3872	24	12	channel	channel	NOUN
easat-3872	24	13	blocker	blocker	NOUN
easat-3872	24	14	,	,	PUNCT
easat-3872	24	15	have	have	AUX
easat-3872	24	16	emerged	emerge	VERB
easat-3872	24	17	as	as	ADP
easat-3872	24	18	viable	viable	ADJ
easat-3872	24	19	second	second	ADJ
easat-3872	24	20	-	-	PUNCT
easat-3872	24	21	line	line	NOUN
easat-3872	24	22	therapies	therapy	NOUN
easat-3872	24	23	in	in	ADP
easat-3872	24	24	such	such	ADJ
easat-3872	24	25	contexts	context	NOUN
easat-3872	24	26	.	.	PUNCT
easat-3872	25	1	several	several	ADJ
easat-3872	25	2	case	case	NOUN
easat-3872	25	3	studies	study	NOUN
easat-3872	25	4	from	from	ADP
easat-3872	25	5	lmics	lmic	NOUN
easat-3872	25	6	,	,	PUNCT
easat-3872	25	7	including	include	VERB
easat-3872	25	8	reports	report	NOUN
easat-3872	25	9	from	from	ADP
easat-3872	25	10	south	south	PROPN
easat-3872	25	11	asia	asia	PROPN
easat-3872	25	12	and	and	CCONJ
easat-3872	25	13	sub	sub	ADJ
easat-3872	25	14	-	-	ADJ
easat-3872	25	15	saharan	saharan	ADJ
easat-3872	25	16	africa	africa	PROPN
easat-3872	25	17	,	,	PUNCT
easat-3872	25	18	have	have	AUX
easat-3872	25	19	demonstrated	demonstrate	VERB
easat-3872	25	20	successful	successful	ADJ
easat-3872	25	21	outcomes	outcome	NOUN
easat-3872	25	22	with	with	ADP
easat-3872	25	23	these	these	DET
easat-3872	25	24	alternatives	alternative	NOUN
easat-3872	25	25	when	when	SCONJ
easat-3872	25	26	diazoxide	diazoxide	NOUN
easat-3872	25	27	is	be	AUX
easat-3872	25	28	unavailable	unavailable	ADJ
easat-3872	25	29	.	.	PUNCT
easat-3872	26	1	for	for	ADP
easat-3872	26	2	instance	instance	NOUN
easat-3872	26	3	,	,	PUNCT
easat-3872	26	4	a	a	DET
easat-3872	26	5	study	study	NOUN
easat-3872	26	6	in	in	ADP
easat-3872	26	7	india	india	PROPN
easat-3872	26	8	reported	report	VERB
easat-3872	26	9	stabilization	stabilization	NOUN
easat-3872	26	10	of	of	ADP
easat-3872	26	11	blood	blood	NOUN
easat-3872	26	12	glucose	glucose	NOUN
easat-3872	26	13	levels	level	NOUN
easat-3872	26	14	in	in	ADP
easat-3872	26	15	infants	infant	NOUN
easat-3872	26	16	treated	treat	VERB
easat-3872	26	17	with	with	ADP
easat-3872	26	18	nifedipine	nifedipine	NOUN
easat-3872	26	19	,	,	PUNCT
easat-3872	26	20	while	while	SCONJ
easat-3872	26	21	similar	similar	ADJ
easat-3872	26	22	results	result	NOUN
easat-3872	26	23	were	be	AUX
easat-3872	26	24	observed	observe	VERB
easat-3872	26	25	in	in	ADP
easat-3872	26	26	nigeria	nigeria	PROPN
easat-3872	26	27	with	with	ADP
easat-3872	26	28	a	a	DET
easat-3872	26	29	combination	combination	NOUN
easat-3872	26	30	of	of	ADP
easat-3872	26	31	octreotide	octreotide	NOUN
easat-3872	26	32	and	and	CCONJ
easat-3872	26	33	nifedipine	nifedipine	NOUN
easat-3872	27	1	[	[	X
easat-3872	27	2	3	3	NUM
easat-3872	27	3	]	]	PUNCT
easat-3872	27	4	.	.	PUNCT
easat-3872	28	1	https://orcid.org/0000-0002-7009-4896	https://orcid.org/0000-0002-7009-4896	PROPN
easat-3872	28	2	https://orcid.org/0000-0002-9626-9615	https://orcid.org/0000-0002-9626-9615	NOUN
easat-3872	28	3	https://orcid.org/0000-0002-1362-108x	https://orcid.org/0000-0002-1362-108x	PROPN
easat-3872	28	4	https://orcid.org/0000-0002-8699-4063	https://orcid.org/0000-0002-8699-4063	PROPN
easat-3872	28	5	8753	8753	NUM
easat-3872	28	6	edelweiss	edelweiss	PROPN
easat-3872	28	7	applied	apply	VERB
easat-3872	28	8	science	science	NOUN
easat-3872	28	9	and	and	CCONJ
easat-3872	28	10	technology	technology	NOUN
easat-3872	28	11	issn	issn	PROPN
easat-3872	28	12	:	:	PUNCT
easat-3872	28	13	2576	2576	NUM
easat-3872	28	14	-	-	SYM
easat-3872	28	15	8484	8484	NUM
easat-3872	28	16	vol	vol	NOUN
easat-3872	28	17	.	.	PROPN
easat-3872	28	18	8	8	NUM
easat-3872	28	19	,	,	PUNCT
easat-3872	28	20	no	no	INTJ
easat-3872	28	21	.	.	NOUN
easat-3872	28	22	6	6	NUM
easat-3872	28	23	:	:	PUNCT
easat-3872	28	24	8752	8752	NUM
easat-3872	28	25	-	-	SYM
easat-3872	28	26	8758	8758	NUM
easat-3872	28	27	,	,	PUNCT
easat-3872	28	28	2024	2024	NUM
easat-3872	28	29	doi	doi	NOUN
easat-3872	28	30	:	:	PUNCT
easat-3872	28	31	10.55214/25768484.v8i6.3872	10.55214/25768484.v8i6.3872	NUM
easat-3872	28	32	©	©	PROPN
easat-3872	28	33	2024	2024	NUM
easat-3872	28	34	by	by	ADP
easat-3872	28	35	the	the	DET
easat-3872	28	36	authors	author	NOUN
easat-3872	28	37	;	;	PUNCT
easat-3872	28	38	licensee	licensee	PROPN
easat-3872	28	39	learning	learning	NOUN
easat-3872	28	40	gate	gate	NOUN
easat-3872	28	41	despite	despite	SCONJ
easat-3872	28	42	their	their	PRON
easat-3872	28	43	promise	promise	NOUN
easat-3872	28	44	,	,	PUNCT
easat-3872	28	45	challenges	challenge	NOUN
easat-3872	28	46	remain	remain	VERB
easat-3872	28	47	.	.	PUNCT
easat-3872	29	1	the	the	DET
easat-3872	29	2	efficacy	efficacy	NOUN
easat-3872	29	3	of	of	ADP
easat-3872	29	4	nifedipine	nifedipine	NOUN
easat-3872	29	5	is	be	AUX
easat-3872	29	6	inconsistent	inconsistent	ADJ
easat-3872	29	7	,	,	PUNCT
easat-3872	29	8	with	with	ADP
easat-3872	29	9	some	some	DET
easat-3872	29	10	studies	study	NOUN
easat-3872	29	11	reporting	report	VERB
easat-3872	29	12	suboptimal	suboptimal	ADJ
easat-3872	29	13	outcomes	outcome	NOUN
easat-3872	29	14	,	,	PUNCT
easat-3872	29	15	particularly	particularly	ADV
easat-3872	29	16	in	in	ADP
easat-3872	29	17	cases	case	NOUN
easat-3872	29	18	with	with	ADP
easat-3872	29	19	severe	severe	ADJ
easat-3872	29	20	genetic	genetic	ADJ
easat-3872	29	21	mutations	mutation	NOUN
easat-3872	29	22	in	in	ADP
easat-3872	29	23	katp	katp	NOUN
easat-3872	29	24	channels	channel	NOUN
easat-3872	29	25	.	.	PUNCT
easat-3872	30	1	octreotide	octreotide	NOUN
easat-3872	30	2	,	,	PUNCT
easat-3872	30	3	although	although	SCONJ
easat-3872	30	4	effective	effective	ADJ
easat-3872	30	5	,	,	PUNCT
easat-3872	30	6	is	be	AUX
easat-3872	30	7	associated	associate	VERB
easat-3872	30	8	with	with	ADP
easat-3872	30	9	dose	dose	NOUN
easat-3872	30	10	-	-	PUNCT
easat-3872	30	11	dependent	dependent	ADJ
easat-3872	30	12	side	side	NOUN
easat-3872	30	13	effects	effect	NOUN
easat-3872	30	14	and	and	CCONJ
easat-3872	30	15	requires	require	VERB
easat-3872	30	16	careful	careful	ADJ
easat-3872	30	17	monitoring	monitoring	NOUN
easat-3872	30	18	.	.	PUNCT
easat-3872	31	1	the	the	DET
easat-3872	31	2	variability	variability	NOUN
easat-3872	31	3	in	in	ADP
easat-3872	31	4	responses	response	NOUN
easat-3872	31	5	to	to	ADP
easat-3872	31	6	these	these	DET
easat-3872	31	7	therapies	therapy	NOUN
easat-3872	31	8	highlights	highlight	NOUN
easat-3872	31	9	the	the	DET
easat-3872	31	10	need	need	NOUN
easat-3872	31	11	for	for	ADP
easat-3872	31	12	individualized	individualized	ADJ
easat-3872	31	13	treatment	treatment	NOUN
easat-3872	31	14	plans	plan	NOUN
easat-3872	31	15	tailored	tailor	VERB
easat-3872	31	16	to	to	ADP
easat-3872	31	17	the	the	DET
easat-3872	31	18	specific	specific	ADJ
easat-3872	31	19	needs	need	NOUN
easat-3872	31	20	and	and	CCONJ
easat-3872	31	21	contexts	context	NOUN
easat-3872	31	22	of	of	ADP
easat-3872	31	23	each	each	DET
easat-3872	31	24	patient	patient	NOUN
easat-3872	31	25	[	[	X
easat-3872	31	26	1	1	NUM
easat-3872	31	27	]	]	PUNCT
easat-3872	31	28	.	.	PUNCT
easat-3872	32	1	this	this	DET
easat-3872	32	2	case	case	NOUN
easat-3872	32	3	report	report	NOUN
easat-3872	32	4	illustrates	illustrate	VERB
easat-3872	32	5	the	the	DET
easat-3872	32	6	successful	successful	ADJ
easat-3872	32	7	management	management	NOUN
easat-3872	32	8	of	of	ADP
easat-3872	32	9	phhi	phhi	NOUN
easat-3872	32	10	in	in	ADP
easat-3872	32	11	a	a	DET
easat-3872	32	12	neonate	neonate	NOUN
easat-3872	32	13	using	use	VERB
easat-3872	32	14	octreotide	octreotide	NOUN
easat-3872	32	15	and	and	CCONJ
easat-3872	32	16	nifedipine	nifedipine	NOUN
easat-3872	32	17	as	as	ADP
easat-3872	32	18	alternative	alternative	ADJ
easat-3872	32	19	therapies	therapy	NOUN
easat-3872	32	20	due	due	ADP
easat-3872	32	21	to	to	ADP
easat-3872	32	22	the	the	DET
easat-3872	32	23	unavailability	unavailability	NOUN
easat-3872	32	24	of	of	ADP
easat-3872	32	25	diazoxide	diazoxide	NOUN
easat-3872	32	26	.	.	PUNCT
easat-3872	33	1	it	it	PRON
easat-3872	33	2	contributes	contribute	VERB
easat-3872	33	3	to	to	ADP
easat-3872	33	4	the	the	DET
easat-3872	33	5	growing	grow	VERB
easat-3872	33	6	body	body	NOUN
easat-3872	33	7	of	of	ADP
easat-3872	33	8	evidence	evidence	NOUN
easat-3872	33	9	supporting	support	VERB
easat-3872	33	10	the	the	DET
easat-3872	33	11	use	use	NOUN
easat-3872	33	12	of	of	ADP
easat-3872	33	13	these	these	DET
easat-3872	33	14	agents	agent	NOUN
easat-3872	33	15	and	and	CCONJ
easat-3872	33	16	emphasizes	emphasize	VERB
easat-3872	33	17	the	the	DET
easat-3872	33	18	importance	importance	NOUN
easat-3872	33	19	of	of	ADP
easat-3872	33	20	adaptable	adaptable	ADJ
easat-3872	33	21	,	,	PUNCT
easat-3872	33	22	evidence	evidence	NOUN
easat-3872	33	23	-	-	PUNCT
easat-3872	33	24	based	base	VERB
easat-3872	33	25	approaches	approach	NOUN
easat-3872	33	26	in	in	ADP
easat-3872	33	27	addressing	address	VERB
easat-3872	33	28	the	the	DET
easat-3872	33	29	unique	unique	ADJ
easat-3872	33	30	challenges	challenge	NOUN
easat-3872	33	31	of	of	ADP
easat-3872	33	32	phhi	phhi	NOUN
easat-3872	33	33	in	in	ADP
easat-3872	33	34	resource	resource	NOUN
easat-3872	33	35	-	-	PUNCT
easat-3872	33	36	limited	limit	VERB
easat-3872	33	37	settings	setting	NOUN
easat-3872	34	1	[	[	X
easat-3872	34	2	2,4	2,4	NUM
easat-3872	34	3	]	]	X
easat-3872	34	4	.	.	PUNCT
easat-3872	35	1	2	2	X
easat-3872	35	2	.	.	X
easat-3872	35	3	case	case	NOUN
easat-3872	35	4	presentation	presentation	NOUN
easat-3872	35	5	a	a	DET
easat-3872	35	6	48	48	NUM
easat-3872	35	7	-	-	PUNCT
easat-3872	35	8	hour	hour	NOUN
easat-3872	35	9	-	-	PUNCT
easat-3872	35	10	old	old	ADJ
easat-3872	35	11	baby	baby	NOUN
easat-3872	35	12	girl	girl	NOUN
easat-3872	35	13	presented	present	VERB
easat-3872	35	14	to	to	ADP
easat-3872	35	15	the	the	DET
easat-3872	35	16	emergency	emergency	NOUN
easat-3872	35	17	department	department	NOUN
easat-3872	35	18	with	with	ADP
easat-3872	35	19	weakness	weakness	NOUN
easat-3872	35	20	and	and	CCONJ
easat-3872	35	21	refusal	refusal	NOUN
easat-3872	35	22	to	to	PART
easat-3872	35	23	breastfeed	breastfeed	VERB
easat-3872	35	24	.	.	PUNCT
easat-3872	36	1	she	she	PRON
easat-3872	36	2	was	be	AUX
easat-3872	36	3	born	bear	VERB
easat-3872	36	4	at	at	ADP
easat-3872	36	5	39	39	NUM
easat-3872	36	6	weeks	week	NOUN
easat-3872	36	7	of	of	ADP
easat-3872	36	8	gestation	gestation	NOUN
easat-3872	36	9	to	to	ADP
easat-3872	36	10	a	a	DET
easat-3872	36	11	32	32	NUM
easat-3872	36	12	-	-	PUNCT
easat-3872	36	13	year	year	NOUN
easat-3872	36	14	-	-	PUNCT
easat-3872	36	15	old	old	ADJ
easat-3872	36	16	primigravida	primigravida	PROPN
easat-3872	36	17	mother	mother	NOUN
easat-3872	36	18	via	via	ADP
easat-3872	36	19	spontaneous	spontaneous	ADJ
easat-3872	36	20	vaginal	vaginal	ADJ
easat-3872	36	21	delivery	delivery	NOUN
easat-3872	36	22	,	,	PUNCT
easat-3872	36	23	with	with	ADP
easat-3872	36	24	no	no	DET
easat-3872	36	25	complications	complication	NOUN
easat-3872	36	26	during	during	ADP
easat-3872	36	27	pregnancy	pregnancy	NOUN
easat-3872	36	28	or	or	CCONJ
easat-3872	36	29	delivery	delivery	NOUN
easat-3872	36	30	.	.	PUNCT
easat-3872	37	1	her	her	PRON
easat-3872	37	2	birth	birth	NOUN
easat-3872	37	3	weight	weight	NOUN
easat-3872	37	4	was	be	AUX
easat-3872	37	5	2,800	2,800	NUM
easat-3872	37	6	grams	gram	NOUN
easat-3872	37	7	,	,	PUNCT
easat-3872	37	8	and	and	CCONJ
easat-3872	37	9	her	her	PRON
easat-3872	37	10	apgar	apgar	NOUN
easat-3872	37	11	scores	score	NOUN
easat-3872	37	12	were	be	AUX
easat-3872	37	13	8	8	NUM
easat-3872	37	14	and	and	CCONJ
easat-3872	37	15	9	9	NUM
easat-3872	37	16	at	at	ADP
easat-3872	37	17	1	1	NUM
easat-3872	37	18	and	and	CCONJ
easat-3872	37	19	5	5	NUM
easat-3872	37	20	minutes	minute	NOUN
easat-3872	37	21	,	,	PUNCT
easat-3872	37	22	respectively	respectively	ADV
easat-3872	37	23	.	.	PUNCT
easat-3872	38	1	the	the	DET
easat-3872	38	2	neonate	neonate	NOUN
easat-3872	38	3	was	be	AUX
easat-3872	38	4	discharged	discharge	VERB
easat-3872	38	5	in	in	ADP
easat-3872	38	6	stable	stable	ADJ
easat-3872	38	7	condition	condition	NOUN
easat-3872	38	8	24	24	NUM
easat-3872	38	9	hours	hour	NOUN
easat-3872	38	10	postpartum	postpartum	NOUN
easat-3872	38	11	,	,	PUNCT
easat-3872	38	12	but	but	CCONJ
easat-3872	38	13	the	the	DET
easat-3872	38	14	mother	mother	NOUN
easat-3872	38	15	noted	note	VERB
easat-3872	38	16	increasing	increase	VERB
easat-3872	38	17	lethargy	lethargy	NOUN
easat-3872	38	18	and	and	CCONJ
easat-3872	38	19	feeding	feed	VERB
easat-3872	38	20	difficulties	difficulty	NOUN
easat-3872	38	21	after	after	ADP
easat-3872	38	22	discharge	discharge	NOUN
easat-3872	38	23	.	.	PUNCT
easat-3872	39	1	upon	upon	SCONJ
easat-3872	39	2	admission	admission	NOUN
easat-3872	39	3	,	,	PUNCT
easat-3872	39	4	the	the	DET
easat-3872	39	5	baby	baby	NOUN
easat-3872	39	6	was	be	AUX
easat-3872	39	7	lethargic	lethargic	ADJ
easat-3872	39	8	but	but	CCONJ
easat-3872	39	9	responsive	responsive	ADJ
easat-3872	39	10	,	,	PUNCT
easat-3872	39	11	with	with	ADP
easat-3872	39	12	normal	normal	ADJ
easat-3872	39	13	vital	vital	ADJ
easat-3872	39	14	signs	sign	NOUN
easat-3872	39	15	except	except	SCONJ
easat-3872	39	16	for	for	ADP
easat-3872	39	17	hypoglycemia	hypoglycemia	NOUN
easat-3872	39	18	,	,	PUNCT
easat-3872	39	19	with	with	SCONJ
easat-3872	39	20	a	a	DET
easat-3872	39	21	blood	blood	NOUN
easat-3872	39	22	glucose	glucose	NOUN
easat-3872	39	23	(	(	PUNCT
easat-3872	39	24	bg	bg	NOUN
easat-3872	39	25	)	)	PUNCT
easat-3872	39	26	level	level	NOUN
easat-3872	39	27	of	of	ADP
easat-3872	39	28	30	30	NUM
easat-3872	39	29	mg	mg	PROPN
easat-3872	39	30	/	/	SYM
easat-3872	39	31	dl	dl	PROPN
easat-3872	39	32	.	.	PROPN
easat-3872	39	33	initial	initial	ADJ
easat-3872	39	34	physical	physical	ADJ
easat-3872	39	35	examination	examination	NOUN
easat-3872	39	36	showed	show	VERB
easat-3872	39	37	no	no	DET
easat-3872	39	38	dysmorphic	dysmorphic	ADJ
easat-3872	39	39	features	feature	NOUN
easat-3872	39	40	,	,	PUNCT
easat-3872	39	41	no	no	DET
easat-3872	39	42	signs	sign	NOUN
easat-3872	39	43	of	of	ADP
easat-3872	39	44	organomegaly	organomegaly	NOUN
easat-3872	39	45	,	,	PUNCT
easat-3872	39	46	and	and	CCONJ
easat-3872	39	47	normal	normal	ADJ
easat-3872	39	48	growth	growth	NOUN
easat-3872	39	49	parameters	parameter	NOUN
easat-3872	39	50	.	.	PUNCT
easat-3872	40	1	there	there	PRON
easat-3872	40	2	was	be	VERB
easat-3872	40	3	no	no	DET
easat-3872	40	4	family	family	NOUN
easat-3872	40	5	history	history	NOUN
easat-3872	40	6	of	of	ADP
easat-3872	40	7	diabetes	diabetes	NOUN
easat-3872	40	8	,	,	PUNCT
easat-3872	40	9	metabolic	metabolic	NOUN
easat-3872	40	10	disorders	disorder	NOUN
easat-3872	40	11	,	,	PUNCT
easat-3872	40	12	or	or	CCONJ
easat-3872	40	13	consanguinity	consanguinity	NOUN
easat-3872	40	14	.	.	PUNCT
easat-3872	41	1	laboratory	laboratory	NOUN
easat-3872	41	2	investigations	investigation	NOUN
easat-3872	41	3	revealed	reveal	VERB
easat-3872	41	4	a	a	DET
easat-3872	41	5	normal	normal	ADJ
easat-3872	41	6	complete	complete	ADJ
easat-3872	41	7	blood	blood	NOUN
easat-3872	41	8	count	count	NOUN
easat-3872	41	9	and	and	CCONJ
easat-3872	41	10	serum	serum	NOUN
easat-3872	41	11	electrolytes	electrolyte	NOUN
easat-3872	41	12	but	but	CCONJ
easat-3872	41	13	confirmed	confirm	VERB
easat-3872	41	14	profound	profound	ADJ
easat-3872	41	15	hypoglycemia	hypoglycemia	NOUN
easat-3872	41	16	.	.	PUNCT
easat-3872	42	1	initial	initial	ADJ
easat-3872	42	2	management	management	NOUN
easat-3872	42	3	included	include	VERB
easat-3872	42	4	intravenous	intravenous	ADJ
easat-3872	42	5	(	(	PUNCT
easat-3872	42	6	iv	iv	X
easat-3872	42	7	)	)	PUNCT
easat-3872	42	8	glucose	glucose	NOUN
easat-3872	42	9	infusion	infusion	NOUN
easat-3872	42	10	at	at	ADP
easat-3872	42	11	8	8	NUM
easat-3872	42	12	mg	mg	NUM
easat-3872	42	13	/	/	SYM
easat-3872	42	14	kg	kg	PROPN
easat-3872	42	15	/	/	SYM
easat-3872	42	16	min	min	NOUN
easat-3872	42	17	,	,	PUNCT
easat-3872	42	18	which	which	PRON
easat-3872	42	19	temporarily	temporarily	ADV
easat-3872	42	20	raised	raise	VERB
easat-3872	42	21	bg	bg	PROPN
easat-3872	42	22	levels	level	NOUN
easat-3872	42	23	to	to	ADP
easat-3872	42	24	55	55	NUM
easat-3872	42	25	mg	mg	PROPN
easat-3872	42	26	/	/	SYM
easat-3872	42	27	dl	dl	PROPN
easat-3872	42	28	.	.	PUNCT
easat-3872	42	29	however	however	ADV
easat-3872	42	30	,	,	PUNCT
easat-3872	42	31	hypoglycemia	hypoglycemia	NOUN
easat-3872	42	32	recurred	recur	VERB
easat-3872	42	33	within	within	ADP
easat-3872	42	34	hours	hour	NOUN
easat-3872	42	35	,	,	PUNCT
easat-3872	42	36	necessitating	necessitate	VERB
easat-3872	42	37	an	an	DET
easat-3872	42	38	increased	increase	VERB
easat-3872	42	39	glucose	glucose	NOUN
easat-3872	42	40	infusion	infusion	NOUN
easat-3872	42	41	rate	rate	NOUN
easat-3872	42	42	to	to	ADP
easat-3872	42	43	12	12	NUM
easat-3872	42	44	mg	mg	PROPN
easat-3872	42	45	/	/	SYM
easat-3872	42	46	kg	kg	PROPN
easat-3872	42	47	/	/	SYM
easat-3872	42	48	min	min	PROPN
easat-3872	42	49	,	,	PUNCT
easat-3872	42	50	then	then	ADV
easat-3872	42	51	20	20	NUM
easat-3872	42	52	mg	mg	NUM
easat-3872	42	53	/	/	SYM
easat-3872	42	54	kg	kg	PROPN
easat-3872	42	55	/	/	SYM
easat-3872	42	56	min	min	PROPN
easat-3872	42	57	.	.	PROPN
easat-3872	42	58	figure	figure	NOUN
easat-3872	42	59	1	1	NUM
easat-3872	42	60	illustrates	illustrate	VERB
easat-3872	42	61	the	the	DET
easat-3872	42	62	blood	blood	NOUN
easat-3872	42	63	glucose	glucose	NOUN
easat-3872	42	64	levels	level	NOUN
easat-3872	42	65	during	during	ADP
easat-3872	42	66	the	the	DET
easat-3872	42	67	initial	initial	ADJ
easat-3872	42	68	days	day	NOUN
easat-3872	42	69	of	of	ADP
easat-3872	42	70	hospitalization	hospitalization	NOUN
easat-3872	42	71	,	,	PUNCT
easat-3872	42	72	showing	show	VERB
easat-3872	42	73	severe	severe	ADJ
easat-3872	42	74	hypoglycemia	hypoglycemia	NOUN
easat-3872	42	75	despite	despite	SCONJ
easat-3872	42	76	high	high	ADJ
easat-3872	42	77	glucose	glucose	NOUN
easat-3872	42	78	infusion	infusion	NOUN
easat-3872	42	79	rates	rate	NOUN
easat-3872	42	80	before	before	ADP
easat-3872	42	81	initiating	initiate	VERB
easat-3872	42	82	octreotide	octreotide	NOUN
easat-3872	42	83	therapy	therapy	NOUN
easat-3872	42	84	.	.	PUNCT
easat-3872	43	1	figure	figure	NOUN
easat-3872	43	2	1	1	NUM
easat-3872	43	3	.	.	PUNCT
easat-3872	43	4	blood	blood	NOUN
easat-3872	43	5	glucose	glucose	NOUN
easat-3872	43	6	levels	level	NOUN
easat-3872	43	7	during	during	ADP
easat-3872	43	8	the	the	DET
easat-3872	43	9	initial	initial	ADJ
easat-3872	43	10	days	day	NOUN
easat-3872	43	11	of	of	ADP
easat-3872	43	12	hospitalization	hospitalization	NOUN
easat-3872	43	13	before	before	ADP
easat-3872	43	14	initiation	initiation	NOUN
easat-3872	43	15	of	of	ADP
easat-3872	43	16	octreotide	octreotide	NOUN
easat-3872	43	17	therapy	therapy	NOUN
easat-3872	43	18	.	.	PUNCT
easat-3872	44	1	further	further	ADJ
easat-3872	44	2	endocrinological	endocrinological	ADJ
easat-3872	44	3	evaluation	evaluation	NOUN
easat-3872	44	4	included	include	VERB
easat-3872	44	5	measurements	measurement	NOUN
easat-3872	44	6	of	of	ADP
easat-3872	44	7	serum	serum	NOUN
easat-3872	44	8	insulin	insulin	NOUN
easat-3872	44	9	,	,	PUNCT
easat-3872	44	10	c	c	NOUN
easat-3872	44	11	-	-	PUNCT
easat-3872	44	12	peptide	peptide	ADJ
easat-3872	44	13	,	,	PUNCT
easat-3872	44	14	growth	growth	NOUN
easat-3872	44	15	hormone	hormone	NOUN
easat-3872	44	16	(	(	PUNCT
easat-3872	44	17	gh	gh	PROPN
easat-3872	44	18	)	)	PUNCT
easat-3872	44	19	,	,	PUNCT
easat-3872	44	20	cortisol	cortisol	NOUN
easat-3872	44	21	,	,	PUNCT
easat-3872	44	22	and	and	CCONJ
easat-3872	44	23	acth	acth	NOUN
easat-3872	44	24	during	during	ADP
easat-3872	44	25	hypoglycemia	hypoglycemia	NOUN
easat-3872	44	26	episodes	episode	NOUN
easat-3872	44	27	.	.	PUNCT
easat-3872	45	1	the	the	DET
easat-3872	45	2	results	result	NOUN
easat-3872	45	3	showed	show	VERB
easat-3872	45	4	elevated	elevated	ADJ
easat-3872	45	5	insulin	insulin	NOUN
easat-3872	45	6	(	(	PUNCT
easat-3872	45	7	5.9	5.9	NUM
easat-3872	45	8	µu	µu	NUM
easat-3872	45	9	/	/	SYM
easat-3872	45	10	ml	ml	NOUN
easat-3872	45	11	)	)	PUNCT
easat-3872	45	12	,	,	PUNCT
easat-3872	45	13	detectable	detectable	ADJ
easat-3872	45	14	c	c	NOUN
easat-3872	45	15	-	-	PUNCT
easat-3872	45	16	peptide	peptide	NOUN
easat-3872	45	17	(	(	PUNCT
easat-3872	45	18	4.4	4.4	NUM
easat-3872	45	19	ng	ng	PROPN
easat-3872	45	20	/	/	SYM
easat-3872	45	21	ml	ml	PROPN
easat-3872	45	22	)	)	PUNCT
easat-3872	45	23	,	,	PUNCT
easat-3872	45	24	and	and	CCONJ
easat-3872	45	25	normal	normal	ADJ
easat-3872	45	26	gh	gh	PROPN
easat-3872	45	27	and	and	CCONJ
easat-3872	45	28	cortisol	cortisol	ADJ
easat-3872	45	29	levels	level	NOUN
easat-3872	45	30	,	,	PUNCT
easat-3872	45	31	consistent	consistent	ADJ
easat-3872	45	32	with	with	ADP
easat-3872	45	33	persistent	persistent	ADJ
easat-3872	45	34	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	45	35	hypoglycemia	hypoglycemia	NOUN
easat-3872	45	36	.	.	PUNCT
easat-3872	46	1	imaging	imaging	NOUN
easat-3872	46	2	studies	study	NOUN
easat-3872	46	3	,	,	PUNCT
easat-3872	46	4	including	include	VERB
easat-3872	46	5	abdominal	abdominal	ADJ
easat-3872	46	6	ultrasound	ultrasound	NOUN
easat-3872	46	7	,	,	PUNCT
easat-3872	46	8	showed	show	VERB
easat-3872	46	9	no	no	DET
easat-3872	46	10	evidence	evidence	NOUN
easat-3872	46	11	of	of	ADP
easat-3872	46	12	pancreatic	pancreatic	ADJ
easat-3872	46	13	lesions	lesion	NOUN
easat-3872	46	14	,	,	PUNCT
easat-3872	46	15	ruling	rule	VERB
easat-3872	46	16	out	out	ADP
easat-3872	46	17	focal	focal	ADJ
easat-3872	46	18	hyperinsulinism	hyperinsulinism	NOUN
easat-3872	46	19	.	.	PUNCT
easat-3872	47	1	genetic	genetic	ADJ
easat-3872	47	2	testing	testing	NOUN
easat-3872	47	3	to	to	PART
easat-3872	47	4	identify	identify	VERB
easat-3872	47	5	mutations	mutation	NOUN
easat-3872	47	6	commonly	commonly	ADV
easat-3872	47	7	associated	associate	VERB
easat-3872	47	8	with	with	ADP
easat-3872	47	9	phhi	phhi	NOUN
easat-3872	47	10	could	could	AUX
easat-3872	47	11	not	not	PART
easat-3872	47	12	be	be	AUX
easat-3872	47	13	performed	perform	VERB
easat-3872	47	14	due	due	ADP
easat-3872	47	15	to	to	ADP
easat-3872	47	16	resource	resource	NOUN
easat-3872	47	17	limitations	limitation	NOUN
easat-3872	47	18	.	.	PUNCT
easat-3872	48	1	based	base	VERB
easat-3872	48	2	on	on	ADP
easat-3872	48	3	the	the	DET
easat-3872	48	4	diagnostic	diagnostic	ADJ
easat-3872	48	5	criteria	criterion	NOUN
easat-3872	48	6	from	from	ADP
easat-3872	48	7	the	the	DET
easat-3872	48	8	2023	2023	NUM
easat-3872	48	9	international	international	ADJ
easat-3872	48	10	guidelines	guideline	NOUN
easat-3872	48	11	for	for	ADP
easat-3872	48	12	the	the	DET
easat-3872	48	13	diagnosis	diagnosis	NOUN
easat-3872	48	14	and	and	CCONJ
easat-3872	48	15	management	management	NOUN
easat-3872	48	16	of	of	ADP
easat-3872	48	17	hyperinsulinism	hyperinsulinism	NOUN
easat-3872	48	18	,	,	PUNCT
easat-3872	48	19	the	the	DET
easat-3872	48	20	patient	patient	NOUN
easat-3872	48	21	was	be	AUX
easat-3872	48	22	diagnosed	diagnose	VERB
easat-3872	48	23	with	with	ADP
easat-3872	48	24	persistent	persistent	ADJ
easat-3872	48	25	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	48	26	hypoglycemia	hypoglycemia	NOUN
easat-3872	48	27	in	in	ADP
easat-3872	48	28	infancy	infancy	NOUN
easat-3872	48	29	(	(	PUNCT
easat-3872	48	30	phhi	phhi	NOUN
easat-3872	48	31	)	)	PUNCT
easat-3872	48	32	,	,	PUNCT
easat-3872	48	33	likely	likely	ADV
easat-3872	48	34	of	of	ADP
easat-3872	48	35	diffuse	diffuse	PROPN
easat-3872	48	36	etiology	etiology	NOUN
easat-3872	48	37	.	.	PUNCT
easat-3872	49	1	diazoxide	diazoxide	PROPN
easat-3872	49	2	,	,	PUNCT
easat-3872	49	3	the	the	DET
easat-3872	49	4	first	first	ADJ
easat-3872	49	5	-	-	PUNCT
easat-3872	49	6	line	line	NOUN
easat-3872	49	7	therapy	therapy	NOUN
easat-3872	49	8	,	,	PUNCT
easat-3872	49	9	was	be	AUX
easat-3872	49	10	8754	8754	NUM
easat-3872	49	11	edelweiss	edelweiss	PROPN
easat-3872	49	12	applied	apply	VERB
easat-3872	49	13	science	science	NOUN
easat-3872	49	14	and	and	CCONJ
easat-3872	49	15	technology	technology	NOUN
easat-3872	49	16	issn	issn	PROPN
easat-3872	49	17	:	:	PUNCT
easat-3872	49	18	2576	2576	NUM
easat-3872	49	19	-	-	SYM
easat-3872	49	20	8484	8484	NUM
easat-3872	49	21	vol	vol	NOUN
easat-3872	49	22	.	.	PROPN
easat-3872	49	23	8	8	NUM
easat-3872	49	24	,	,	PUNCT
easat-3872	49	25	no	no	INTJ
easat-3872	49	26	.	.	NOUN
easat-3872	50	1	6	6	NUM
easat-3872	50	2	:	:	PUNCT
easat-3872	50	3	8752	8752	NUM
easat-3872	50	4	-	-	SYM
easat-3872	50	5	8758	8758	NUM
easat-3872	50	6	,	,	PUNCT
easat-3872	50	7	2024	2024	NUM
easat-3872	50	8	doi	doi	NOUN
easat-3872	50	9	:	:	PUNCT
easat-3872	50	10	10.55214/25768484.v8i6.3872	10.55214/25768484.v8i6.3872	NUM
easat-3872	50	11	©	©	PROPN
easat-3872	50	12	2024	2024	NUM
easat-3872	50	13	by	by	ADP
easat-3872	50	14	the	the	DET
easat-3872	50	15	authors	author	NOUN
easat-3872	50	16	;	;	PUNCT
easat-3872	50	17	licensee	licensee	PROPN
easat-3872	50	18	learning	learn	VERB
easat-3872	50	19	gate	gate	NOUN
easat-3872	50	20	unavailable	unavailable	ADJ
easat-3872	50	21	,	,	PUNCT
easat-3872	50	22	prompting	prompt	VERB
easat-3872	50	23	the	the	DET
easat-3872	50	24	initiation	initiation	NOUN
easat-3872	50	25	of	of	ADP
easat-3872	50	26	subcutaneous	subcutaneous	ADJ
easat-3872	50	27	octreotide	octreotide	NOUN
easat-3872	50	28	injections	injection	NOUN
easat-3872	50	29	at	at	ADP
easat-3872	50	30	5	5	NUM
easat-3872	50	31	µg	µg	ADV
easat-3872	50	32	/	/	SYM
easat-3872	50	33	kg	kg	NOUN
easat-3872	50	34	/	/	SYM
easat-3872	50	35	day	day	NOUN
easat-3872	50	36	.	.	PUNCT
easat-3872	51	1	despite	despite	SCONJ
easat-3872	51	2	initial	initial	ADJ
easat-3872	51	3	improvements	improvement	NOUN
easat-3872	51	4	,	,	PUNCT
easat-3872	51	5	bg	bg	PROPN
easat-3872	51	6	levels	level	NOUN
easat-3872	51	7	fluctuated	fluctuate	VERB
easat-3872	51	8	,	,	PUNCT
easat-3872	51	9	necessitating	necessitate	VERB
easat-3872	51	10	dose	dose	NOUN
easat-3872	51	11	adjustments	adjustment	NOUN
easat-3872	51	12	up	up	ADP
easat-3872	51	13	to	to	PART
easat-3872	51	14	10	10	NUM
easat-3872	51	15	µg	µg	NOUN
easat-3872	51	16	/	/	SYM
easat-3872	51	17	kg	kg	NOUN
easat-3872	51	18	/	/	SYM
easat-3872	51	19	day	day	NOUN
easat-3872	51	20	.	.	PUNCT
easat-3872	52	1	however	however	ADV
easat-3872	52	2	,	,	PUNCT
easat-3872	52	3	hypoglycemia	hypoglycemia	NOUN
easat-3872	52	4	episodes	episode	NOUN
easat-3872	52	5	persisted	persist	VERB
easat-3872	52	6	.	.	PUNCT
easat-3872	53	1	figure	figure	NOUN
easat-3872	53	2	2	2	NUM
easat-3872	53	3	demonstrates	demonstrate	VERB
easat-3872	53	4	the	the	DET
easat-3872	53	5	blood	blood	NOUN
easat-3872	53	6	glucose	glucose	NOUN
easat-3872	53	7	levels	level	NOUN
easat-3872	53	8	after	after	ADP
easat-3872	53	9	the	the	DET
easat-3872	53	10	initiation	initiation	NOUN
easat-3872	53	11	of	of	ADP
easat-3872	53	12	octreotide	octreotide	NOUN
easat-3872	53	13	therapy	therapy	NOUN
easat-3872	53	14	,	,	PUNCT
easat-3872	53	15	indicating	indicate	VERB
easat-3872	53	16	partial	partial	ADJ
easat-3872	53	17	stabilization	stabilization	NOUN
easat-3872	53	18	but	but	CCONJ
easat-3872	53	19	with	with	ADP
easat-3872	53	20	persistent	persistent	ADJ
easat-3872	53	21	fluctuations	fluctuation	NOUN
easat-3872	53	22	.	.	PUNCT
easat-3872	54	1	figure	figure	VERB
easat-3872	54	2	2	2	NUM
easat-3872	54	3	.	.	PUNCT
easat-3872	54	4	blood	blood	NOUN
easat-3872	54	5	glucose	glucose	NOUN
easat-3872	54	6	levels	level	NOUN
easat-3872	54	7	after	after	ADP
easat-3872	54	8	the	the	DET
easat-3872	54	9	initiation	initiation	NOUN
easat-3872	54	10	of	of	ADP
easat-3872	54	11	octreotide	octreotide	NOUN
easat-3872	54	12	therapy	therapy	NOUN
easat-3872	54	13	,	,	PUNCT
easat-3872	54	14	showing	show	VERB
easat-3872	54	15	partial	partial	ADJ
easat-3872	54	16	stabilization	stabilization	NOUN
easat-3872	54	17	with	with	ADP
easat-3872	54	18	persistent	persistent	ADJ
easat-3872	54	19	fluctuations	fluctuation	NOUN
easat-3872	54	20	.	.	PUNCT
easat-3872	55	1	given	give	VERB
easat-3872	55	2	the	the	DET
easat-3872	55	3	suboptimal	suboptimal	ADJ
easat-3872	55	4	response	response	NOUN
easat-3872	55	5	to	to	ADP
easat-3872	55	6	octreotide	octreotide	NOUN
easat-3872	55	7	alone	alone	ADV
easat-3872	55	8	,	,	PUNCT
easat-3872	55	9	oral	oral	ADJ
easat-3872	55	10	nifedipine	nifedipine	NOUN
easat-3872	55	11	was	be	AUX
easat-3872	55	12	introduced	introduce	VERB
easat-3872	55	13	at	at	ADP
easat-3872	55	14	1	1	NUM
easat-3872	55	15	mg	mg	PROPN
easat-3872	55	16	/	/	SYM
easat-3872	55	17	kg	kg	NOUN
easat-3872	55	18	/	/	SYM
easat-3872	55	19	day	day	NOUN
easat-3872	55	20	in	in	ADP
easat-3872	55	21	divided	divided	ADJ
easat-3872	55	22	doses	dose	NOUN
easat-3872	55	23	.	.	PUNCT
easat-3872	56	1	within	within	ADP
easat-3872	56	2	48	48	NUM
easat-3872	56	3	hours	hour	NOUN
easat-3872	56	4	,	,	PUNCT
easat-3872	56	5	bg	bg	PROPN
easat-3872	56	6	levels	level	NOUN
easat-3872	56	7	stabilized	stabilize	VERB
easat-3872	56	8	between	between	ADP
easat-3872	56	9	66–90	66–90	NUM
easat-3872	56	10	mg	mg	PROPN
easat-3872	56	11	/	/	SYM
easat-3872	56	12	dl	dl	PROPN
easat-3872	56	13	.	.	PUNCT
easat-3872	57	1	the	the	DET
easat-3872	57	2	combination	combination	NOUN
easat-3872	57	3	therapy	therapy	NOUN
easat-3872	57	4	allowed	allow	VERB
easat-3872	57	5	for	for	ADP
easat-3872	57	6	gradual	gradual	ADJ
easat-3872	57	7	tapering	tapering	NOUN
easat-3872	57	8	of	of	ADP
easat-3872	57	9	glucose	glucose	NOUN
easat-3872	57	10	infusion	infusion	NOUN
easat-3872	57	11	,	,	PUNCT
easat-3872	57	12	eventually	eventually	ADV
easat-3872	57	13	discontinuing	discontinue	VERB
easat-3872	57	14	iv	iv	NUM
easat-3872	57	15	glucose	glucose	NOUN
easat-3872	57	16	by	by	ADP
easat-3872	57	17	day	day	NOUN
easat-3872	57	18	10	10	NUM
easat-3872	57	19	.	.	PUNCT
easat-3872	58	1	the	the	DET
easat-3872	58	2	patient	patient	NOUN
easat-3872	58	3	tolerated	tolerate	VERB
easat-3872	58	4	nifedipine	nifedipine	NOUN
easat-3872	58	5	well	well	ADV
easat-3872	58	6	,	,	PUNCT
easat-3872	58	7	with	with	ADP
easat-3872	58	8	no	no	DET
easat-3872	58	9	adverse	adverse	ADJ
easat-3872	58	10	effects	effect	NOUN
easat-3872	58	11	noted	note	VERB
easat-3872	58	12	on	on	ADP
easat-3872	58	13	cardiovascular	cardiovascular	ADJ
easat-3872	58	14	monitoring	monitoring	NOUN
easat-3872	58	15	.	.	PUNCT
easat-3872	59	1	figure	figure	NOUN
easat-3872	59	2	3	3	NUM
easat-3872	59	3	shows	show	VERB
easat-3872	59	4	the	the	DET
easat-3872	59	5	blood	blood	NOUN
easat-3872	59	6	glucose	glucose	NOUN
easat-3872	59	7	levels	level	NOUN
easat-3872	59	8	after	after	ADP
easat-3872	59	9	combined	combined	ADJ
easat-3872	59	10	treatment	treatment	NOUN
easat-3872	59	11	with	with	ADP
easat-3872	59	12	octreotide	octreotide	NOUN
easat-3872	59	13	and	and	CCONJ
easat-3872	59	14	nifedipine	nifedipine	NOUN
easat-3872	59	15	,	,	PUNCT
easat-3872	59	16	reflecting	reflect	VERB
easat-3872	59	17	stable	stable	ADJ
easat-3872	59	18	glycemic	glycemic	ADJ
easat-3872	59	19	control	control	NOUN
easat-3872	59	20	achieved	achieve	VERB
easat-3872	59	21	with	with	ADP
easat-3872	59	22	the	the	DET
easat-3872	59	23	dual	dual	ADJ
easat-3872	59	24	therapy	therapy	NOUN
easat-3872	59	25	.	.	PUNCT
easat-3872	60	1	figure	figure	VERB
easat-3872	60	2	3	3	NUM
easat-3872	60	3	.	.	PUNCT
easat-3872	60	4	blood	blood	NOUN
easat-3872	60	5	glucose	glucose	NOUN
easat-3872	60	6	levels	level	NOUN
easat-3872	60	7	after	after	ADP
easat-3872	60	8	combined	combined	ADJ
easat-3872	60	9	treatment	treatment	NOUN
easat-3872	60	10	with	with	ADP
easat-3872	60	11	octreotide	octreotide	NOUN
easat-3872	60	12	and	and	CCONJ
easat-3872	60	13	nifedipine	nifedipine	NOUN
easat-3872	60	14	,	,	PUNCT
easat-3872	60	15	showing	show	VERB
easat-3872	60	16	stable	stable	ADJ
easat-3872	60	17	glycemic	glycemic	ADJ
easat-3872	60	18	control	control	NOUN
easat-3872	60	19	.	.	PUNCT
easat-3872	61	1	during	during	ADP
easat-3872	61	2	the	the	DET
easat-3872	61	3	hospitalization	hospitalization	NOUN
easat-3872	61	4	,	,	PUNCT
easat-3872	61	5	the	the	DET
easat-3872	61	6	baby	baby	NOUN
easat-3872	61	7	developed	develop	VERB
easat-3872	61	8	hospital	hospital	NOUN
easat-3872	61	9	-	-	PUNCT
easat-3872	61	10	acquired	acquire	VERB
easat-3872	61	11	pneumonia	pneumonia	NOUN
easat-3872	61	12	(	(	PUNCT
easat-3872	61	13	hap	hap	NOUN
easat-3872	61	14	)	)	PUNCT
easat-3872	61	15	on	on	ADP
easat-3872	61	16	day	day	NOUN
easat-3872	61	17	6	6	NUM
easat-3872	61	18	,	,	PUNCT
easat-3872	61	19	presenting	present	VERB
easat-3872	61	20	with	with	ADP
easat-3872	61	21	fever	fever	NOUN
easat-3872	61	22	,	,	PUNCT
easat-3872	61	23	respiratory	respiratory	ADJ
easat-3872	61	24	distress	distress	NOUN
easat-3872	61	25	,	,	PUNCT
easat-3872	61	26	and	and	CCONJ
easat-3872	61	27	leukocytosis	leukocytosis	NOUN
easat-3872	61	28	.	.	PUNCT
easat-3872	62	1	chest	chest	PROPN
easat-3872	62	2	radiography	radiography	NOUN
easat-3872	62	3	confirmed	confirm	VERB
easat-3872	62	4	bilateral	bilateral	ADJ
easat-3872	62	5	infiltrates	infiltrate	NOUN
easat-3872	62	6	shown	show	VERB
easat-3872	62	7	in	in	ADP
easat-3872	62	8	figure	figure	NOUN
easat-3872	62	9	4	4	NUM
easat-3872	62	10	.	.	PUNCT
easat-3872	63	1	she	she	PRON
easat-3872	63	2	was	be	AUX
easat-3872	63	3	treated	treat	VERB
easat-3872	63	4	with	with	ADP
easat-3872	63	5	levofloxacin	levofloxacin	NOUN
easat-3872	63	6	for	for	ADP
easat-3872	63	7	5	5	NUM
easat-3872	63	8	days	day	NOUN
easat-3872	63	9	,	,	PUNCT
easat-3872	63	10	with	with	ADP
easat-3872	63	11	complete	complete	ADJ
easat-3872	63	12	resolution	resolution	NOUN
easat-3872	63	13	of	of	ADP
easat-3872	63	14	symptoms	symptom	NOUN
easat-3872	63	15	.	.	PUNCT
easat-3872	64	1	subsequent	subsequent	ADJ
easat-3872	64	2	cultures	culture	NOUN
easat-3872	64	3	were	be	AUX
easat-3872	64	4	negative	negative	ADJ
easat-3872	64	5	,	,	PUNCT
easat-3872	64	6	and	and	CCONJ
easat-3872	64	7	inflammatory	inflammatory	ADJ
easat-3872	64	8	markers	marker	NOUN
easat-3872	64	9	normalized	normalize	VERB
easat-3872	64	10	.	.	PUNCT
easat-3872	65	1	8755	8755	NUM
easat-3872	65	2	edelweiss	edelweiss	PROPN
easat-3872	65	3	applied	apply	VERB
easat-3872	65	4	science	science	NOUN
easat-3872	65	5	and	and	CCONJ
easat-3872	65	6	technology	technology	NOUN
easat-3872	65	7	issn	issn	PROPN
easat-3872	65	8	:	:	PUNCT
easat-3872	65	9	2576	2576	NUM
easat-3872	65	10	-	-	SYM
easat-3872	65	11	8484	8484	NUM
easat-3872	65	12	vol	vol	NOUN
easat-3872	65	13	.	.	PROPN
easat-3872	65	14	8	8	NUM
easat-3872	65	15	,	,	PUNCT
easat-3872	65	16	no	no	INTJ
easat-3872	65	17	.	.	NOUN
easat-3872	65	18	6	6	NUM
easat-3872	65	19	:	:	PUNCT
easat-3872	65	20	8752	8752	NUM
easat-3872	65	21	-	-	SYM
easat-3872	65	22	8758	8758	NUM
easat-3872	65	23	,	,	PUNCT
easat-3872	65	24	2024	2024	NUM
easat-3872	65	25	doi	doi	NOUN
easat-3872	65	26	:	:	PUNCT
easat-3872	65	27	10.55214/25768484.v8i6.3872	10.55214/25768484.v8i6.3872	NUM
easat-3872	65	28	©	©	PROPN
easat-3872	65	29	2024	2024	NUM
easat-3872	65	30	by	by	ADP
easat-3872	65	31	the	the	DET
easat-3872	65	32	authors	author	NOUN
easat-3872	65	33	;	;	PUNCT
easat-3872	65	34	licensee	licensee	PROPN
easat-3872	65	35	learning	learn	VERB
easat-3872	65	36	gate	gate	NOUN
easat-3872	65	37	figure	figure	NOUN
easat-3872	65	38	4	4	NUM
easat-3872	65	39	.	.	PUNCT
easat-3872	65	40	chest	chest	NOUN
easat-3872	65	41	x	x	NOUN
easat-3872	65	42	-	-	NOUN
easat-3872	65	43	ray	ray	NOUN
easat-3872	65	44	of	of	ADP
easat-3872	65	45	the	the	DET
easat-3872	65	46	neonate	neonate	NOUN
easat-3872	65	47	demonstrating	demonstrate	VERB
easat-3872	65	48	bilateral	bilateral	ADJ
easat-3872	65	49	infiltrates	infiltrate	NOUN
easat-3872	65	50	consistent	consistent	ADJ
easat-3872	65	51	with	with	ADP
easat-3872	65	52	pneumonia	pneumonia	NOUN
easat-3872	65	53	.	.	PUNCT
easat-3872	66	1	by	by	ADP
easat-3872	66	2	day	day	NOUN
easat-3872	66	3	14	14	NUM
easat-3872	66	4	,	,	PUNCT
easat-3872	66	5	the	the	DET
easat-3872	66	6	patient	patient	NOUN
easat-3872	66	7	showed	show	VERB
easat-3872	66	8	no	no	DET
easat-3872	66	9	signs	sign	NOUN
easat-3872	66	10	of	of	ADP
easat-3872	66	11	hypoglycemia	hypoglycemia	NOUN
easat-3872	66	12	,	,	PUNCT
easat-3872	66	13	respiratory	respiratory	ADJ
easat-3872	66	14	distress	distress	NOUN
easat-3872	66	15	,	,	PUNCT
easat-3872	66	16	or	or	CCONJ
easat-3872	66	17	other	other	ADJ
easat-3872	66	18	complications	complication	NOUN
easat-3872	66	19	.	.	PUNCT
easat-3872	67	1	she	she	PRON
easat-3872	67	2	was	be	AUX
easat-3872	67	3	discharged	discharge	VERB
easat-3872	67	4	on	on	ADP
easat-3872	67	5	oral	oral	ADJ
easat-3872	67	6	nifedipine	nifedipine	NOUN
easat-3872	67	7	with	with	ADP
easat-3872	67	8	a	a	DET
easat-3872	67	9	scheduled	schedule	VERB
easat-3872	67	10	follow	follow	NOUN
easat-3872	67	11	-	-	PUNCT
easat-3872	67	12	up	up	NOUN
easat-3872	67	13	in	in	ADP
easat-3872	67	14	the	the	DET
easat-3872	67	15	pediatric	pediatric	ADJ
easat-3872	67	16	endocrinology	endocrinology	NOUN
easat-3872	67	17	clinic	clinic	NOUN
easat-3872	67	18	.	.	PUNCT
easat-3872	68	1	parents	parent	NOUN
easat-3872	68	2	were	be	AUX
easat-3872	68	3	educated	educate	VERB
easat-3872	68	4	on	on	ADP
easat-3872	68	5	recognizing	recognize	VERB
easat-3872	68	6	hypoglycemia	hypoglycemia	NOUN
easat-3872	68	7	symptoms	symptom	NOUN
easat-3872	68	8	and	and	CCONJ
easat-3872	68	9	instructed	instruct	VERB
easat-3872	68	10	on	on	ADP
easat-3872	68	11	home	home	NOUN
easat-3872	68	12	bg	bg	PROPN
easat-3872	68	13	monitoring	monitoring	NOUN
easat-3872	68	14	.	.	PUNCT
easat-3872	69	1	discussion	discussion	NOUN
easat-3872	69	2	persistent	persistent	ADJ
easat-3872	69	3	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	69	4	hypoglycemia	hypoglycemia	NOUN
easat-3872	69	5	in	in	ADP
easat-3872	69	6	infancy	infancy	NOUN
easat-3872	69	7	(	(	PUNCT
easat-3872	69	8	phhi	phhi	NOUN
easat-3872	69	9	)	)	PUNCT
easat-3872	69	10	represents	represent	VERB
easat-3872	69	11	a	a	DET
easat-3872	69	12	significant	significant	ADJ
easat-3872	69	13	challenge	challenge	NOUN
easat-3872	69	14	in	in	ADP
easat-3872	69	15	neonatal	neonatal	ADJ
easat-3872	69	16	metabolic	metabolic	NOUN
easat-3872	69	17	management	management	NOUN
easat-3872	69	18	due	due	ADP
easat-3872	69	19	to	to	ADP
easat-3872	69	20	its	its	PRON
easat-3872	69	21	rarity	rarity	NOUN
easat-3872	69	22	and	and	CCONJ
easat-3872	69	23	potential	potential	NOUN
easat-3872	69	24	for	for	ADP
easat-3872	69	25	severe	severe	ADJ
easat-3872	69	26	neurological	neurological	ADJ
easat-3872	69	27	complications	complication	NOUN
easat-3872	69	28	[	[	X
easat-3872	69	29	5	5	NUM
easat-3872	69	30	]	]	PUNCT
easat-3872	69	31	.	.	PUNCT
easat-3872	70	1	this	this	DET
easat-3872	70	2	case	case	NOUN
easat-3872	70	3	highlights	highlight	VERB
easat-3872	70	4	the	the	DET
easat-3872	70	5	complexity	complexity	NOUN
easat-3872	70	6	of	of	ADP
easat-3872	70	7	diagnosing	diagnosing	NOUN
easat-3872	70	8	and	and	CCONJ
easat-3872	70	9	managing	managing	NOUN
easat-3872	70	10	phhi	phhi	NOUN
easat-3872	70	11	,	,	PUNCT
easat-3872	70	12	emphasizing	emphasize	VERB
easat-3872	70	13	the	the	DET
easat-3872	70	14	need	need	NOUN
easat-3872	70	15	for	for	ADP
easat-3872	70	16	prompt	prompt	ADJ
easat-3872	70	17	,	,	PUNCT
easat-3872	70	18	flexible	flexible	ADJ
easat-3872	70	19	,	,	PUNCT
easat-3872	70	20	and	and	CCONJ
easat-3872	70	21	evidence	evidence	NOUN
easat-3872	70	22	-	-	PUNCT
easat-3872	70	23	based	base	VERB
easat-3872	70	24	approaches	approach	NOUN
easat-3872	70	25	to	to	PART
easat-3872	70	26	avoid	avoid	VERB
easat-3872	70	27	long	long	ADJ
easat-3872	70	28	-	-	PUNCT
easat-3872	70	29	term	term	NOUN
easat-3872	70	30	sequelae	sequelae	NOUN
easat-3872	70	31	[	[	X
easat-3872	70	32	2	2	NUM
easat-3872	70	33	]	]	PUNCT
easat-3872	70	34	.	.	PUNCT
easat-3872	71	1	the	the	DET
easat-3872	71	2	clinical	clinical	ADJ
easat-3872	71	3	presentation	presentation	NOUN
easat-3872	71	4	of	of	ADP
easat-3872	71	5	this	this	DET
easat-3872	71	6	neonate	neonate	NOUN
easat-3872	71	7	,	,	PUNCT
easat-3872	71	8	including	include	VERB
easat-3872	71	9	lethargy	lethargy	NOUN
easat-3872	71	10	,	,	PUNCT
easat-3872	71	11	poor	poor	ADJ
easat-3872	71	12	feeding	feeding	NOUN
easat-3872	71	13	,	,	PUNCT
easat-3872	71	14	and	and	CCONJ
easat-3872	71	15	seizures	seizure	NOUN
easat-3872	71	16	within	within	ADP
easat-3872	71	17	48	48	NUM
easat-3872	71	18	hours	hour	NOUN
easat-3872	71	19	of	of	ADP
easat-3872	71	20	birth	birth	NOUN
easat-3872	71	21	,	,	PUNCT
easat-3872	71	22	aligns	align	VERB
easat-3872	71	23	with	with	ADP
easat-3872	71	24	established	establish	VERB
easat-3872	71	25	descriptions	description	NOUN
easat-3872	71	26	of	of	ADP
easat-3872	71	27	phhi	phhi	NOUN
easat-3872	71	28	.	.	PUNCT
easat-3872	72	1	early	early	ADJ
easat-3872	72	2	neonatal	neonatal	ADJ
easat-3872	72	3	hypoglycemia	hypoglycemia	NOUN
easat-3872	72	4	often	often	ADV
easat-3872	72	5	presents	present	VERB
easat-3872	72	6	with	with	ADP
easat-3872	72	7	nonspecific	nonspecific	ADJ
easat-3872	72	8	symptoms	symptom	NOUN
easat-3872	72	9	,	,	PUNCT
easat-3872	72	10	potentially	potentially	ADV
easat-3872	72	11	delaying	delay	VERB
easat-3872	72	12	diagnosis	diagnosis	NOUN
easat-3872	72	13	without	without	ADP
easat-3872	72	14	vigilant	vigilant	ADJ
easat-3872	72	15	monitoring	monitoring	NOUN
easat-3872	72	16	.	.	PUNCT
easat-3872	73	1	according	accord	VERB
easat-3872	73	2	to	to	ADP
easat-3872	73	3	recent	recent	ADJ
easat-3872	73	4	guidelines	guideline	NOUN
easat-3872	73	5	,	,	PUNCT
easat-3872	73	6	phhi	phhi	NOUN
easat-3872	73	7	should	should	AUX
easat-3872	73	8	be	be	AUX
easat-3872	73	9	suspected	suspect	VERB
easat-3872	73	10	when	when	SCONJ
easat-3872	73	11	hypoglycemia	hypoglycemia	NOUN
easat-3872	73	12	persists	persist	VERB
easat-3872	73	13	despite	despite	SCONJ
easat-3872	73	14	glucose	glucose	NOUN
easat-3872	73	15	infusion	infusion	NOUN
easat-3872	73	16	rates	rate	NOUN
easat-3872	73	17	exceeding	exceed	VERB
easat-3872	73	18	8	8	NUM
easat-3872	73	19	mg	mg	NUM
easat-3872	73	20	/	/	SYM
easat-3872	73	21	kg	kg	PROPN
easat-3872	73	22	/	/	SYM
easat-3872	73	23	min	min	NOUN
easat-3872	73	24	,	,	PUNCT
easat-3872	73	25	as	as	SCONJ
easat-3872	73	26	seen	see	VERB
easat-3872	73	27	in	in	ADP
easat-3872	73	28	this	this	DET
easat-3872	73	29	case	case	NOUN
easat-3872	74	1	[	[	X
easat-3872	74	2	6	6	NUM
easat-3872	74	3	]	]	PUNCT
easat-3872	74	4	.	.	PUNCT
easat-3872	74	5	elevated	elevated	ADJ
easat-3872	74	6	insulin	insulin	NOUN
easat-3872	74	7	and	and	CCONJ
easat-3872	74	8	c	c	NOUN
easat-3872	74	9	-	-	PUNCT
easat-3872	74	10	peptide	peptide	NOUN
easat-3872	74	11	levels	level	NOUN
easat-3872	74	12	confirmed	confirm	VERB
easat-3872	74	13	the	the	DET
easat-3872	74	14	diagnosis	diagnosis	NOUN
easat-3872	74	15	,	,	PUNCT
easat-3872	74	16	consistent	consistent	ADJ
easat-3872	74	17	with	with	ADP
easat-3872	74	18	the	the	DET
easat-3872	74	19	diagnostic	diagnostic	ADJ
easat-3872	74	20	criteria	criterion	NOUN
easat-3872	74	21	outlined	outline	VERB
easat-3872	74	22	in	in	ADP
easat-3872	74	23	recent	recent	ADJ
easat-3872	74	24	studies	study	NOUN
easat-3872	74	25	.	.	PUNCT
easat-3872	75	1	this	this	DET
easat-3872	75	2	highlights	highlight	VERB
easat-3872	75	3	the	the	DET
easat-3872	75	4	critical	critical	ADJ
easat-3872	75	5	role	role	NOUN
easat-3872	75	6	of	of	ADP
easat-3872	75	7	biochemical	biochemical	ADJ
easat-3872	75	8	markers	marker	NOUN
easat-3872	75	9	in	in	ADP
easat-3872	75	10	diagnosing	diagnose	VERB
easat-3872	75	11	phhi	phhi	NOUN
easat-3872	76	1	[	[	X
easat-3872	76	2	7	7	NUM
easat-3872	76	3	]	]	PUNCT
easat-3872	76	4	.	.	PUNCT
easat-3872	77	1	in	in	ADP
easat-3872	77	2	this	this	DET
easat-3872	77	3	case	case	NOUN
easat-3872	77	4	,	,	PUNCT
easat-3872	77	5	the	the	DET
easat-3872	77	6	unavailability	unavailability	NOUN
easat-3872	77	7	of	of	ADP
easat-3872	77	8	diazoxide	diazoxide	NOUN
easat-3872	77	9	necessitated	necessitate	VERB
easat-3872	77	10	alternative	alternative	ADJ
easat-3872	77	11	therapies	therapy	NOUN
easat-3872	77	12	,	,	PUNCT
easat-3872	77	13	illustrating	illustrate	VERB
easat-3872	77	14	disparities	disparity	NOUN
easat-3872	77	15	in	in	ADP
easat-3872	77	16	healthcare	healthcare	NOUN
easat-3872	77	17	resource	resource	NOUN
easat-3872	77	18	access	access	NOUN
easat-3872	77	19	.	.	PUNCT
easat-3872	78	1	the	the	DET
easat-3872	78	2	successful	successful	ADJ
easat-3872	78	3	management	management	NOUN
easat-3872	78	4	of	of	ADP
easat-3872	78	5	the	the	DET
easat-3872	78	6	patient	patient	NOUN
easat-3872	78	7	using	use	VERB
easat-3872	78	8	a	a	DET
easat-3872	78	9	combination	combination	NOUN
easat-3872	78	10	of	of	ADP
easat-3872	78	11	octreotide	octreotide	NOUN
easat-3872	78	12	and	and	CCONJ
easat-3872	78	13	nifedipine	nifedipine	NOUN
easat-3872	78	14	underscores	underscore	VERB
easat-3872	78	15	the	the	DET
easat-3872	78	16	importance	importance	NOUN
easat-3872	78	17	of	of	ADP
easat-3872	78	18	second	second	ADJ
easat-3872	78	19	-	-	PUNCT
easat-3872	78	20	line	line	NOUN
easat-3872	78	21	therapies	therapy	NOUN
easat-3872	78	22	when	when	SCONJ
easat-3872	78	23	standard	standard	ADJ
easat-3872	78	24	treatments	treatment	NOUN
easat-3872	78	25	are	be	AUX
easat-3872	78	26	not	not	PART
easat-3872	78	27	feasible	feasible	ADJ
easat-3872	78	28	[	[	PUNCT
easat-3872	78	29	8	8	NUM
easat-3872	78	30	]	]	PUNCT
easat-3872	78	31	.	.	PUNCT
easat-3872	79	1	recent	recent	ADJ
easat-3872	79	2	studies	study	NOUN
easat-3872	79	3	also	also	ADV
easat-3872	79	4	document	document	VERB
easat-3872	79	5	variable	variable	ADJ
easat-3872	79	6	responses	response	NOUN
easat-3872	79	7	to	to	ADP
easat-3872	79	8	nifedipine	nifedipine	NOUN
easat-3872	79	9	in	in	ADP
easat-3872	79	10	phhi	phhi	NOUN
easat-3872	79	11	,	,	PUNCT
easat-3872	79	12	with	with	ADP
easat-3872	79	13	promising	promising	ADJ
easat-3872	79	14	but	but	CCONJ
easat-3872	79	15	limited	limited	ADJ
easat-3872	79	16	evidence	evidence	NOUN
easat-3872	79	17	supporting	support	VERB
easat-3872	79	18	its	its	PRON
easat-3872	79	19	efficacy	efficacy	NOUN
easat-3872	79	20	,	,	PUNCT
easat-3872	79	21	particularly	particularly	ADV
easat-3872	79	22	in	in	ADP
easat-3872	79	23	diazoxide	diazoxide	NOUN
easat-3872	79	24	-	-	PUNCT
easat-3872	79	25	unresponsive	unresponsive	ADJ
easat-3872	79	26	cases	case	NOUN
easat-3872	79	27	[	[	X
easat-3872	79	28	3	3	NUM
easat-3872	79	29	]	]	PUNCT
easat-3872	79	30	.	.	PUNCT
easat-3872	80	1	the	the	DET
easat-3872	80	2	pathophysiology	pathophysiology	NOUN
easat-3872	80	3	of	of	ADP
easat-3872	80	4	persistent	persistent	ADJ
easat-3872	80	5	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	80	6	hypoglycemia	hypoglycemia	NOUN
easat-3872	80	7	in	in	ADP
easat-3872	80	8	infancy	infancy	NOUN
easat-3872	80	9	(	(	PUNCT
easat-3872	80	10	phhi	phhi	NOUN
easat-3872	80	11	)	)	PUNCT
easat-3872	80	12	involves	involve	VERB
easat-3872	80	13	mutations	mutation	NOUN
easat-3872	80	14	in	in	ADP
easat-3872	80	15	the	the	DET
easat-3872	80	16	atp	atp	NOUN
easat-3872	80	17	-	-	PUNCT
easat-3872	80	18	sensitive	sensitive	ADJ
easat-3872	80	19	potassium	potassium	NOUN
easat-3872	80	20	(	(	PUNCT
easat-3872	80	21	katp	katp	NOUN
easat-3872	80	22	)	)	PUNCT
easat-3872	80	23	channels	channel	NOUN
easat-3872	80	24	within	within	ADP
easat-3872	80	25	pancreatic	pancreatic	ADJ
easat-3872	80	26	β	β	NOUN
easat-3872	80	27	-	-	NOUN
easat-3872	80	28	cells	cell	NOUN
easat-3872	80	29	,	,	PUNCT
easat-3872	80	30	leading	lead	VERB
easat-3872	80	31	to	to	ADP
easat-3872	80	32	dysregulated	dysregulated	ADJ
easat-3872	80	33	insulin	insulin	NOUN
easat-3872	80	34	secretion	secretion	NOUN
easat-3872	80	35	.	.	PUNCT
easat-3872	81	1	these	these	DET
easat-3872	81	2	mutations	mutation	NOUN
easat-3872	81	3	,	,	PUNCT
easat-3872	81	4	particularly	particularly	ADV
easat-3872	81	5	in	in	ADP
easat-3872	81	6	the	the	DET
easat-3872	81	7	kcnj11	kcnj11	NOUN
easat-3872	81	8	or	or	CCONJ
easat-3872	81	9	abcc8	abcc8	NOUN
easat-3872	81	10	genes	gene	NOUN
easat-3872	81	11	,	,	PUNCT
easat-3872	81	12	impair	impair	VERB
easat-3872	81	13	the	the	DET
easat-3872	81	14	functionality	functionality	NOUN
easat-3872	81	15	of	of	ADP
easat-3872	81	16	the	the	DET
easat-3872	81	17	katp	katp	NOUN
easat-3872	81	18	channels	channel	NOUN
easat-3872	81	19	,	,	PUNCT
easat-3872	81	20	causing	cause	VERB
easat-3872	81	21	unregulated	unregulated	ADJ
easat-3872	81	22	insulin	insulin	NOUN
easat-3872	81	23	release	release	NOUN
easat-3872	81	24	even	even	ADV
easat-3872	81	25	under	under	ADP
easat-3872	81	26	hypoglycemic	hypoglycemic	ADJ
easat-3872	81	27	conditions	condition	NOUN
easat-3872	81	28	[	[	X
easat-3872	81	29	9	9	NUM
easat-3872	81	30	]	]	PUNCT
easat-3872	81	31	.	.	PUNCT
easat-3872	82	1	while	while	SCONJ
easat-3872	82	2	focal	focal	ADJ
easat-3872	82	3	phhi	phhi	NOUN
easat-3872	82	4	cases	case	NOUN
easat-3872	82	5	often	often	ADV
easat-3872	82	6	respond	respond	VERB
easat-3872	82	7	well	well	ADV
easat-3872	82	8	to	to	ADP
easat-3872	82	9	surgical	surgical	ADJ
easat-3872	82	10	resection	resection	NOUN
easat-3872	82	11	,	,	PUNCT
easat-3872	82	12	diffuse	diffuse	PROPN
easat-3872	82	13	cases	case	NOUN
easat-3872	82	14	,	,	PUNCT
easat-3872	82	15	as	as	SCONJ
easat-3872	82	16	suspected	suspect	VERB
easat-3872	82	17	in	in	ADP
easat-3872	82	18	this	this	DET
easat-3872	82	19	neonate	neonate	NOUN
easat-3872	82	20	,	,	PUNCT
easat-3872	82	21	require	require	VERB
easat-3872	82	22	medical	medical	ADJ
easat-3872	82	23	management	management	NOUN
easat-3872	82	24	due	due	ADP
easat-3872	82	25	to	to	ADP
easat-3872	82	26	the	the	DET
easat-3872	82	27	absence	absence	NOUN
easat-3872	82	28	of	of	ADP
easat-3872	82	29	localized	localize	VERB
easat-3872	82	30	pancreatic	pancreatic	ADJ
easat-3872	82	31	lesions	lesion	NOUN
easat-3872	82	32	.	.	PUNCT
easat-3872	83	1	imaging	imaging	NOUN
easat-3872	83	2	that	that	PRON
easat-3872	83	3	fails	fail	VERB
easat-3872	83	4	to	to	PART
easat-3872	83	5	reveal	reveal	VERB
easat-3872	83	6	focal	focal	ADJ
easat-3872	83	7	lesions	lesion	NOUN
easat-3872	83	8	and	and	CCONJ
easat-3872	83	9	a	a	DET
easat-3872	83	10	favorable	favorable	ADJ
easat-3872	83	11	clinical	clinical	ADJ
easat-3872	83	12	response	response	NOUN
easat-3872	83	13	to	to	ADP
easat-3872	83	14	pharmacological	pharmacological	NOUN
easat-3872	83	15	therapy	therapy	NOUN
easat-3872	83	16	further	far	ADV
easat-3872	83	17	supports	support	VERB
easat-3872	83	18	8756	8756	NUM
easat-3872	83	19	edelweiss	edelweiss	PROPN
easat-3872	83	20	applied	apply	VERB
easat-3872	83	21	science	science	NOUN
easat-3872	83	22	and	and	CCONJ
easat-3872	83	23	technology	technology	NOUN
easat-3872	83	24	issn	issn	PROPN
easat-3872	83	25	:	:	PUNCT
easat-3872	83	26	2576	2576	NUM
easat-3872	83	27	-	-	SYM
easat-3872	83	28	8484	8484	NUM
easat-3872	83	29	vol	vol	NOUN
easat-3872	83	30	.	.	PROPN
easat-3872	83	31	8	8	NUM
easat-3872	83	32	,	,	PUNCT
easat-3872	83	33	no	no	INTJ
easat-3872	83	34	.	.	NOUN
easat-3872	84	1	6	6	NUM
easat-3872	84	2	:	:	PUNCT
easat-3872	84	3	8752	8752	NUM
easat-3872	84	4	-	-	SYM
easat-3872	84	5	8758	8758	NUM
easat-3872	84	6	,	,	PUNCT
easat-3872	84	7	2024	2024	NUM
easat-3872	84	8	doi	doi	NOUN
easat-3872	84	9	:	:	PUNCT
easat-3872	84	10	10.55214/25768484.v8i6.3872	10.55214/25768484.v8i6.3872	NUM
easat-3872	84	11	©	©	PROPN
easat-3872	84	12	2024	2024	NUM
easat-3872	84	13	by	by	ADP
easat-3872	84	14	the	the	DET
easat-3872	84	15	authors	author	NOUN
easat-3872	84	16	;	;	PUNCT
easat-3872	84	17	licensee	licensee	PROPN
easat-3872	84	18	learning	learning	NOUN
easat-3872	84	19	gate	gate	VERB
easat-3872	84	20	a	a	DET
easat-3872	84	21	diffuse	diffuse	NOUN
easat-3872	84	22	etiology	etiology	NOUN
easat-3872	84	23	[	[	X
easat-3872	84	24	7	7	NUM
easat-3872	84	25	]	]	PUNCT
easat-3872	84	26	.	.	PUNCT
easat-3872	85	1	early	early	ADJ
easat-3872	85	2	diagnosis	diagnosis	NOUN
easat-3872	85	3	is	be	AUX
easat-3872	85	4	crucial	crucial	ADJ
easat-3872	85	5	to	to	PART
easat-3872	85	6	mitigate	mitigate	VERB
easat-3872	85	7	the	the	DET
easat-3872	85	8	risk	risk	NOUN
easat-3872	85	9	of	of	ADP
easat-3872	85	10	permanent	permanent	ADJ
easat-3872	85	11	brain	brain	NOUN
easat-3872	85	12	injury	injury	NOUN
easat-3872	85	13	caused	cause	VERB
easat-3872	85	14	by	by	ADP
easat-3872	85	15	prolonged	prolonged	ADJ
easat-3872	85	16	hypoglycemia	hypoglycemia	NOUN
easat-3872	85	17	and	and	CCONJ
easat-3872	85	18	neurotoxicity	neurotoxicity	NOUN
easat-3872	85	19	[	[	X
easat-3872	85	20	10	10	NUM
easat-3872	85	21	]	]	PUNCT
easat-3872	85	22	.	.	PUNCT
easat-3872	86	1	nifedipine	nifedipine	PROPN
easat-3872	86	2	,	,	PUNCT
easat-3872	86	3	a	a	DET
easat-3872	86	4	calcium	calcium	NOUN
easat-3872	86	5	channel	channel	NOUN
easat-3872	86	6	blocker	blocker	NOUN
easat-3872	86	7	typically	typically	ADV
easat-3872	86	8	used	use	VERB
easat-3872	86	9	for	for	ADP
easat-3872	86	10	hypertension	hypertension	NOUN
easat-3872	86	11	,	,	PUNCT
easat-3872	86	12	may	may	AUX
easat-3872	86	13	also	also	ADV
easat-3872	86	14	influence	influence	VERB
easat-3872	86	15	insulin	insulin	NOUN
easat-3872	86	16	release	release	NOUN
easat-3872	86	17	in	in	ADP
easat-3872	86	18	phhi	phhi	NOUN
easat-3872	86	19	.	.	PUNCT
easat-3872	87	1	by	by	ADP
easat-3872	87	2	reducing	reduce	VERB
easat-3872	87	3	calcium	calcium	NOUN
easat-3872	87	4	influx	influx	NOUN
easat-3872	87	5	,	,	PUNCT
easat-3872	87	6	it	it	PRON
easat-3872	87	7	potentially	potentially	ADV
easat-3872	87	8	modulates	modulate	VERB
easat-3872	87	9	insulin	insulin	NOUN
easat-3872	87	10	secretion	secretion	NOUN
easat-3872	87	11	,	,	PUNCT
easat-3872	87	12	offering	offer	VERB
easat-3872	87	13	a	a	DET
easat-3872	87	14	novel	novel	ADJ
easat-3872	87	15	therapeutic	therapeutic	ADJ
easat-3872	87	16	pathway	pathway	NOUN
easat-3872	87	17	.	.	PUNCT
easat-3872	88	1	however	however	ADV
easat-3872	88	2	,	,	PUNCT
easat-3872	88	3	its	its	PRON
easat-3872	88	4	variable	variable	ADJ
easat-3872	88	5	efficacy	efficacy	NOUN
easat-3872	88	6	across	across	ADP
easat-3872	88	7	cases	case	NOUN
easat-3872	88	8	highlights	highlight	NOUN
easat-3872	88	9	the	the	DET
easat-3872	88	10	need	need	NOUN
easat-3872	88	11	for	for	ADP
easat-3872	88	12	further	further	ADJ
easat-3872	88	13	investigation	investigation	NOUN
easat-3872	88	14	to	to	PART
easat-3872	88	15	develop	develop	VERB
easat-3872	88	16	standardized	standardized	ADJ
easat-3872	88	17	treatment	treatment	NOUN
easat-3872	88	18	protocols	protocol	NOUN
easat-3872	88	19	[	[	X
easat-3872	88	20	10	10	NUM
easat-3872	88	21	]	]	PUNCT
easat-3872	88	22	.	.	PUNCT
easat-3872	89	1	octreotide	octreotide	NOUN
easat-3872	89	2	,	,	PUNCT
easat-3872	89	3	a	a	DET
easat-3872	89	4	somatostatin	somatostatin	NOUN
easat-3872	89	5	analog	analog	NOUN
easat-3872	89	6	,	,	PUNCT
easat-3872	89	7	exerts	exert	VERB
easat-3872	89	8	its	its	PRON
easat-3872	89	9	effect	effect	NOUN
easat-3872	89	10	by	by	ADP
easat-3872	89	11	binding	bind	VERB
easat-3872	89	12	to	to	ADP
easat-3872	89	13	somatostatin	somatostatin	NOUN
easat-3872	89	14	receptors	receptor	NOUN
easat-3872	89	15	,	,	PUNCT
easat-3872	89	16	predominantly	predominantly	ADV
easat-3872	89	17	sstr2	sstr2	NOUN
easat-3872	89	18	and	and	CCONJ
easat-3872	89	19	sstr5	sstr5	NOUN
easat-3872	89	20	,	,	PUNCT
easat-3872	89	21	on	on	ADP
easat-3872	89	22	pancreatic	pancreatic	ADJ
easat-3872	89	23	β	β	NOUN
easat-3872	89	24	-	-	NOUN
easat-3872	89	25	cells	cell	NOUN
easat-3872	89	26	.	.	PUNCT
easat-3872	90	1	this	this	DET
easat-3872	90	2	binding	bind	VERB
easat-3872	90	3	inhibits	inhibit	VERB
easat-3872	90	4	cyclic	cyclic	ADJ
easat-3872	90	5	adenosine	adenosine	NOUN
easat-3872	90	6	monophosphate	monophosphate	NOUN
easat-3872	90	7	(	(	PUNCT
easat-3872	90	8	camp	camp	NOUN
easat-3872	90	9	)	)	PUNCT
easat-3872	90	10	production	production	NOUN
easat-3872	90	11	,	,	PUNCT
easat-3872	90	12	subsequently	subsequently	ADV
easat-3872	90	13	reducing	reduce	VERB
easat-3872	90	14	calcium	calcium	NOUN
easat-3872	90	15	influx	influx	NOUN
easat-3872	90	16	and	and	CCONJ
easat-3872	90	17	insulin	insulin	NOUN
easat-3872	90	18	secretion	secretion	NOUN
easat-3872	90	19	.	.	PUNCT
easat-3872	91	1	despite	despite	SCONJ
easat-3872	91	2	its	its	PRON
easat-3872	91	3	efficacy	efficacy	NOUN
easat-3872	91	4	in	in	ADP
easat-3872	91	5	suppressing	suppress	VERB
easat-3872	91	6	insulin	insulin	NOUN
easat-3872	91	7	secretion	secretion	NOUN
easat-3872	91	8	,	,	PUNCT
easat-3872	91	9	studies	study	NOUN
easat-3872	91	10	have	have	AUX
easat-3872	91	11	reported	report	VERB
easat-3872	91	12	tachyphylaxis	tachyphylaxis	ADV
easat-3872	91	13	with	with	ADP
easat-3872	91	14	prolonged	prolonged	ADJ
easat-3872	91	15	use	use	NOUN
easat-3872	91	16	,	,	PUNCT
easat-3872	91	17	necessitating	necessitate	VERB
easat-3872	91	18	dose	dose	NOUN
easat-3872	91	19	adjustments	adjustment	NOUN
easat-3872	91	20	or	or	CCONJ
easat-3872	91	21	combination	combination	NOUN
easat-3872	91	22	therapy	therapy	NOUN
easat-3872	91	23	[	[	X
easat-3872	91	24	1	1	NUM
easat-3872	91	25	]	]	PUNCT
easat-3872	91	26	.	.	PUNCT
easat-3872	92	1	research	research	NOUN
easat-3872	92	2	has	have	AUX
easat-3872	92	3	shown	show	VERB
easat-3872	92	4	octreotide	octreotide	NOUN
easat-3872	92	5	to	to	PART
easat-3872	92	6	be	be	AUX
easat-3872	92	7	effective	effective	ADJ
easat-3872	92	8	in	in	ADP
easat-3872	92	9	managing	manage	VERB
easat-3872	92	10	hyperinsulinism	hyperinsulinism	NOUN
easat-3872	92	11	,	,	PUNCT
easat-3872	92	12	particularly	particularly	ADV
easat-3872	92	13	in	in	ADP
easat-3872	92	14	diazoxide	diazoxide	NOUN
easat-3872	92	15	-	-	PUNCT
easat-3872	92	16	unresponsive	unresponsive	ADJ
easat-3872	92	17	cases	case	NOUN
easat-3872	92	18	[	[	X
easat-3872	92	19	7	7	NUM
easat-3872	92	20	]	]	PUNCT
easat-3872	92	21	.	.	PUNCT
easat-3872	93	1	however	however	ADV
easat-3872	93	2	,	,	PUNCT
easat-3872	93	3	side	side	ADJ
easat-3872	93	4	effects	effect	NOUN
easat-3872	93	5	such	such	ADJ
easat-3872	93	6	as	as	ADP
easat-3872	93	7	gastrointestinal	gastrointestinal	ADJ
easat-3872	93	8	disturbances	disturbance	NOUN
easat-3872	93	9	and	and	CCONJ
easat-3872	93	10	growth	growth	NOUN
easat-3872	93	11	suppression	suppression	NOUN
easat-3872	93	12	remain	remain	VERB
easat-3872	93	13	concerns	concern	NOUN
easat-3872	93	14	,	,	PUNCT
easat-3872	93	15	particularly	particularly	ADV
easat-3872	93	16	with	with	ADP
easat-3872	93	17	long	long	ADJ
easat-3872	93	18	-	-	PUNCT
easat-3872	93	19	term	term	NOUN
easat-3872	93	20	use	use	NOUN
easat-3872	93	21	[	[	X
easat-3872	93	22	5	5	NUM
easat-3872	93	23	]	]	PUNCT
easat-3872	93	24	.	.	PUNCT
easat-3872	94	1	conversely	conversely	ADV
easat-3872	94	2	,	,	PUNCT
easat-3872	94	3	nifedipine	nifedipine	NOUN
easat-3872	94	4	blocks	block	NOUN
easat-3872	94	5	l	l	ADJ
easat-3872	94	6	-	-	PUNCT
easat-3872	94	7	type	type	NOUN
easat-3872	94	8	calcium	calcium	NOUN
easat-3872	94	9	channels	channel	NOUN
easat-3872	94	10	,	,	PUNCT
easat-3872	94	11	directly	directly	ADV
easat-3872	94	12	inhibiting	inhibit	VERB
easat-3872	94	13	the	the	DET
easat-3872	94	14	calcium	calcium	NOUN
easat-3872	94	15	influx	influx	NOUN
easat-3872	94	16	necessary	necessary	ADJ
easat-3872	94	17	for	for	ADP
easat-3872	94	18	insulin	insulin	NOUN
easat-3872	94	19	granule	granule	NOUN
easat-3872	94	20	exocytosis	exocytosis	NOUN
easat-3872	94	21	.	.	PUNCT
easat-3872	95	1	this	this	DET
easat-3872	95	2	mechanism	mechanism	NOUN
easat-3872	95	3	aligns	align	VERB
easat-3872	95	4	with	with	ADP
easat-3872	95	5	studies	study	NOUN
easat-3872	95	6	that	that	PRON
easat-3872	95	7	report	report	VERB
easat-3872	95	8	effective	effective	ADJ
easat-3872	95	9	glycemic	glycemic	ADJ
easat-3872	95	10	control	control	NOUN
easat-3872	95	11	in	in	ADP
easat-3872	95	12	infants	infant	NOUN
easat-3872	95	13	with	with	ADP
easat-3872	95	14	phhi	phhi	NOUN
easat-3872	95	15	treated	treat	VERB
easat-3872	95	16	with	with	ADP
easat-3872	95	17	nifedipine	nifedipine	NOUN
easat-3872	95	18	[	[	X
easat-3872	95	19	4	4	NUM
easat-3872	95	20	]	]	PUNCT
easat-3872	95	21	.	.	PUNCT
easat-3872	96	1	a	a	DET
easat-3872	96	2	recent	recent	ADJ
easat-3872	96	3	study	study	NOUN
easat-3872	96	4	highlighted	highlight	VERB
easat-3872	96	5	that	that	SCONJ
easat-3872	96	6	nifedipine	nifedipine	NOUN
easat-3872	96	7	achieved	achieve	VERB
easat-3872	96	8	glycemic	glycemic	ADJ
easat-3872	96	9	stability	stability	NOUN
easat-3872	96	10	in	in	ADP
easat-3872	96	11	70	70	NUM
easat-3872	96	12	%	%	NOUN
easat-3872	96	13	of	of	ADP
easat-3872	96	14	cases	case	NOUN
easat-3872	96	15	when	when	SCONJ
easat-3872	96	16	combined	combine	VERB
easat-3872	96	17	with	with	ADP
easat-3872	96	18	octreotide	octreotide	NOUN
easat-3872	96	19	.	.	PUNCT
easat-3872	97	1	however	however	ADV
easat-3872	97	2	,	,	PUNCT
easat-3872	97	3	other	other	ADJ
easat-3872	97	4	studies	study	NOUN
easat-3872	97	5	question	question	VERB
easat-3872	97	6	its	its	PRON
easat-3872	97	7	standalone	standalone	ADJ
easat-3872	97	8	efficacy	efficacy	NOUN
easat-3872	97	9	,	,	PUNCT
easat-3872	97	10	with	with	ADP
easat-3872	97	11	some	some	PRON
easat-3872	97	12	reporting	report	VERB
easat-3872	97	13	inadequate	inadequate	ADJ
easat-3872	97	14	glycemic	glycemic	ADJ
easat-3872	97	15	control	control	NOUN
easat-3872	97	16	or	or	CCONJ
easat-3872	97	17	lack	lack	NOUN
easat-3872	97	18	of	of	ADP
easat-3872	97	19	response	response	NOUN
easat-3872	97	20	,	,	PUNCT
easat-3872	97	21	particularly	particularly	ADV
easat-3872	97	22	in	in	ADP
easat-3872	97	23	cases	case	NOUN
easat-3872	97	24	associated	associate	VERB
easat-3872	97	25	with	with	ADP
easat-3872	97	26	severe	severe	ADJ
easat-3872	97	27	genetic	genetic	ADJ
easat-3872	97	28	mutations	mutation	NOUN
easat-3872	97	29	in	in	ADP
easat-3872	97	30	katp	katp	NOUN
easat-3872	97	31	channels	channel	NOUN
easat-3872	97	32	[	[	X
easat-3872	97	33	7	7	NUM
easat-3872	97	34	]	]	PUNCT
easat-3872	97	35	.	.	PUNCT
easat-3872	98	1	the	the	DET
easat-3872	98	2	variability	variability	NOUN
easat-3872	98	3	in	in	ADP
easat-3872	98	4	response	response	NOUN
easat-3872	98	5	necessitates	necessitate	VERB
easat-3872	98	6	a	a	DET
easat-3872	98	7	cautious	cautious	ADJ
easat-3872	98	8	,	,	PUNCT
easat-3872	98	9	case	case	NOUN
easat-3872	98	10	-	-	PUNCT
easat-3872	98	11	by	by	ADP
easat-3872	98	12	-	-	PUNCT
easat-3872	98	13	case	case	NOUN
easat-3872	98	14	approach	approach	NOUN
easat-3872	98	15	[	[	X
easat-3872	98	16	2	2	NUM
easat-3872	98	17	]	]	PUNCT
easat-3872	98	18	.	.	PUNCT
easat-3872	99	1	the	the	DET
easat-3872	99	2	unavailability	unavailability	NOUN
easat-3872	99	3	of	of	ADP
easat-3872	99	4	diazoxide	diazoxide	NOUN
easat-3872	99	5	presented	present	VERB
easat-3872	99	6	a	a	DET
easat-3872	99	7	significant	significant	ADJ
easat-3872	99	8	challenge	challenge	NOUN
easat-3872	99	9	in	in	ADP
easat-3872	99	10	this	this	DET
easat-3872	99	11	case	case	NOUN
easat-3872	99	12	.	.	PUNCT
easat-3872	100	1	octreotide	octreotide	NOUN
easat-3872	100	2	,	,	PUNCT
easat-3872	100	3	a	a	DET
easat-3872	100	4	somatostatin	somatostatin	NOUN
easat-3872	100	5	analog	analog	NOUN
easat-3872	100	6	,	,	PUNCT
easat-3872	100	7	was	be	AUX
easat-3872	100	8	successfully	successfully	ADV
easat-3872	100	9	used	use	VERB
easat-3872	100	10	to	to	PART
easat-3872	100	11	suppress	suppress	VERB
easat-3872	100	12	insulin	insulin	NOUN
easat-3872	100	13	secretion	secretion	NOUN
easat-3872	100	14	,	,	PUNCT
easat-3872	100	15	although	although	SCONJ
easat-3872	100	16	its	its	PRON
easat-3872	100	17	efficacy	efficacy	NOUN
easat-3872	100	18	fluctuated	fluctuate	VERB
easat-3872	100	19	.	.	PUNCT
easat-3872	101	1	this	this	PRON
easat-3872	101	2	aligns	align	VERB
easat-3872	101	3	with	with	ADP
easat-3872	101	4	its	its	PRON
easat-3872	101	5	recommended	recommend	VERB
easat-3872	101	6	use	use	NOUN
easat-3872	101	7	in	in	ADP
easat-3872	101	8	cases	case	NOUN
easat-3872	101	9	where	where	SCONJ
easat-3872	101	10	diazoxide	diazoxide	NOUN
easat-3872	101	11	is	be	AUX
easat-3872	101	12	ineffective	ineffective	ADJ
easat-3872	101	13	or	or	CCONJ
easat-3872	101	14	contraindicated	contraindicate	VERB
easat-3872	101	15	,	,	PUNCT
easat-3872	101	16	as	as	SCONJ
easat-3872	101	17	supported	support	VERB
easat-3872	101	18	by	by	ADP
easat-3872	101	19	recent	recent	ADJ
easat-3872	101	20	studies	study	NOUN
easat-3872	101	21	[	[	X
easat-3872	101	22	8	8	NUM
easat-3872	101	23	]	]	PUNCT
easat-3872	101	24	.	.	PUNCT
easat-3872	102	1	the	the	DET
easat-3872	102	2	combination	combination	NOUN
easat-3872	102	3	of	of	ADP
easat-3872	102	4	octreotide	octreotide	NOUN
easat-3872	102	5	with	with	ADP
easat-3872	102	6	nifedipine	nifedipine	NOUN
easat-3872	102	7	was	be	AUX
easat-3872	102	8	pivotal	pivotal	ADJ
easat-3872	102	9	in	in	ADP
easat-3872	102	10	achieving	achieve	VERB
easat-3872	102	11	stable	stable	ADJ
easat-3872	102	12	blood	blood	NOUN
easat-3872	102	13	glucose	glucose	NOUN
easat-3872	102	14	levels	level	NOUN
easat-3872	102	15	,	,	PUNCT
easat-3872	102	16	facilitating	facilitate	VERB
easat-3872	102	17	the	the	DET
easat-3872	102	18	gradual	gradual	ADJ
easat-3872	102	19	reduction	reduction	NOUN
easat-3872	102	20	and	and	CCONJ
easat-3872	102	21	eventual	eventual	ADJ
easat-3872	102	22	cessation	cessation	NOUN
easat-3872	102	23	of	of	ADP
easat-3872	102	24	intravenous	intravenous	ADJ
easat-3872	102	25	glucose	glucose	NOUN
easat-3872	102	26	infusion	infusion	NOUN
easat-3872	102	27	.	.	PUNCT
easat-3872	103	1	this	this	DET
easat-3872	103	2	therapeutic	therapeutic	ADJ
easat-3872	103	3	combination	combination	NOUN
easat-3872	103	4	highlights	highlight	VERB
easat-3872	103	5	the	the	DET
easat-3872	103	6	potential	potential	ADJ
easat-3872	103	7	role	role	NOUN
easat-3872	103	8	of	of	ADP
easat-3872	103	9	calcium	calcium	NOUN
easat-3872	103	10	channel	channel	NOUN
easat-3872	103	11	blockers	blocker	NOUN
easat-3872	103	12	in	in	ADP
easat-3872	103	13	phhi	phhi	NOUN
easat-3872	103	14	management	management	NOUN
easat-3872	103	15	when	when	SCONJ
easat-3872	103	16	conventional	conventional	ADJ
easat-3872	103	17	treatments	treatment	NOUN
easat-3872	103	18	are	be	AUX
easat-3872	103	19	insufficient	insufficient	ADJ
easat-3872	104	1	[	[	X
easat-3872	104	2	3	3	NUM
easat-3872	104	3	]	]	PUNCT
easat-3872	104	4	.	.	PUNCT
easat-3872	105	1	this	this	DET
easat-3872	105	2	approach	approach	NOUN
easat-3872	105	3	reflects	reflect	VERB
easat-3872	105	4	the	the	DET
easat-3872	105	5	growing	grow	VERB
easat-3872	105	6	trend	trend	NOUN
easat-3872	105	7	towards	towards	ADP
easat-3872	105	8	individualized	individualized	ADJ
easat-3872	105	9	patient	patient	NOUN
easat-3872	105	10	care	care	NOUN
easat-3872	105	11	,	,	PUNCT
easat-3872	105	12	particularly	particularly	ADV
easat-3872	105	13	in	in	ADP
easat-3872	105	14	resource	resource	NOUN
easat-3872	105	15	-	-	PUNCT
easat-3872	105	16	constrained	constrain	VERB
easat-3872	105	17	settings	setting	NOUN
easat-3872	105	18	.	.	PUNCT
easat-3872	106	1	the	the	DET
easat-3872	106	2	success	success	NOUN
easat-3872	106	3	of	of	ADP
easat-3872	106	4	such	such	ADJ
easat-3872	106	5	strategies	strategy	NOUN
easat-3872	106	6	underscores	underscore	VERB
easat-3872	106	7	the	the	DET
easat-3872	106	8	need	need	NOUN
easat-3872	106	9	for	for	ADP
easat-3872	106	10	further	further	ADJ
easat-3872	106	11	research	research	NOUN
easat-3872	106	12	to	to	PART
easat-3872	106	13	evaluate	evaluate	VERB
easat-3872	106	14	the	the	DET
easat-3872	106	15	long	long	ADJ
easat-3872	106	16	-	-	PUNCT
easat-3872	106	17	term	term	NOUN
easat-3872	106	18	safety	safety	NOUN
easat-3872	106	19	and	and	CCONJ
easat-3872	106	20	efficacy	efficacy	NOUN
easat-3872	106	21	of	of	ADP
easat-3872	106	22	nifedipine	nifedipine	NOUN
easat-3872	106	23	in	in	ADP
easat-3872	106	24	phhi	phhi	NOUN
easat-3872	106	25	management	management	NOUN
easat-3872	106	26	.	.	PUNCT
easat-3872	107	1	additionally	additionally	ADV
easat-3872	107	2	,	,	PUNCT
easat-3872	107	3	this	this	DET
easat-3872	107	4	case	case	NOUN
easat-3872	107	5	emphasizes	emphasize	VERB
easat-3872	107	6	the	the	DET
easat-3872	107	7	importance	importance	NOUN
easat-3872	107	8	of	of	ADP
easat-3872	107	9	following	follow	VERB
easat-3872	107	10	updated	update	VERB
easat-3872	107	11	international	international	ADJ
easat-3872	107	12	guidelines	guideline	NOUN
easat-3872	107	13	that	that	PRON
easat-3872	107	14	advocate	advocate	VERB
easat-3872	107	15	for	for	ADP
easat-3872	107	16	a	a	DET
easat-3872	107	17	multidisciplinary	multidisciplinary	ADJ
easat-3872	107	18	approach	approach	NOUN
easat-3872	107	19	to	to	PART
easat-3872	107	20	optimize	optimize	VERB
easat-3872	107	21	clinical	clinical	ADJ
easat-3872	107	22	outcomes	outcome	NOUN
easat-3872	107	23	[	[	X
easat-3872	107	24	7	7	NUM
easat-3872	107	25	]	]	PUNCT
easat-3872	107	26	.	.	PUNCT
easat-3872	108	1	the	the	DET
easat-3872	108	2	occurrence	occurrence	NOUN
easat-3872	108	3	of	of	ADP
easat-3872	108	4	hospital	hospital	NOUN
easat-3872	108	5	-	-	PUNCT
easat-3872	108	6	acquired	acquire	VERB
easat-3872	108	7	pneumonia	pneumonia	NOUN
easat-3872	108	8	(	(	PUNCT
easat-3872	108	9	hap	hap	NOUN
easat-3872	108	10	)	)	PUNCT
easat-3872	108	11	during	during	ADP
easat-3872	108	12	hospitalization	hospitalization	NOUN
easat-3872	108	13	illustrates	illustrate	VERB
easat-3872	108	14	the	the	DET
easat-3872	108	15	heightened	heighten	VERB
easat-3872	108	16	vulnerability	vulnerability	NOUN
easat-3872	108	17	of	of	ADP
easat-3872	108	18	neonates	neonate	NOUN
easat-3872	108	19	with	with	ADP
easat-3872	108	20	phhi	phhi	NOUN
easat-3872	108	21	to	to	ADP
easat-3872	108	22	secondary	secondary	ADJ
easat-3872	108	23	infections	infection	NOUN
easat-3872	108	24	.	.	PUNCT
easat-3872	109	1	prompt	prompt	ADJ
easat-3872	109	2	identification	identification	NOUN
easat-3872	109	3	and	and	CCONJ
easat-3872	109	4	treatment	treatment	NOUN
easat-3872	109	5	with	with	ADP
easat-3872	109	6	levofloxacin	levofloxacin	NOUN
easat-3872	109	7	were	be	AUX
easat-3872	109	8	crucial	crucial	ADJ
easat-3872	109	9	in	in	ADP
easat-3872	109	10	averting	avert	VERB
easat-3872	109	11	further	further	ADJ
easat-3872	109	12	complications	complication	NOUN
easat-3872	109	13	[	[	X
easat-3872	109	14	11	11	NUM
easat-3872	109	15	]	]	PUNCT
easat-3872	109	16	.	.	PUNCT
easat-3872	110	1	this	this	PRON
easat-3872	110	2	underscores	underscore	VERB
easat-3872	110	3	the	the	DET
easat-3872	110	4	necessity	necessity	NOUN
easat-3872	110	5	for	for	ADP
easat-3872	110	6	vigilant	vigilant	ADJ
easat-3872	110	7	monitoring	monitoring	NOUN
easat-3872	110	8	of	of	ADP
easat-3872	110	9	nosocomial	nosocomial	ADJ
easat-3872	110	10	infections	infection	NOUN
easat-3872	110	11	,	,	PUNCT
easat-3872	110	12	particularly	particularly	ADV
easat-3872	110	13	in	in	ADP
easat-3872	110	14	neonates	neonate	NOUN
easat-3872	110	15	undergoing	undergo	VERB
easat-3872	110	16	prolonged	prolonged	ADJ
easat-3872	110	17	hospital	hospital	NOUN
easat-3872	110	18	stays	stay	NOUN
easat-3872	110	19	and	and	CCONJ
easat-3872	110	20	invasive	invasive	ADJ
easat-3872	110	21	procedures	procedure	NOUN
easat-3872	110	22	[	[	X
easat-3872	110	23	12	12	NUM
easat-3872	110	24	]	]	PUNCT
easat-3872	110	25	.	.	PUNCT
easat-3872	111	1	despite	despite	SCONJ
easat-3872	111	2	these	these	DET
easat-3872	111	3	challenges	challenge	NOUN
easat-3872	111	4	,	,	PUNCT
easat-3872	111	5	the	the	DET
easat-3872	111	6	neonate	neonate	NOUN
easat-3872	111	7	in	in	ADP
easat-3872	111	8	this	this	DET
easat-3872	111	9	case	case	NOUN
easat-3872	111	10	showed	show	VERB
easat-3872	111	11	marked	mark	VERB
easat-3872	111	12	improvement	improvement	NOUN
easat-3872	111	13	,	,	PUNCT
easat-3872	111	14	attaining	attain	VERB
easat-3872	111	15	stable	stable	ADJ
easat-3872	111	16	glycemic	glycemic	ADJ
easat-3872	111	17	control	control	NOUN
easat-3872	111	18	without	without	ADP
easat-3872	111	19	requiring	require	VERB
easat-3872	111	20	surgical	surgical	ADJ
easat-3872	111	21	intervention	intervention	NOUN
easat-3872	111	22	.	.	PUNCT
easat-3872	112	1	this	this	DET
easat-3872	112	2	favorable	favorable	ADJ
easat-3872	112	3	outcome	outcome	NOUN
easat-3872	112	4	,	,	PUNCT
easat-3872	112	5	including	include	VERB
easat-3872	112	6	normal	normal	ADJ
easat-3872	112	7	growth	growth	NOUN
easat-3872	112	8	and	and	CCONJ
easat-3872	112	9	development	development	NOUN
easat-3872	112	10	at	at	ADP
easat-3872	112	11	discharge	discharge	NOUN
easat-3872	112	12	,	,	PUNCT
easat-3872	112	13	contrasts	contrast	VERB
easat-3872	112	14	sharply	sharply	ADV
easat-3872	112	15	with	with	ADP
easat-3872	112	16	reports	report	NOUN
easat-3872	112	17	highlighting	highlight	VERB
easat-3872	112	18	the	the	DET
easat-3872	112	19	high	high	ADJ
easat-3872	112	20	morbidity	morbidity	NOUN
easat-3872	112	21	and	and	CCONJ
easat-3872	112	22	mortality	mortality	NOUN
easat-3872	112	23	rates	rate	NOUN
easat-3872	112	24	in	in	ADP
easat-3872	112	25	untreated	untreated	ADJ
easat-3872	112	26	or	or	CCONJ
easat-3872	112	27	poorly	poorly	ADV
easat-3872	112	28	managed	manage	VERB
easat-3872	112	29	phhi	phhi	NOUN
easat-3872	112	30	cases	case	NOUN
easat-3872	112	31	[	[	X
easat-3872	112	32	13	13	NUM
easat-3872	112	33	]	]	PUNCT
easat-3872	112	34	.	.	PUNCT
easat-3872	113	1	research	research	NOUN
easat-3872	113	2	indicates	indicate	VERB
easat-3872	113	3	that	that	SCONJ
easat-3872	113	4	severe	severe	ADJ
easat-3872	113	5	phhi	phhi	NOUN
easat-3872	113	6	,	,	PUNCT
easat-3872	113	7	if	if	SCONJ
easat-3872	113	8	not	not	PART
easat-3872	113	9	adequately	adequately	ADV
easat-3872	113	10	managed	manage	VERB
easat-3872	113	11	,	,	PUNCT
easat-3872	113	12	can	can	AUX
easat-3872	113	13	lead	lead	VERB
easat-3872	113	14	to	to	ADP
easat-3872	113	15	neurological	neurological	ADJ
easat-3872	113	16	impairments	impairment	NOUN
easat-3872	113	17	in	in	ADP
easat-3872	113	18	up	up	ADP
easat-3872	113	19	to	to	PART
easat-3872	113	20	50	50	NUM
easat-3872	113	21	%	%	NOUN
easat-3872	113	22	of	of	ADP
easat-3872	113	23	cases	case	NOUN
easat-3872	113	24	[	[	X
easat-3872	113	25	14	14	NUM
easat-3872	113	26	]	]	PUNCT
easat-3872	113	27	.	.	PUNCT
easat-3872	114	1	this	this	DET
easat-3872	114	2	case	case	NOUN
easat-3872	114	3	contributes	contribute	VERB
easat-3872	114	4	significantly	significantly	ADV
easat-3872	114	5	to	to	ADP
easat-3872	114	6	the	the	DET
easat-3872	114	7	emerging	emerge	VERB
easat-3872	114	8	evidence	evidence	NOUN
easat-3872	114	9	supporting	support	VERB
easat-3872	114	10	the	the	DET
easat-3872	114	11	use	use	NOUN
easat-3872	114	12	of	of	ADP
easat-3872	114	13	nifedipine	nifedipine	NOUN
easat-3872	114	14	in	in	ADP
easat-3872	114	15	the	the	DET
easat-3872	114	16	management	management	NOUN
easat-3872	114	17	of	of	ADP
easat-3872	114	18	phhi	phhi	NOUN
easat-3872	114	19	.	.	PUNCT
easat-3872	115	1	its	its	PRON
easat-3872	115	2	successful	successful	ADJ
easat-3872	115	3	application	application	NOUN
easat-3872	115	4	here	here	ADV
easat-3872	115	5	not	not	PART
easat-3872	115	6	only	only	ADV
easat-3872	115	7	underscores	underscore	VERB
easat-3872	115	8	an	an	DET
easat-3872	115	9	alternative	alternative	ADJ
easat-3872	115	10	therapeutic	therapeutic	ADJ
easat-3872	115	11	avenue	avenue	NOUN
easat-3872	115	12	but	but	CCONJ
easat-3872	115	13	also	also	ADV
easat-3872	115	14	prompts	prompt	VERB
easat-3872	115	15	the	the	DET
easat-3872	115	16	reevaluation	reevaluation	NOUN
easat-3872	115	17	of	of	ADP
easat-3872	115	18	treatment	treatment	NOUN
easat-3872	115	19	protocols	protocol	NOUN
easat-3872	115	20	in	in	ADP
easat-3872	115	21	resource	resource	NOUN
easat-3872	115	22	-	-	PUNCT
easat-3872	115	23	limited	limit	VERB
easat-3872	115	24	settings	setting	NOUN
easat-3872	115	25	.	.	PUNCT
easat-3872	116	1	this	this	DET
easat-3872	116	2	adaptability	adaptability	NOUN
easat-3872	116	3	aligns	align	VERB
easat-3872	116	4	with	with	ADP
easat-3872	116	5	international	international	ADJ
easat-3872	116	6	guidelines	guideline	NOUN
easat-3872	116	7	,	,	PUNCT
easat-3872	116	8	suggesting	suggest	VERB
easat-3872	116	9	a	a	DET
easat-3872	116	10	model	model	NOUN
easat-3872	116	11	for	for	ADP
easat-3872	116	12	other	other	ADJ
easat-3872	116	13	clinicians	clinician	NOUN
easat-3872	116	14	facing	face	VERB
easat-3872	116	15	similar	similar	ADJ
easat-3872	116	16	resource	resource	NOUN
easat-3872	116	17	constraints	constraint	NOUN
easat-3872	116	18	[	[	X
easat-3872	116	19	6	6	NUM
easat-3872	116	20	]	]	PUNCT
easat-3872	116	21	.	.	PUNCT
easat-3872	117	1	moreover	moreover	ADV
easat-3872	117	2	,	,	PUNCT
easat-3872	117	3	the	the	DET
easat-3872	117	4	synergistic	synergistic	ADJ
easat-3872	117	5	use	use	NOUN
easat-3872	117	6	of	of	ADP
easat-3872	117	7	octreotide	octreotide	NOUN
easat-3872	117	8	and	and	CCONJ
easat-3872	117	9	nifedipine	nifedipine	NOUN
easat-3872	117	10	may	may	AUX
easat-3872	117	11	represent	represent	VERB
easat-3872	117	12	an	an	DET
easat-3872	117	13	innovative	innovative	ADJ
easat-3872	117	14	therapeutic	therapeutic	ADJ
easat-3872	117	15	approach	approach	NOUN
easat-3872	117	16	,	,	PUNCT
easat-3872	117	17	meriting	merit	VERB
easat-3872	117	18	further	further	ADJ
easat-3872	117	19	exploration	exploration	NOUN
easat-3872	117	20	.	.	PUNCT
easat-3872	118	1	such	such	ADJ
easat-3872	118	2	combinations	combination	NOUN
easat-3872	118	3	could	could	AUX
easat-3872	118	4	expand	expand	VERB
easat-3872	118	5	the	the	DET
easat-3872	118	6	treatment	treatment	NOUN
easat-3872	118	7	arsenal	arsenal	NOUN
easat-3872	118	8	for	for	ADP
easat-3872	118	9	phhi	phhi	NOUN
easat-3872	118	10	,	,	PUNCT
easat-3872	118	11	particularly	particularly	ADV
easat-3872	118	12	in	in	ADP
easat-3872	118	13	cases	case	NOUN
easat-3872	118	14	where	where	SCONJ
easat-3872	118	15	surgery	surgery	NOUN
easat-3872	118	16	is	be	AUX
easat-3872	118	17	not	not	PART
easat-3872	118	18	an	an	DET
easat-3872	118	19	option	option	NOUN
easat-3872	118	20	or	or	CCONJ
easat-3872	118	21	monotherapy	monotherapy	NOUN
easat-3872	118	22	proves	prove	VERB
easat-3872	118	23	insufficient	insufficient	ADJ
easat-3872	118	24	[	[	X
easat-3872	118	25	2	2	NUM
easat-3872	118	26	]	]	PUNCT
easat-3872	118	27	.	.	PUNCT
easat-3872	119	1	8757	8757	NUM
easat-3872	119	2	edelweiss	edelweiss	PROPN
easat-3872	119	3	applied	apply	VERB
easat-3872	119	4	science	science	NOUN
easat-3872	119	5	and	and	CCONJ
easat-3872	119	6	technology	technology	NOUN
easat-3872	119	7	issn	issn	PROPN
easat-3872	119	8	:	:	PUNCT
easat-3872	119	9	2576	2576	NUM
easat-3872	119	10	-	-	SYM
easat-3872	119	11	8484	8484	NUM
easat-3872	119	12	vol	vol	NOUN
easat-3872	119	13	.	.	PROPN
easat-3872	119	14	8	8	NUM
easat-3872	119	15	,	,	PUNCT
easat-3872	119	16	no	no	INTJ
easat-3872	119	17	.	.	NOUN
easat-3872	119	18	6	6	NUM
easat-3872	119	19	:	:	PUNCT
easat-3872	119	20	8752	8752	NUM
easat-3872	119	21	-	-	SYM
easat-3872	119	22	8758	8758	NUM
easat-3872	119	23	,	,	PUNCT
easat-3872	119	24	2024	2024	NUM
easat-3872	119	25	doi	doi	NOUN
easat-3872	119	26	:	:	PUNCT
easat-3872	119	27	10.55214/25768484.v8i6.3872	10.55214/25768484.v8i6.3872	NUM
easat-3872	119	28	©	©	PROPN
easat-3872	119	29	2024	2024	NUM
easat-3872	119	30	by	by	ADP
easat-3872	119	31	the	the	DET
easat-3872	119	32	authors	author	NOUN
easat-3872	119	33	;	;	PUNCT
easat-3872	119	34	licensee	licensee	PROPN
easat-3872	119	35	learning	learning	NOUN
easat-3872	119	36	gate	gate	VERB
easat-3872	119	37	the	the	DET
easat-3872	119	38	primary	primary	ADJ
easat-3872	119	39	limitation	limitation	NOUN
easat-3872	119	40	of	of	ADP
easat-3872	119	41	this	this	DET
easat-3872	119	42	case	case	NOUN
easat-3872	119	43	is	be	AUX
easat-3872	119	44	the	the	DET
easat-3872	119	45	short	short	ADJ
easat-3872	119	46	follow	follow	NOUN
easat-3872	119	47	-	-	PUNCT
easat-3872	119	48	up	up	NOUN
easat-3872	119	49	period	period	NOUN
easat-3872	119	50	,	,	PUNCT
easat-3872	119	51	which	which	PRON
easat-3872	119	52	restricts	restrict	VERB
easat-3872	119	53	the	the	DET
easat-3872	119	54	ability	ability	NOUN
easat-3872	119	55	to	to	PART
easat-3872	119	56	assess	assess	VERB
easat-3872	119	57	long	long	ADJ
easat-3872	119	58	-	-	PUNCT
easat-3872	119	59	term	term	NOUN
easat-3872	119	60	outcomes	outcome	NOUN
easat-3872	119	61	,	,	PUNCT
easat-3872	119	62	such	such	ADJ
easat-3872	119	63	as	as	ADP
easat-3872	119	64	neurodevelopmental	neurodevelopmental	ADJ
easat-3872	119	65	delays	delay	NOUN
easat-3872	119	66	or	or	CCONJ
easat-3872	119	67	the	the	DET
easat-3872	119	68	potential	potential	ADJ
easat-3872	119	69	risk	risk	NOUN
easat-3872	119	70	of	of	ADP
easat-3872	119	71	diabetes	diabetes	NOUN
easat-3872	119	72	mellitus	mellitus	NOUN
easat-3872	119	73	.	.	PUNCT
easat-3872	120	1	longitudinal	longitudinal	ADJ
easat-3872	120	2	studies	study	NOUN
easat-3872	120	3	are	be	AUX
easat-3872	120	4	essential	essential	ADJ
easat-3872	120	5	to	to	PART
easat-3872	120	6	evaluate	evaluate	VERB
easat-3872	120	7	the	the	DET
easat-3872	120	8	sustainability	sustainability	NOUN
easat-3872	120	9	of	of	ADP
easat-3872	120	10	glycemic	glycemic	ADJ
easat-3872	120	11	control	control	NOUN
easat-3872	120	12	and	and	CCONJ
easat-3872	120	13	broader	broad	ADJ
easat-3872	120	14	patient	patient	ADJ
easat-3872	120	15	outcomes	outcome	NOUN
easat-3872	120	16	,	,	PUNCT
easat-3872	120	17	as	as	SCONJ
easat-3872	120	18	highlighted	highlight	VERB
easat-3872	120	19	in	in	ADP
easat-3872	120	20	similar	similar	ADJ
easat-3872	120	21	research	research	NOUN
easat-3872	120	22	focusing	focus	VERB
easat-3872	120	23	on	on	ADP
easat-3872	120	24	chronic	chronic	ADJ
easat-3872	120	25	conditions	condition	NOUN
easat-3872	120	26	in	in	ADP
easat-3872	120	27	neonates	neonate	NOUN
easat-3872	120	28	[	[	X
easat-3872	120	29	15	15	NUM
easat-3872	120	30	]	]	PUNCT
easat-3872	120	31	.	.	PUNCT
easat-3872	121	1	while	while	SCONJ
easat-3872	121	2	this	this	DET
easat-3872	121	3	case	case	NOUN
easat-3872	121	4	underscores	underscore	VERB
easat-3872	121	5	the	the	DET
easat-3872	121	6	utility	utility	NOUN
easat-3872	121	7	of	of	ADP
easat-3872	121	8	nifedipine	nifedipine	NOUN
easat-3872	121	9	in	in	ADP
easat-3872	121	10	managing	manage	VERB
easat-3872	121	11	phhi	phhi	NOUN
easat-3872	121	12	,	,	PUNCT
easat-3872	121	13	the	the	DET
easat-3872	121	14	absence	absence	NOUN
easat-3872	121	15	of	of	ADP
easat-3872	121	16	large	large	ADJ
easat-3872	121	17	-	-	PUNCT
easat-3872	121	18	scale	scale	NOUN
easat-3872	121	19	,	,	PUNCT
easat-3872	121	20	randomized	randomize	VERB
easat-3872	121	21	controlled	control	VERB
easat-3872	121	22	trials	trial	NOUN
easat-3872	121	23	limits	limit	VERB
easat-3872	121	24	the	the	DET
easat-3872	121	25	generalizability	generalizability	NOUN
easat-3872	121	26	of	of	ADP
easat-3872	121	27	these	these	DET
easat-3872	121	28	findings	finding	NOUN
easat-3872	121	29	.	.	PUNCT
easat-3872	122	1	future	future	ADJ
easat-3872	122	2	research	research	NOUN
easat-3872	122	3	should	should	AUX
easat-3872	122	4	prioritize	prioritize	VERB
easat-3872	122	5	these	these	DET
easat-3872	122	6	trials	trial	NOUN
easat-3872	122	7	to	to	PART
easat-3872	122	8	establish	establish	VERB
easat-3872	122	9	nifedipine	nifedipine	PROPN
easat-3872	122	10	’s	’s	PART
easat-3872	122	11	efficacy	efficacy	NOUN
easat-3872	122	12	,	,	PUNCT
easat-3872	122	13	optimal	optimal	ADJ
easat-3872	122	14	dosing	dosing	NOUN
easat-3872	122	15	,	,	PUNCT
easat-3872	122	16	and	and	CCONJ
easat-3872	122	17	safety	safety	NOUN
easat-3872	122	18	profile	profile	NOUN
easat-3872	122	19	in	in	ADP
easat-3872	122	20	phhi	phhi	NOUN
easat-3872	122	21	management	management	NOUN
easat-3872	122	22	.	.	PUNCT
easat-3872	123	1	such	such	ADJ
easat-3872	123	2	studies	study	NOUN
easat-3872	123	3	would	would	AUX
easat-3872	123	4	strengthen	strengthen	VERB
easat-3872	123	5	the	the	DET
easat-3872	123	6	evidence	evidence	NOUN
easat-3872	123	7	base	base	NOUN
easat-3872	123	8	and	and	CCONJ
easat-3872	123	9	provide	provide	VERB
easat-3872	123	10	clear	clear	ADJ
easat-3872	123	11	guidance	guidance	NOUN
easat-3872	123	12	for	for	ADP
easat-3872	123	13	clinical	clinical	ADJ
easat-3872	123	14	practice	practice	NOUN
easat-3872	123	15	[	[	X
easat-3872	123	16	16	16	NUM
easat-3872	123	17	]	]	PUNCT
easat-3872	123	18	.	.	PUNCT
easat-3872	124	1	the	the	DET
easat-3872	124	2	significance	significance	NOUN
easat-3872	124	3	of	of	ADP
easat-3872	124	4	this	this	DET
easat-3872	124	5	case	case	NOUN
easat-3872	124	6	lies	lie	VERB
easat-3872	124	7	not	not	PART
easat-3872	124	8	only	only	ADV
easat-3872	124	9	in	in	ADP
easat-3872	124	10	its	its	PRON
easat-3872	124	11	management	management	NOUN
easat-3872	124	12	strategy	strategy	NOUN
easat-3872	124	13	but	but	CCONJ
easat-3872	124	14	also	also	ADV
easat-3872	124	15	in	in	ADP
easat-3872	124	16	its	its	PRON
easat-3872	124	17	potential	potential	NOUN
easat-3872	124	18	to	to	PART
easat-3872	124	19	broaden	broaden	VERB
easat-3872	124	20	the	the	DET
easat-3872	124	21	understanding	understanding	NOUN
easat-3872	124	22	of	of	ADP
easat-3872	124	23	therapeutic	therapeutic	ADJ
easat-3872	124	24	flexibility	flexibility	NOUN
easat-3872	124	25	in	in	ADP
easat-3872	124	26	phhi	phhi	NOUN
easat-3872	124	27	.	.	PUNCT
easat-3872	125	1	it	it	PRON
easat-3872	125	2	underscores	underscore	VERB
easat-3872	125	3	the	the	DET
easat-3872	125	4	importance	importance	NOUN
easat-3872	125	5	of	of	ADP
easat-3872	125	6	tailoring	tailor	VERB
easat-3872	125	7	treatment	treatment	NOUN
easat-3872	125	8	to	to	ADP
easat-3872	125	9	individual	individual	ADJ
easat-3872	125	10	patient	patient	NOUN
easat-3872	125	11	needs	need	NOUN
easat-3872	125	12	,	,	PUNCT
easat-3872	125	13	particularly	particularly	ADV
easat-3872	125	14	in	in	ADP
easat-3872	125	15	resource	resource	NOUN
easat-3872	125	16	-	-	PUNCT
easat-3872	125	17	constrained	constrain	VERB
easat-3872	125	18	settings	setting	NOUN
easat-3872	125	19	where	where	SCONJ
easat-3872	125	20	standard	standard	ADJ
easat-3872	125	21	therapies	therapy	NOUN
easat-3872	125	22	may	may	AUX
easat-3872	125	23	be	be	AUX
easat-3872	125	24	inaccessible	inaccessible	ADJ
easat-3872	125	25	[	[	X
easat-3872	125	26	1	1	NUM
easat-3872	125	27	]	]	PUNCT
easat-3872	125	28	.	.	PUNCT
easat-3872	126	1	additionally	additionally	ADV
easat-3872	126	2	,	,	PUNCT
easat-3872	126	3	it	it	PRON
easat-3872	126	4	provides	provide	VERB
easat-3872	126	5	valuable	valuable	ADJ
easat-3872	126	6	clinical	clinical	ADJ
easat-3872	126	7	insights	insight	NOUN
easat-3872	126	8	into	into	ADP
easat-3872	126	9	the	the	DET
easat-3872	126	10	efficacy	efficacy	NOUN
easat-3872	126	11	of	of	ADP
easat-3872	126	12	nifedipine	nifedipine	NOUN
easat-3872	126	13	in	in	ADP
easat-3872	126	14	managing	manage	VERB
easat-3872	126	15	a	a	DET
easat-3872	126	16	condition	condition	NOUN
easat-3872	126	17	historically	historically	ADV
easat-3872	126	18	treated	treat	VERB
easat-3872	126	19	with	with	ADP
easat-3872	126	20	more	more	ADJ
easat-3872	126	21	conventional	conventional	ADJ
easat-3872	126	22	pharmacological	pharmacological	ADJ
easat-3872	126	23	agents	agent	NOUN
easat-3872	126	24	.	.	PUNCT
easat-3872	127	1	this	this	DET
easat-3872	127	2	case	case	NOUN
easat-3872	127	3	serves	serve	VERB
easat-3872	127	4	as	as	ADP
easat-3872	127	5	an	an	DET
easat-3872	127	6	important	important	ADJ
easat-3872	127	7	contribution	contribution	NOUN
easat-3872	127	8	to	to	ADP
easat-3872	127	9	the	the	DET
easat-3872	127	10	growing	grow	VERB
easat-3872	127	11	body	body	NOUN
easat-3872	127	12	of	of	ADP
easat-3872	127	13	knowledge	knowledge	NOUN
easat-3872	127	14	on	on	ADP
easat-3872	127	15	phhi	phhi	NOUN
easat-3872	127	16	,	,	PUNCT
easat-3872	127	17	illustrating	illustrate	VERB
easat-3872	127	18	the	the	DET
easat-3872	127	19	critical	critical	ADJ
easat-3872	127	20	need	need	NOUN
easat-3872	127	21	for	for	ADP
easat-3872	127	22	early	early	ADJ
easat-3872	127	23	diagnosis	diagnosis	NOUN
easat-3872	127	24	and	and	CCONJ
easat-3872	127	25	intervention	intervention	NOUN
easat-3872	127	26	to	to	PART
easat-3872	127	27	prevent	prevent	VERB
easat-3872	127	28	severe	severe	ADJ
easat-3872	127	29	outcomes	outcome	NOUN
easat-3872	127	30	.	.	PUNCT
easat-3872	128	1	it	it	PRON
easat-3872	128	2	also	also	ADV
easat-3872	128	3	opens	open	VERB
easat-3872	128	4	a	a	DET
easat-3872	128	5	dialogue	dialogue	NOUN
easat-3872	128	6	on	on	ADP
easat-3872	128	7	the	the	DET
easat-3872	128	8	potential	potential	ADJ
easat-3872	128	9	role	role	NOUN
easat-3872	128	10	of	of	ADP
easat-3872	128	11	alternative	alternative	ADJ
easat-3872	128	12	therapies	therapy	NOUN
easat-3872	128	13	,	,	PUNCT
easat-3872	128	14	paving	pave	VERB
easat-3872	128	15	the	the	DET
easat-3872	128	16	way	way	NOUN
easat-3872	128	17	for	for	ADP
easat-3872	128	18	further	further	ADJ
easat-3872	128	19	research	research	NOUN
easat-3872	128	20	and	and	CCONJ
easat-3872	128	21	consideration	consideration	NOUN
easat-3872	128	22	of	of	ADP
easat-3872	128	23	novel	novel	ADJ
easat-3872	128	24	management	management	NOUN
easat-3872	128	25	strategies	strategy	NOUN
easat-3872	128	26	in	in	ADP
easat-3872	128	27	the	the	DET
easat-3872	128	28	context	context	NOUN
easat-3872	128	29	of	of	ADP
easat-3872	128	30	persistent	persistent	ADJ
easat-3872	128	31	neonatal	neonatal	ADJ
easat-3872	128	32	hypoglycemia	hypoglycemia	NOUN
easat-3872	128	33	.	.	PUNCT
easat-3872	129	1	3	3	X
easat-3872	129	2	.	.	X
easat-3872	129	3	conclusion	conclusion	NOUN
easat-3872	129	4	this	this	DET
easat-3872	129	5	case	case	NOUN
easat-3872	129	6	highlights	highlight	VERB
easat-3872	129	7	the	the	DET
easat-3872	129	8	successful	successful	ADJ
easat-3872	129	9	management	management	NOUN
easat-3872	129	10	of	of	ADP
easat-3872	129	11	phhi	phhi	NOUN
easat-3872	129	12	using	use	VERB
easat-3872	129	13	octreotide	octreotide	NOUN
easat-3872	129	14	and	and	CCONJ
easat-3872	129	15	nifedipine	nifedipine	NOUN
easat-3872	129	16	,	,	PUNCT
easat-3872	129	17	demonstrating	demonstrate	VERB
easat-3872	129	18	their	their	PRON
easat-3872	129	19	potential	potential	NOUN
easat-3872	129	20	as	as	ADP
easat-3872	129	21	effective	effective	ADJ
easat-3872	129	22	alternatives	alternative	NOUN
easat-3872	129	23	when	when	SCONJ
easat-3872	129	24	first	first	ADJ
easat-3872	129	25	-	-	PUNCT
easat-3872	129	26	line	line	NOUN
easat-3872	129	27	therapy	therapy	NOUN
easat-3872	129	28	is	be	AUX
easat-3872	129	29	unavailable	unavailable	ADJ
easat-3872	129	30	.	.	PUNCT
easat-3872	130	1	it	it	PRON
easat-3872	130	2	underscores	underscore	VERB
easat-3872	130	3	the	the	DET
easat-3872	130	4	importance	importance	NOUN
easat-3872	130	5	of	of	ADP
easat-3872	130	6	early	early	ADJ
easat-3872	130	7	diagnosis	diagnosis	NOUN
easat-3872	130	8	and	and	CCONJ
easat-3872	130	9	individualized	individualized	ADJ
easat-3872	130	10	treatment	treatment	NOUN
easat-3872	130	11	in	in	ADP
easat-3872	130	12	preventing	prevent	VERB
easat-3872	130	13	severe	severe	ADJ
easat-3872	130	14	complications	complication	NOUN
easat-3872	130	15	.	.	PUNCT
easat-3872	131	1	the	the	DET
easat-3872	131	2	findings	finding	NOUN
easat-3872	131	3	suggest	suggest	VERB
easat-3872	131	4	a	a	DET
easat-3872	131	5	broader	broad	ADJ
easat-3872	131	6	exploration	exploration	NOUN
easat-3872	131	7	of	of	ADP
easat-3872	131	8	nifedipine	nifedipine	NOUN
easat-3872	131	9	’s	’s	PART
easat-3872	131	10	role	role	NOUN
easat-3872	131	11	in	in	ADP
easat-3872	131	12	phhi	phhi	NOUN
easat-3872	131	13	,	,	PUNCT
easat-3872	131	14	especially	especially	ADV
easat-3872	131	15	in	in	ADP
easat-3872	131	16	resource	resource	NOUN
easat-3872	131	17	-	-	PUNCT
easat-3872	131	18	limited	limit	VERB
easat-3872	131	19	settings	setting	NOUN
easat-3872	131	20	,	,	PUNCT
easat-3872	131	21	and	and	CCONJ
easat-3872	131	22	emphasize	emphasize	VERB
easat-3872	131	23	the	the	DET
easat-3872	131	24	need	need	NOUN
easat-3872	131	25	for	for	SCONJ
easat-3872	131	26	updated	update	VERB
easat-3872	131	27	clinical	clinical	ADJ
easat-3872	131	28	protocols	protocol	NOUN
easat-3872	131	29	to	to	PART
easat-3872	131	30	optimize	optimize	VERB
easat-3872	131	31	neonatal	neonatal	ADJ
easat-3872	131	32	outcomes	outcome	NOUN
easat-3872	131	33	.	.	PUNCT
easat-3872	132	1	this	this	DET
easat-3872	132	2	case	case	NOUN
easat-3872	132	3	serves	serve	VERB
easat-3872	132	4	as	as	ADP
easat-3872	132	5	a	a	DET
easat-3872	132	6	critical	critical	ADJ
easat-3872	132	7	reference	reference	NOUN
easat-3872	132	8	for	for	ADP
easat-3872	132	9	advancing	advance	VERB
easat-3872	132	10	future	future	ADJ
easat-3872	132	11	research	research	NOUN
easat-3872	132	12	and	and	CCONJ
easat-3872	132	13	clinical	clinical	ADJ
easat-3872	132	14	practice	practice	NOUN
easat-3872	132	15	.	.	PUNCT
easat-3872	133	1	4	4	X
easat-3872	133	2	.	.	X
easat-3872	133	3	recommendation	recommendation	NOUN
easat-3872	133	4	based	base	VERB
easat-3872	133	5	on	on	ADP
easat-3872	133	6	this	this	DET
easat-3872	133	7	case	case	NOUN
easat-3872	133	8	,	,	PUNCT
easat-3872	133	9	we	we	PRON
easat-3872	133	10	recommend	recommend	VERB
easat-3872	133	11	expanding	expand	VERB
easat-3872	133	12	the	the	DET
easat-3872	133	13	use	use	NOUN
easat-3872	133	14	of	of	ADP
easat-3872	133	15	nifedipine	nifedipine	NOUN
easat-3872	133	16	as	as	ADP
easat-3872	133	17	a	a	DET
easat-3872	133	18	second	second	ADJ
easat-3872	133	19	-	-	PUNCT
easat-3872	133	20	line	line	NOUN
easat-3872	133	21	therapy	therapy	NOUN
easat-3872	133	22	for	for	ADP
easat-3872	133	23	persistent	persistent	ADJ
easat-3872	133	24	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	133	25	hypoglycemia	hypoglycemia	NOUN
easat-3872	133	26	in	in	ADP
easat-3872	133	27	infancy	infancy	NOUN
easat-3872	133	28	(	(	PUNCT
easat-3872	133	29	phhi	phhi	NOUN
easat-3872	133	30	)	)	PUNCT
easat-3872	133	31	,	,	PUNCT
easat-3872	133	32	especially	especially	ADV
easat-3872	133	33	in	in	ADP
easat-3872	133	34	settings	setting	NOUN
easat-3872	133	35	where	where	SCONJ
easat-3872	133	36	diazoxide	diazoxide	NOUN
easat-3872	133	37	is	be	AUX
easat-3872	133	38	unavailable	unavailable	ADJ
easat-3872	133	39	.	.	PUNCT
easat-3872	134	1	standardizing	standardize	VERB
easat-3872	134	2	dosing	dose	VERB
easat-3872	134	3	and	and	CCONJ
easat-3872	134	4	evaluating	evaluate	VERB
easat-3872	134	5	long	long	ADJ
easat-3872	134	6	-	-	PUNCT
easat-3872	134	7	term	term	NOUN
easat-3872	134	8	efficacy	efficacy	NOUN
easat-3872	134	9	through	through	ADP
easat-3872	134	10	multicenter	multicenter	ADJ
easat-3872	134	11	clinical	clinical	ADJ
easat-3872	134	12	trials	trial	NOUN
easat-3872	134	13	is	be	AUX
easat-3872	134	14	essential	essential	ADJ
easat-3872	134	15	.	.	PUNCT
easat-3872	135	1	early	early	ADJ
easat-3872	135	2	diagnosis	diagnosis	NOUN
easat-3872	135	3	and	and	CCONJ
easat-3872	135	4	adherence	adherence	NOUN
easat-3872	135	5	to	to	ADP
easat-3872	135	6	international	international	ADJ
easat-3872	135	7	guidelines	guideline	NOUN
easat-3872	135	8	are	be	AUX
easat-3872	135	9	critical	critical	ADJ
easat-3872	135	10	to	to	ADP
easat-3872	135	11	preventing	prevent	VERB
easat-3872	135	12	severe	severe	ADJ
easat-3872	135	13	complications	complication	NOUN
easat-3872	135	14	.	.	PUNCT
easat-3872	136	1	to	to	PART
easat-3872	136	2	address	address	VERB
easat-3872	136	3	challenges	challenge	NOUN
easat-3872	136	4	in	in	ADP
easat-3872	136	5	resource	resource	NOUN
easat-3872	136	6	-	-	PUNCT
easat-3872	136	7	limited	limit	VERB
easat-3872	136	8	settings	setting	NOUN
easat-3872	136	9	,	,	PUNCT
easat-3872	136	10	we	we	PRON
easat-3872	136	11	advocate	advocate	VERB
easat-3872	136	12	for	for	ADP
easat-3872	136	13	the	the	DET
easat-3872	136	14	development	development	NOUN
easat-3872	136	15	of	of	ADP
easat-3872	136	16	regional	regional	ADJ
easat-3872	136	17	guidelines	guideline	NOUN
easat-3872	136	18	that	that	PRON
easat-3872	136	19	integrate	integrate	VERB
easat-3872	136	20	alternative	alternative	ADJ
easat-3872	136	21	therapies	therapy	NOUN
easat-3872	136	22	like	like	ADP
easat-3872	136	23	nifedipine	nifedipine	NOUN
easat-3872	136	24	and	and	CCONJ
easat-3872	136	25	octreotide	octreotide	NOUN
easat-3872	136	26	.	.	PUNCT
easat-3872	137	1	structured	structured	ADJ
easat-3872	137	2	training	training	NOUN
easat-3872	137	3	programs	program	NOUN
easat-3872	137	4	for	for	ADP
easat-3872	137	5	healthcare	healthcare	NOUN
easat-3872	137	6	professionals	professional	NOUN
easat-3872	137	7	in	in	ADP
easat-3872	137	8	lowand	lowand	ADJ
easat-3872	137	9	middle	middle	ADJ
easat-3872	137	10	-	-	PUNCT
easat-3872	137	11	income	income	NOUN
easat-3872	137	12	countries	country	NOUN
easat-3872	137	13	are	be	AUX
easat-3872	137	14	crucial	crucial	ADJ
easat-3872	137	15	to	to	PART
easat-3872	137	16	enhance	enhance	VERB
easat-3872	137	17	diagnostic	diagnostic	ADJ
easat-3872	137	18	and	and	CCONJ
easat-3872	137	19	therapeutic	therapeutic	ADJ
easat-3872	137	20	capacity	capacity	NOUN
easat-3872	137	21	.	.	PUNCT
easat-3872	138	1	multidisciplinary	multidisciplinary	ADJ
easat-3872	138	2	collaboration	collaboration	NOUN
easat-3872	138	3	among	among	ADP
easat-3872	138	4	neonatologists	neonatologist	NOUN
easat-3872	138	5	,	,	PUNCT
easat-3872	138	6	endocrinologists	endocrinologist	NOUN
easat-3872	138	7	,	,	PUNCT
easat-3872	138	8	and	and	CCONJ
easat-3872	138	9	pediatricians	pediatrician	NOUN
easat-3872	138	10	is	be	AUX
easat-3872	138	11	essential	essential	ADJ
easat-3872	138	12	for	for	ADP
easat-3872	138	13	holistic	holistic	ADJ
easat-3872	138	14	management	management	NOUN
easat-3872	138	15	.	.	PUNCT
easat-3872	139	1	establishing	establish	VERB
easat-3872	139	2	registries	registry	NOUN
easat-3872	139	3	to	to	PART
easat-3872	139	4	systematically	systematically	ADV
easat-3872	139	5	collect	collect	VERB
easat-3872	139	6	data	datum	NOUN
easat-3872	139	7	on	on	ADP
easat-3872	139	8	alternative	alternative	ADJ
easat-3872	139	9	therapies	therapy	NOUN
easat-3872	139	10	will	will	AUX
easat-3872	139	11	strengthen	strengthen	VERB
easat-3872	139	12	evidence	evidence	NOUN
easat-3872	139	13	-	-	PUNCT
easat-3872	139	14	based	base	VERB
easat-3872	139	15	practice	practice	NOUN
easat-3872	139	16	and	and	CCONJ
easat-3872	139	17	inform	inform	VERB
easat-3872	139	18	clinical	clinical	ADJ
easat-3872	139	19	protocols	protocol	NOUN
easat-3872	139	20	.	.	PUNCT
easat-3872	140	1	these	these	DET
easat-3872	140	2	efforts	effort	NOUN
easat-3872	140	3	aim	aim	VERB
easat-3872	140	4	to	to	PART
easat-3872	140	5	improve	improve	VERB
easat-3872	140	6	phhi	phhi	NOUN
easat-3872	140	7	outcomes	outcome	NOUN
easat-3872	140	8	globally	globally	ADV
easat-3872	140	9	,	,	PUNCT
easat-3872	140	10	particularly	particularly	ADV
easat-3872	140	11	in	in	ADP
easat-3872	140	12	resource	resource	NOUN
easat-3872	140	13	-	-	PUNCT
easat-3872	140	14	constrained	constrain	VERB
easat-3872	140	15	environments	environment	NOUN
easat-3872	140	16	,	,	PUNCT
easat-3872	140	17	while	while	SCONJ
easat-3872	140	18	paving	pave	VERB
easat-3872	140	19	the	the	DET
easat-3872	140	20	way	way	NOUN
easat-3872	140	21	for	for	ADP
easat-3872	140	22	innovative	innovative	ADJ
easat-3872	140	23	and	and	CCONJ
easat-3872	140	24	accessible	accessible	ADJ
easat-3872	140	25	treatment	treatment	NOUN
easat-3872	140	26	approaches	approach	NOUN
easat-3872	140	27	.	.	PUNCT
easat-3872	141	1	conflict	conflict	NOUN
easat-3872	141	2	of	of	ADP
easat-3872	141	3	interest	interest	NOUN
easat-3872	141	4	:	:	PUNCT
easat-3872	141	5	the	the	DET
easat-3872	141	6	authors	author	NOUN
easat-3872	141	7	declare	declare	VERB
easat-3872	141	8	that	that	SCONJ
easat-3872	141	9	there	there	PRON
easat-3872	141	10	is	be	VERB
easat-3872	141	11	no	no	DET
easat-3872	141	12	conflict	conflict	NOUN
easat-3872	141	13	of	of	ADP
easat-3872	141	14	interest	interest	NOUN
easat-3872	141	15	regarding	regard	VERB
easat-3872	141	16	the	the	DET
easat-3872	141	17	publication	publication	NOUN
easat-3872	141	18	of	of	ADP
easat-3872	141	19	this	this	DET
easat-3872	141	20	manuscript	manuscript	NOUN
easat-3872	141	21	.	.	PUNCT
easat-3872	142	1	no	no	DET
easat-3872	142	2	financial	financial	ADJ
easat-3872	142	3	support	support	NOUN
easat-3872	142	4	,	,	PUNCT
easat-3872	142	5	sponsorship	sponsorship	NOUN
easat-3872	142	6	,	,	PUNCT
easat-3872	142	7	or	or	CCONJ
easat-3872	142	8	external	external	ADJ
easat-3872	142	9	funding	funding	NOUN
easat-3872	142	10	was	be	AUX
easat-3872	142	11	received	receive	VERB
easat-3872	142	12	for	for	ADP
easat-3872	142	13	this	this	DET
easat-3872	142	14	case	case	NOUN
easat-3872	142	15	report	report	NOUN
easat-3872	142	16	.	.	PUNCT
easat-3872	143	1	the	the	DET
easat-3872	143	2	authors	author	NOUN
easat-3872	143	3	affirm	affirm	VERB
easat-3872	143	4	that	that	SCONJ
easat-3872	143	5	there	there	PRON
easat-3872	143	6	are	be	VERB
easat-3872	143	7	no	no	DET
easat-3872	143	8	personal	personal	ADJ
easat-3872	143	9	or	or	CCONJ
easat-3872	143	10	institutional	institutional	ADJ
easat-3872	143	11	relationships	relationship	NOUN
easat-3872	143	12	that	that	PRON
easat-3872	143	13	could	could	AUX
easat-3872	143	14	be	be	AUX
easat-3872	143	15	perceived	perceive	VERB
easat-3872	143	16	as	as	ADP
easat-3872	143	17	influencing	influence	VERB
easat-3872	143	18	the	the	DET
easat-3872	143	19	work	work	NOUN
easat-3872	143	20	presented	present	VERB
easat-3872	143	21	in	in	ADP
easat-3872	143	22	this	this	DET
easat-3872	143	23	manuscript	manuscript	NOUN
easat-3872	143	24	.	.	PUNCT
easat-3872	144	1	8758	8758	NUM
easat-3872	144	2	edelweiss	edelweiss	PROPN
easat-3872	144	3	applied	apply	VERB
easat-3872	144	4	science	science	NOUN
easat-3872	144	5	and	and	CCONJ
easat-3872	144	6	technology	technology	NOUN
easat-3872	144	7	issn	issn	PROPN
easat-3872	144	8	:	:	PUNCT
easat-3872	144	9	2576	2576	NUM
easat-3872	144	10	-	-	SYM
easat-3872	144	11	8484	8484	NUM
easat-3872	144	12	vol	vol	NOUN
easat-3872	144	13	.	.	PROPN
easat-3872	144	14	8	8	NUM
easat-3872	144	15	,	,	PUNCT
easat-3872	144	16	no	no	INTJ
easat-3872	144	17	.	.	NOUN
easat-3872	144	18	6	6	NUM
easat-3872	144	19	:	:	PUNCT
easat-3872	144	20	8752	8752	NUM
easat-3872	144	21	-	-	SYM
easat-3872	144	22	8758	8758	NUM
easat-3872	144	23	,	,	PUNCT
easat-3872	144	24	2024	2024	NUM
easat-3872	144	25	doi	doi	NOUN
easat-3872	144	26	:	:	PUNCT
easat-3872	144	27	10.55214/25768484.v8i6.3872	10.55214/25768484.v8i6.3872	NUM
easat-3872	144	28	©	©	PROPN
easat-3872	144	29	2024	2024	NUM
easat-3872	144	30	by	by	ADP
easat-3872	144	31	the	the	DET
easat-3872	144	32	authors	author	NOUN
easat-3872	144	33	;	;	PUNCT
easat-3872	144	34	licensee	licensee	PROPN
easat-3872	144	35	learning	learn	VERB
easat-3872	144	36	gate	gate	NOUN
easat-3872	144	37	acknowledgments	acknowledgment	NOUN
easat-3872	144	38	:	:	PUNCT
easat-3872	144	39	the	the	DET
easat-3872	144	40	authors	author	NOUN
easat-3872	144	41	would	would	AUX
easat-3872	144	42	like	like	VERB
easat-3872	144	43	to	to	PART
easat-3872	144	44	thank	thank	VERB
easat-3872	144	45	the	the	DET
easat-3872	144	46	medical	medical	ADJ
easat-3872	144	47	staff	staff	NOUN
easat-3872	144	48	and	and	CCONJ
easat-3872	144	49	healthcare	healthcare	NOUN
easat-3872	144	50	professionals	professional	NOUN
easat-3872	144	51	involved	involve	VERB
easat-3872	144	52	in	in	ADP
easat-3872	144	53	the	the	DET
easat-3872	144	54	diagnosis	diagnosis	NOUN
easat-3872	144	55	and	and	CCONJ
easat-3872	144	56	treatment	treatment	NOUN
easat-3872	144	57	of	of	ADP
easat-3872	144	58	the	the	DET
easat-3872	144	59	patient	patient	NOUN
easat-3872	144	60	.	.	PUNCT
easat-3872	145	1	we	we	PRON
easat-3872	145	2	would	would	AUX
easat-3872	145	3	like	like	VERB
easat-3872	145	4	to	to	PART
easat-3872	145	5	thank	thank	VERB
easat-3872	145	6	our	our	PRON
easat-3872	145	7	colleagues	colleague	NOUN
easat-3872	145	8	for	for	ADP
easat-3872	145	9	their	their	PRON
easat-3872	145	10	insightful	insightful	ADJ
easat-3872	145	11	discussions	discussion	NOUN
easat-3872	145	12	and	and	CCONJ
easat-3872	145	13	support	support	NOUN
easat-3872	145	14	throughout	throughout	ADP
easat-3872	145	15	the	the	DET
easat-3872	145	16	preparation	preparation	NOUN
easat-3872	145	17	of	of	ADP
easat-3872	145	18	this	this	DET
easat-3872	145	19	manuscript	manuscript	NOUN
easat-3872	145	20	.	.	PUNCT
easat-3872	146	1	copyright	copyright	NOUN
easat-3872	146	2	:	:	PUNCT
easat-3872	146	3	©	©	PROPN
easat-3872	146	4	2024	2024	NUM
easat-3872	146	5	by	by	ADP
easat-3872	146	6	the	the	DET
easat-3872	146	7	authors	author	NOUN
easat-3872	146	8	.	.	PUNCT
easat-3872	147	1	this	this	DET
easat-3872	147	2	article	article	NOUN
easat-3872	147	3	is	be	AUX
easat-3872	147	4	an	an	DET
easat-3872	147	5	open	open	ADJ
easat-3872	147	6	access	access	NOUN
easat-3872	147	7	article	article	NOUN
easat-3872	147	8	distributed	distribute	VERB
easat-3872	147	9	under	under	ADP
easat-3872	147	10	the	the	DET
easat-3872	147	11	terms	term	NOUN
easat-3872	147	12	and	and	CCONJ
easat-3872	147	13	conditions	condition	NOUN
easat-3872	147	14	of	of	ADP
easat-3872	147	15	the	the	DET
easat-3872	147	16	creative	creative	ADJ
easat-3872	147	17	commons	common	NOUN
easat-3872	147	18	attribution	attribution	NOUN
easat-3872	147	19	(	(	PUNCT
easat-3872	147	20	cc	cc	NOUN
easat-3872	147	21	by	by	ADP
easat-3872	147	22	)	)	PUNCT
easat-3872	147	23	license	license	NOUN
easat-3872	147	24	(	(	PUNCT
easat-3872	147	25	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-3872	147	26	)	)	PUNCT
easat-3872	147	27	.	.	PUNCT
easat-3872	148	1	references	reference	NOUN
easat-3872	148	2	[	[	X
easat-3872	148	3	1	1	NUM
easat-3872	148	4	]	]	X
easat-3872	148	5	y.	y.	NOUN
easat-3872	148	6	hosokawa	hosokawa	PROPN
easat-3872	148	7	,	,	PUNCT
easat-3872	148	8	r.	r.	PROPN
easat-3872	148	9	kawakita	kawakita	PROPN
easat-3872	148	10	,	,	PUNCT
easat-3872	148	11	s.	s.	PROPN
easat-3872	148	12	yokoya	yokoya	PROPN
easat-3872	148	13	,	,	PUNCT
easat-3872	148	14	et	et	PROPN
easat-3872	148	15	al	al	PROPN
easat-3872	148	16	.	.	PROPN
easat-3872	148	17	,	,	PUNCT
easat-3872	148	18	"	"	PUNCT
easat-3872	148	19	efficacy	efficacy	NOUN
easat-3872	148	20	and	and	CCONJ
easat-3872	148	21	safety	safety	NOUN
easat-3872	148	22	of	of	ADP
easat-3872	148	23	octreotide	octreotide	NOUN
easat-3872	148	24	for	for	ADP
easat-3872	148	25	the	the	DET
easat-3872	148	26	treatment	treatment	NOUN
easat-3872	148	27	of	of	ADP
easat-3872	148	28	congenital	congenital	ADJ
easat-3872	148	29	hyperinsulinism	hyperinsulinism	NOUN
easat-3872	148	30	:	:	PUNCT
easat-3872	148	31	a	a	DET
easat-3872	148	32	prospective	prospective	ADJ
easat-3872	148	33	,	,	PUNCT
easat-3872	148	34	open	open	ADJ
easat-3872	148	35	-	-	PUNCT
easat-3872	148	36	label	label	NOUN
easat-3872	148	37	clinical	clinical	ADJ
easat-3872	148	38	trial	trial	NOUN
easat-3872	148	39	and	and	CCONJ
easat-3872	148	40	an	an	DET
easat-3872	148	41	observational	observational	ADJ
easat-3872	148	42	study	study	NOUN
easat-3872	148	43	in	in	ADP
easat-3872	148	44	japan	japan	PROPN
easat-3872	148	45	,	,	PUNCT
easat-3872	148	46	"	"	PUNCT
easat-3872	148	47	endocr	endocr	PROPN
easat-3872	148	48	j.	j.	PROPN
easat-3872	148	49	,	,	PUNCT
easat-3872	148	50	69	69	NUM
easat-3872	148	51	,	,	PUNCT
easat-3872	148	52	pp	pp	ADJ
easat-3872	148	53	.	.	PUNCT
easat-3872	148	54	867880	867880	NUM
easat-3872	148	55	,	,	PUNCT
easat-3872	148	56	2022	2022	NUM
easat-3872	148	57	.	.	PUNCT
easat-3872	149	1	doi	doi	NOUN
easat-3872	149	2	:	:	PUNCT
easat-3872	149	3	10.1507	10.1507	NUM
easat-3872	149	4	/	/	SYM
easat-3872	149	5	endocrj	endocrj	NOUN
easat-3872	149	6	.	.	PUNCT
easat-3872	150	1	ej17	ej17	PROPN
easat-3872	150	2	-	-	PUNCT
easat-3872	150	3	0024	0024	NUM
easat-3872	150	4	.	.	PUNCT
easat-3872	151	1	[	[	X
easat-3872	151	2	2	2	NUM
easat-3872	151	3	]	]	PUNCT
easat-3872	151	4	a.	a.	NOUN
easat-3872	151	5	muslihatin	muslihatin	PROPN
easat-3872	151	6	,	,	PUNCT
easat-3872	151	7	n.	n.	NOUN
easat-3872	151	8	rochmah	rochmah	PROPN
easat-3872	151	9	,	,	PUNCT
easat-3872	151	10	m.	m.	NOUN
easat-3872	151	11	faizi	faizi	PROPN
easat-3872	151	12	,	,	PUNCT
easat-3872	151	13	and	and	CCONJ
easat-3872	151	14	q.	q.	PROPN
easat-3872	151	15	a.	a.	PROPN
easat-3872	151	16	n.	n.	PROPN
easat-3872	151	17	putri	putri	PROPN
easat-3872	151	18	,	,	PUNCT
easat-3872	151	19	"	"	PUNCT
easat-3872	151	20	management	management	NOUN
easat-3872	151	21	of	of	ADP
easat-3872	151	22	persistent	persistent	ADJ
easat-3872	151	23	hyperinsulinemia	hyperinsulinemia	NOUN
easat-3872	151	24	hypoglycemia	hypoglycemia	NOUN
easat-3872	151	25	of	of	ADP
easat-3872	151	26	infancy	infancy	NOUN
easat-3872	151	27	,	,	PUNCT
easat-3872	151	28	"	"	PUNCT
easat-3872	151	29	international	international	ADJ
easat-3872	151	30	journal	journal	NOUN
easat-3872	151	31	of	of	ADP
easat-3872	151	32	health	health	PROPN
easat-3872	151	33	sciences	sciences	PROPN
easat-3872	151	34	,	,	PUNCT
easat-3872	151	35	6	6	NUM
easat-3872	151	36	,	,	PUNCT
easat-3872	151	37	pp	pp	PROPN
easat-3872	151	38	.	.	PUNCT
easat-3872	151	39	-	-	PUNCT
easat-3872	151	40	,	,	PUNCT
easat-3872	151	41	2022	2022	NUM
easat-3872	151	42	.	.	PUNCT
easat-3872	152	1	doi	doi	NOUN
easat-3872	152	2	:	:	PUNCT
easat-3872	152	3	10.53730	10.53730	NUM
easat-3872	152	4	/	/	SYM
easat-3872	152	5	ijhs.v6ns9.12350	ijhs.v6ns9.12350	NOUN
easat-3872	152	6	.	.	PUNCT
easat-3872	153	1	[	[	X
easat-3872	153	2	3	3	X
easat-3872	153	3	]	]	X
easat-3872	153	4	e.	e.	PROPN
easat-3872	153	5	durmaz	durmaz	PROPN
easat-3872	153	6	,	,	PUNCT
easat-3872	153	7	s.	s.	PROPN
easat-3872	153	8	flanagan	flanagan	PROPN
easat-3872	153	9	,	,	PUNCT
easat-3872	153	10	m.	m.	NOUN
easat-3872	153	11	parlak	parlak	NOUN
easat-3872	153	12	,	,	PUNCT
easat-3872	153	13	s.	s.	PROPN
easat-3872	153	14	ellard	ellard	PROPN
easat-3872	153	15	,	,	PUNCT
easat-3872	153	16	s.	s.	PROPN
easat-3872	153	17	akçurin	akçurin	PROPN
easat-3872	153	18	,	,	PUNCT
easat-3872	153	19	and	and	CCONJ
easat-3872	153	20	i̇.	i̇.	PROPN
easat-3872	153	21	bircan	bircan	NOUN
easat-3872	153	22	,	,	PUNCT
easat-3872	153	23	"	"	PUNCT
easat-3872	153	24	a	a	DET
easat-3872	153	25	combination	combination	NOUN
easat-3872	153	26	of	of	ADP
easat-3872	153	27	nifedipine	nifedipine	NOUN
easat-3872	153	28	and	and	CCONJ
easat-3872	153	29	octreotide	octreotide	NOUN
easat-3872	153	30	treatment	treatment	NOUN
easat-3872	153	31	in	in	ADP
easat-3872	153	32	a	a	DET
easat-3872	153	33	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	153	34	hypoglycemic	hypoglycemic	ADJ
easat-3872	153	35	infant	infant	NOUN
easat-3872	153	36	,	,	PUNCT
easat-3872	153	37	"	"	PUNCT
easat-3872	153	38	journal	journal	NOUN
easat-3872	153	39	of	of	ADP
easat-3872	153	40	clinical	clinical	ADJ
easat-3872	153	41	research	research	NOUN
easat-3872	153	42	in	in	ADP
easat-3872	153	43	pediatric	pediatric	ADJ
easat-3872	153	44	endocrinology	endocrinology	NOUN
easat-3872	153	45	,	,	PUNCT
easat-3872	153	46	6	6	NUM
easat-3872	153	47	,	,	PUNCT
easat-3872	153	48	pp	pp	ADJ
easat-3872	153	49	.	.	PUNCT
easat-3872	154	1	119	119	NUM
easat-3872	154	2	-	-	SYM
easat-3872	154	3	121	121	NUM
easat-3872	154	4	,	,	PUNCT
easat-3872	154	5	2014	2014	NUM
easat-3872	154	6	.	.	PUNCT
easat-3872	155	1	doi	doi	NOUN
easat-3872	155	2	:	:	PUNCT
easat-3872	155	3	10.4274	10.4274	NUM
easat-3872	155	4	/	/	SYM
easat-3872	155	5	jcrpe.1230	jcrpe.1230	NOUN
easat-3872	155	6	.	.	PUNCT
easat-3872	156	1	[	[	X
easat-3872	156	2	4	4	X
easat-3872	156	3	]	]	PUNCT
easat-3872	156	4	p.	p.	NOUN
easat-3872	156	5	khawash	khawash	PROPN
easat-3872	156	6	,	,	PUNCT
easat-3872	156	7	k.	k.	PROPN
easat-3872	156	8	hussain	hussain	PROPN
easat-3872	156	9	,	,	PUNCT
easat-3872	156	10	s.	s.	PROPN
easat-3872	156	11	flanagan	flanagan	PROPN
easat-3872	156	12	,	,	PUNCT
easat-3872	156	13	s.	s.	PROPN
easat-3872	156	14	chatterjee	chatterjee	PROPN
easat-3872	156	15	,	,	PUNCT
easat-3872	156	16	and	and	CCONJ
easat-3872	156	17	d.	d.	PROPN
easat-3872	156	18	basak	basak	PROPN
easat-3872	156	19	,	,	PUNCT
easat-3872	156	20	"	"	PUNCT
easat-3872	156	21	nifedipine	nifedipine	NOUN
easat-3872	156	22	in	in	ADP
easat-3872	156	23	congenital	congenital	ADJ
easat-3872	156	24	hyperinsulinism	hyperinsulinism	NOUN
easat-3872	156	25	:	:	PUNCT
easat-3872	156	26	a	a	DET
easat-3872	156	27	case	case	NOUN
easat-3872	156	28	report	report	NOUN
easat-3872	156	29	,	,	PUNCT
easat-3872	156	30	"	"	PUNCT
easat-3872	156	31	journal	journal	NOUN
easat-3872	156	32	of	of	ADP
easat-3872	156	33	clinical	clinical	ADJ
easat-3872	156	34	research	research	NOUN
easat-3872	156	35	in	in	ADP
easat-3872	156	36	pediatric	pediatric	ADJ
easat-3872	156	37	endocrinology	endocrinology	NOUN
easat-3872	156	38	,	,	PUNCT
easat-3872	156	39	7	7	NUM
easat-3872	156	40	,	,	PUNCT
easat-3872	156	41	pp	pp	ADJ
easat-3872	156	42	.	.	PUNCT
easat-3872	157	1	151	151	NUM
easat-3872	157	2	-	-	SYM
easat-3872	157	3	154	154	NUM
easat-3872	157	4	,	,	PUNCT
easat-3872	157	5	2015	2015	NUM
easat-3872	157	6	.	.	PUNCT
easat-3872	158	1	doi	doi	NOUN
easat-3872	158	2	:	:	PUNCT
easat-3872	158	3	10.4274	10.4274	NUM
easat-3872	158	4	/	/	SYM
easat-3872	158	5	jcrpe.1978	jcrpe.1978	PROPN
easat-3872	158	6	.	.	PUNCT
easat-3872	159	1	[	[	X
easat-3872	159	2	5	5	X
easat-3872	159	3	]	]	PUNCT
easat-3872	159	4	l.	l.	PROPN
easat-3872	159	5	a.	a.	PROPN
easat-3872	159	6	markham	markham	PROPN
easat-3872	159	7	,	,	PUNCT
easat-3872	159	8	"	"	PUNCT
easat-3872	159	9	persistent	persistent	ADJ
easat-3872	159	10	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	159	11	hypoglycemia	hypoglycemia	NOUN
easat-3872	159	12	in	in	ADP
easat-3872	159	13	infants	infant	NOUN
easat-3872	159	14	,	,	PUNCT
easat-3872	159	15	"	"	PUNCT
easat-3872	159	16	newborn	newborn	ADJ
easat-3872	159	17	and	and	CCONJ
easat-3872	159	18	infant	infant	NOUN
easat-3872	159	19	nursing	nursing	NOUN
easat-3872	159	20	reviews	review	NOUN
easat-3872	159	21	,	,	PUNCT
easat-3872	159	22	20	20	NUM
easat-3872	159	23	,	,	PUNCT
easat-3872	159	24	pp	pp	ADJ
easat-3872	159	25	.	.	PUNCT
easat-3872	160	1	156	156	NUM
easat-3872	160	2	-	-	SYM
easat-3872	160	3	165	165	NUM
easat-3872	160	4	,	,	PUNCT
easat-3872	160	5	2003	2003	NUM
easat-3872	160	6	.	.	PUNCT
easat-3872	161	1	doi	doi	NOUN
easat-3872	161	2	:	:	PUNCT
easat-3872	161	3	10.1053	10.1053	NUM
easat-3872	161	4	/	/	SYM
easat-3872	161	5	s1527	s1527	PROPN
easat-3872	161	6	-	-	PUNCT
easat-3872	161	7	3369(03)00115	3369(03)00115	NOUN
easat-3872	161	8	-	-	PUNCT
easat-3872	161	9	6	6	NUM
easat-3872	161	10	.	.	PUNCT
easat-3872	162	1	[	[	X
easat-3872	162	2	6	6	NUM
easat-3872	162	3	]	]	PUNCT
easat-3872	162	4	m.	m.	NOUN
easat-3872	162	5	hyunjung	hyunjung	PROPN
easat-3872	162	6	kim	kim	PROPN
easat-3872	162	7	,	,	PUNCT
easat-3872	162	8	j.	j.	PROPN
easat-3872	162	9	kim	kim	PROPN
easat-3872	162	10	,	,	PUNCT
easat-3872	162	11	h.	h.	PROPN
easat-3872	162	12	shin	shin	PROPN
easat-3872	162	13	,	,	PUNCT
easat-3872	162	14	et	et	PROPN
easat-3872	162	15	al	al	PROPN
easat-3872	162	16	.	.	PROPN
easat-3872	162	17	,	,	PUNCT
easat-3872	162	18	"	"	PUNCT
easat-3872	162	19	medical	medical	ADJ
easat-3872	162	20	therapy	therapy	NOUN
easat-3872	162	21	in	in	ADP
easat-3872	162	22	children	child	NOUN
easat-3872	162	23	with	with	ADP
easat-3872	162	24	persistent	persistent	ADJ
easat-3872	162	25	hyperinsulinemic	hyperinsulinemic	ADJ
easat-3872	162	26	hypoglycemia	hypoglycemia	NOUN
easat-3872	162	27	of	of	ADP
easat-3872	162	28	infancy	infancy	NOUN
easat-3872	162	29	(	(	PUNCT
easat-3872	162	30	phhi	phhi	NOUN
easat-3872	162	31	)	)	PUNCT
easat-3872	162	32	,	,	PUNCT
easat-3872	162	33	"	"	PUNCT
easat-3872	162	34	korean	korean	ADJ
easat-3872	162	35	journal	journal	NOUN
easat-3872	162	36	of	of	ADP
easat-3872	162	37	pediatrics	pediatric	NOUN
easat-3872	162	38	,	,	PUNCT
easat-3872	162	39	43	43	NUM
easat-3872	162	40	,	,	PUNCT
easat-3872	162	41	pp	pp	ADJ
easat-3872	162	42	.	.	PUNCT
easat-3872	162	43	253	253	NUM
easat-3872	162	44	-	-	SYM
easat-3872	162	45	259	259	NUM
easat-3872	162	46	,	,	PUNCT
easat-3872	162	47	2000	2000	NUM
easat-3872	162	48	.	.	PUNCT
easat-3872	163	1	[	[	X
easat-3872	163	2	7	7	X
easat-3872	163	3	]	]	PUNCT
easat-3872	163	4	s.	s.	PROPN
easat-3872	163	5	l.	l.	PROPN
easat-3872	163	6	shyng	shyng	PROPN
easat-3872	163	7	,	,	PUNCT
easat-3872	163	8	"	"	PUNCT
easat-3872	163	9	katp	katp	X
easat-3872	163	10	channel	channel	NOUN
easat-3872	163	11	function	function	NOUN
easat-3872	163	12	:	:	PUNCT
easat-3872	163	13	more	more	ADV
easat-3872	163	14	than	than	ADP
easat-3872	163	15	meets	meet	VERB
easat-3872	163	16	the	the	DET
easat-3872	163	17	eye	eye	NOUN
easat-3872	163	18	,	,	PUNCT
easat-3872	163	19	"	"	PUNCT
easat-3872	163	20	function	function	NOUN
easat-3872	163	21	,	,	PUNCT
easat-3872	163	22	3	3	NUM
easat-3872	163	23	,	,	PUNCT
easat-3872	163	24	pp	pp	ADJ
easat-3872	163	25	.	.	PUNCT
easat-3872	164	1	zqab070	zqab070	NOUN
easat-3872	164	2	,	,	PUNCT
easat-3872	164	3	2022	2022	NUM
easat-3872	164	4	.	.	PUNCT
easat-3872	165	1	doi	doi	NOUN
easat-3872	165	2	:	:	PUNCT
easat-3872	165	3	10.1093	10.1093	NUM
easat-3872	165	4	/	/	SYM
easat-3872	165	5	function	function	NOUN
easat-3872	165	6	/	/	SYM
easat-3872	165	7	zqab070	zqab070	PROPN
easat-3872	165	8	.	.	PUNCT
easat-3872	166	1	[	[	X
easat-3872	166	2	8	8	X
easat-3872	166	3	]	]	PUNCT
easat-3872	166	4	s.	s.	PROPN
easat-3872	166	5	a.	a.	PROPN
easat-3872	166	6	zaki	zaki	PROPN
easat-3872	166	7	,	,	PUNCT
easat-3872	166	8	m.	m.	PROPN
easat-3872	166	9	b.	b.	PROPN
easat-3872	166	10	krishnamurthy	krishnamurthy	PROPN
easat-3872	166	11	,	,	PUNCT
easat-3872	166	12	and	and	CCONJ
easat-3872	166	13	a.	a.	PROPN
easat-3872	166	14	malhotra	malhotra	PROPN
easat-3872	166	15	,	,	PUNCT
easat-3872	166	16	"	"	PUNCT
easat-3872	166	17	octreotide	octreotide	NOUN
easat-3872	166	18	use	use	NOUN
easat-3872	166	19	in	in	ADP
easat-3872	166	20	neonates	neonate	NOUN
easat-3872	166	21	:	:	PUNCT
easat-3872	166	22	a	a	DET
easat-3872	166	23	case	case	NOUN
easat-3872	166	24	series	series	NOUN
easat-3872	166	25	,	,	PUNCT
easat-3872	166	26	"	"	PUNCT
easat-3872	166	27	drugs	drug	NOUN
easat-3872	166	28	in	in	ADP
easat-3872	166	29	r&d	r&d	NOUN
easat-3872	166	30	,	,	PUNCT
easat-3872	166	31	18	18	NUM
easat-3872	166	32	,	,	PUNCT
easat-3872	166	33	pp	pp	ADJ
easat-3872	166	34	.	.	PUNCT
easat-3872	167	1	191	191	NUM
easat-3872	167	2	-	-	SYM
easat-3872	167	3	198	198	NUM
easat-3872	167	4	,	,	PUNCT
easat-3872	167	5	2018	2018	NUM
easat-3872	167	6	.	.	PUNCT
easat-3872	168	1	doi	doi	NOUN
easat-3872	168	2	:	:	PUNCT
easat-3872	168	3	10.1007	10.1007	NUM
easat-3872	168	4	/	/	SYM
easat-3872	168	5	s40268	s40268	NOUN
easat-3872	168	6	-	-	PUNCT
easat-3872	168	7	018	018	NUM
easat-3872	168	8	-	-	PUNCT
easat-3872	168	9	0237	0237	NUM
easat-3872	168	10	-	-	SYM
easat-3872	168	11	9	9	NUM
easat-3872	168	12	.	.	PUNCT
easat-3872	169	1	[	[	X
easat-3872	169	2	9	9	NUM
easat-3872	169	3	]	]	PUNCT
easat-3872	169	4	t.	t.	NOUN
easat-3872	169	5	pipatpolkai	pipatpolkai	PROPN
easat-3872	169	6	,	,	PUNCT
easat-3872	169	7	s.	s.	PROPN
easat-3872	169	8	g.	g.	PROPN
easat-3872	169	9	usher	usher	PROPN
easat-3872	169	10	,	,	PUNCT
easat-3872	169	11	p.	p.	PROPN
easat-3872	169	12	j.	j.	PROPN
easat-3872	169	13	stansfeld	stansfeld	PROPN
easat-3872	169	14	,	,	PUNCT
easat-3872	169	15	and	and	CCONJ
easat-3872	169	16	f.	f.	PROPN
easat-3872	169	17	m.	m.	PROPN
easat-3872	169	18	ashcroft	ashcroft	PROPN
easat-3872	169	19	,	,	PUNCT
easat-3872	169	20	"	"	PUNCT
easat-3872	169	21	new	new	ADJ
easat-3872	169	22	insights	insight	NOUN
easat-3872	169	23	into	into	ADP
easat-3872	169	24	katp	katp	NOUN
easat-3872	169	25	channel	channel	NOUN
easat-3872	169	26	gene	gene	NOUN
easat-3872	169	27	mutations	mutation	NOUN
easat-3872	169	28	and	and	CCONJ
easat-3872	169	29	neonatal	neonatal	ADJ
easat-3872	169	30	diabetes	diabetes	NOUN
easat-3872	169	31	mellitus	mellitus	NOUN
easat-3872	169	32	,	,	PUNCT
easat-3872	169	33	"	"	PUNCT
easat-3872	169	34	nature	nature	NOUN
easat-3872	169	35	reviews	review	VERB
easat-3872	169	36	endocrinology	endocrinology	NOUN
easat-3872	169	37	,	,	PUNCT
easat-3872	169	38	16	16	NUM
easat-3872	169	39	,	,	PUNCT
easat-3872	169	40	pp	pp	ADJ
easat-3872	169	41	.	.	PUNCT
easat-3872	170	1	378	378	NUM
easat-3872	170	2	-	-	SYM
easat-3872	170	3	393	393	NUM
easat-3872	170	4	,	,	PUNCT
easat-3872	170	5	2020	2020	NUM
easat-3872	170	6	.	.	PUNCT
easat-3872	171	1	doi	doi	NOUN
easat-3872	171	2	:	:	PUNCT
easat-3872	171	3	10.1038	10.1038	NUM
easat-3872	171	4	/	/	SYM
easat-3872	171	5	s41574	s41574	NOUN
easat-3872	171	6	-	-	PUNCT
easat-3872	171	7	0200351	0200351	NUM
easat-3872	171	8	-	-	PUNCT
easat-3872	171	9	y.	y.	NOUN
easat-3872	172	1	[	[	X
easat-3872	172	2	10	10	NUM
easat-3872	172	3	]	]	X
easat-3872	172	4	y.	y.	PROPN
easat-3872	172	5	y.	y.	PROPN
easat-3872	172	6	yang	yang	PROPN
easat-3872	172	7	,	,	PUNCT
easat-3872	172	8	s.	s.	PROPN
easat-3872	172	9	ferrara	ferrara	PROPN
easat-3872	172	10	,	,	PUNCT
easat-3872	172	11	c.	c.	PROPN
easat-3872	172	12	long	long	PROPN
easat-3872	172	13	,	,	PUNCT
easat-3872	172	14	et	et	PROPN
easat-3872	172	15	al	al	PROPN
easat-3872	172	16	.	.	PROPN
easat-3872	172	17	,	,	PUNCT
easat-3872	172	18	"	"	PUNCT
easat-3872	172	19	a	a	DET
easat-3872	172	20	new	new	ADJ
easat-3872	172	21	familial	familial	ADJ
easat-3872	172	22	form	form	NOUN
easat-3872	172	23	of	of	ADP
easat-3872	172	24	late	late	ADJ
easat-3872	172	25	-	-	PUNCT
easat-3872	172	26	onset	onset	NOUN
easat-3872	172	27	phhi	phhi	NOUN
easat-3872	172	28	caused	cause	VERB
easat-3872	172	29	by	by	ADP
easat-3872	172	30	a	a	DET
easat-3872	172	31	novel	novel	ADJ
easat-3872	172	32	mutation	mutation	NOUN
easat-3872	172	33	in	in	ADP
easat-3872	172	34	kcnj11	kcnj11	NOUN
easat-3872	172	35	,	,	PUNCT
easat-3872	172	36	"	"	PUNCT
easat-3872	172	37	channels	channel	NOUN
easat-3872	172	38	,	,	PUNCT
easat-3872	172	39	11	11	NUM
easat-3872	172	40	,	,	PUNCT
easat-3872	172	41	pp	pp	ADJ
easat-3872	172	42	.	.	PUNCT
easat-3872	173	1	636	636	NUM
easat-3872	173	2	-	-	SYM
easat-3872	173	3	647	647	NUM
easat-3872	173	4	,	,	PUNCT
easat-3872	173	5	2017	2017	NUM
easat-3872	173	6	.	.	PUNCT
easat-3872	174	1	doi	doi	NOUN
easat-3872	174	2	:	:	PUNCT
easat-3872	174	3	10.1080/19336950.2017.1393131	10.1080/19336950.2017.1393131	NUM
easat-3872	174	4	.	.	PUNCT
easat-3872	175	1	[	[	X
easat-3872	175	2	11	11	NUM
easat-3872	175	3	]	]	PUNCT
easat-3872	175	4	r.	r.	PROPN
easat-3872	175	5	männikkö	männikkö	PROPN
easat-3872	175	6	,	,	PUNCT
easat-3872	175	7	s.	s.	PROPN
easat-3872	175	8	e.	e.	PROPN
easat-3872	175	9	flanagan	flanagan	PROPN
easat-3872	175	10	,	,	PUNCT
easat-3872	175	11	x.	x.	PROPN
easat-3872	175	12	sim	sim	PROPN
easat-3872	175	13	,	,	PUNCT
easat-3872	175	14	et	et	PROPN
easat-3872	175	15	al	al	PROPN
easat-3872	175	16	.	.	PROPN
easat-3872	175	17	,	,	PUNCT
easat-3872	175	18	"	"	PUNCT
easat-3872	175	19	mutations	mutation	NOUN
easat-3872	175	20	of	of	ADP
easat-3872	175	21	the	the	DET
easat-3872	175	22	same	same	ADJ
easat-3872	175	23	conserved	conserve	VERB
easat-3872	175	24	glutamate	glutamate	NOUN
easat-3872	175	25	residue	residue	NOUN
easat-3872	175	26	in	in	ADP
easat-3872	175	27	nbd2	nbd2	NOUN
easat-3872	175	28	of	of	ADP
easat-3872	175	29	the	the	DET
easat-3872	175	30	sulfonylurea	sulfonylurea	NOUN
easat-3872	175	31	receptor	receptor	NOUN
easat-3872	175	32	1	1	NUM
easat-3872	175	33	subunit	subunit	NOUN
easat-3872	175	34	of	of	ADP
easat-3872	175	35	the	the	DET
easat-3872	175	36	katp	katp	NOUN
easat-3872	175	37	channel	channel	NOUN
easat-3872	175	38	can	can	AUX
easat-3872	175	39	result	result	VERB
easat-3872	175	40	in	in	ADP
easat-3872	175	41	either	either	CCONJ
easat-3872	175	42	hyperinsulinism	hyperinsulinism	NOUN
easat-3872	175	43	or	or	CCONJ
easat-3872	175	44	neonatal	neonatal	ADJ
easat-3872	175	45	diabetes	diabetes	NOUN
easat-3872	175	46	,	,	PUNCT
easat-3872	175	47	"	"	PUNCT
easat-3872	175	48	diabetes	diabetes	NOUN
easat-3872	175	49	,	,	PUNCT
easat-3872	175	50	60	60	NUM
easat-3872	175	51	,	,	PUNCT
easat-3872	175	52	pp	pp	ADJ
easat-3872	175	53	.	.	PUNCT
easat-3872	176	1	1813	1813	NUM
easat-3872	176	2	-	-	SYM
easat-3872	176	3	1822	1822	NUM
easat-3872	176	4	,	,	PUNCT
easat-3872	176	5	2011	2011	NUM
easat-3872	176	6	.	.	PUNCT
easat-3872	177	1	doi	doi	NOUN
easat-3872	177	2	:	:	PUNCT
easat-3872	177	3	10.2337	10.2337	NUM
easat-3872	177	4	/	/	SYM
easat-3872	177	5	db10	db10	PROPN
easat-3872	177	6	-	-	PUNCT
easat-3872	177	7	1583	1583	NUM
easat-3872	177	8	.	.	PUNCT
easat-3872	178	1	[	[	X
easat-3872	178	2	12	12	NUM
easat-3872	178	3	]	]	PUNCT
easat-3872	178	4	m.	m.	NOUN
easat-3872	178	5	ceparano	ceparano	PROPN
easat-3872	178	6	,	,	PUNCT
easat-3872	178	7	a.	a.	PROPN
easat-3872	178	8	sciurti	sciurti	PROPN
easat-3872	178	9	,	,	PUNCT
easat-3872	178	10	c.	c.	PROPN
easat-3872	178	11	isonne	isonne	PROPN
easat-3872	178	12	,	,	PUNCT
easat-3872	178	13	et	et	PROPN
easat-3872	178	14	al	al	PROPN
easat-3872	178	15	.	.	PROPN
easat-3872	178	16	,	,	PUNCT
easat-3872	178	17	"	"	PUNCT
easat-3872	178	18	incidence	incidence	NOUN
easat-3872	178	19	of	of	ADP
easat-3872	178	20	healthcare	healthcare	NOUN
easat-3872	178	21	-	-	PUNCT
easat-3872	178	22	associated	associate	VERB
easat-3872	178	23	infections	infection	NOUN
easat-3872	178	24	in	in	ADP
easat-3872	178	25	a	a	DET
easat-3872	178	26	neonatal	neonatal	ADJ
easat-3872	178	27	intensive	intensive	ADJ
easat-3872	178	28	care	care	NOUN
easat-3872	178	29	unit	unit	NOUN
easat-3872	178	30	before	before	ADP
easat-3872	178	31	and	and	CCONJ
easat-3872	178	32	during	during	ADP
easat-3872	178	33	the	the	DET
easat-3872	178	34	covid-19	covid-19	PROPN
easat-3872	178	35	pandemic	pandemic	NOUN
easat-3872	178	36	:	:	PUNCT
easat-3872	178	37	a	a	DET
easat-3872	178	38	four	four	NUM
easat-3872	178	39	-	-	PUNCT
easat-3872	178	40	year	year	NOUN
easat-3872	178	41	retrospective	retrospective	ADJ
easat-3872	178	42	cohort	cohort	NOUN
easat-3872	178	43	study	study	NOUN
easat-3872	178	44	,	,	PUNCT
easat-3872	178	45	"	"	PUNCT
easat-3872	178	46	journal	journal	NOUN
easat-3872	178	47	of	of	ADP
easat-3872	178	48	clinical	clinical	ADJ
easat-3872	178	49	medicine	medicine	NOUN
easat-3872	178	50	,	,	PUNCT
easat-3872	178	51	12	12	NUM
easat-3872	178	52	,	,	PUNCT
easat-3872	178	53	pp	pp	ADJ
easat-3872	178	54	.	.	PUNCT
easat-3872	178	55	2621	2621	NUM
easat-3872	178	56	,	,	PUNCT
easat-3872	178	57	2023	2023	NUM
easat-3872	178	58	.	.	PUNCT
easat-3872	179	1	doi	doi	NOUN
easat-3872	179	2	:	:	PUNCT
easat-3872	179	3	10.3390	10.3390	NUM
easat-3872	179	4	/	/	SYM
easat-3872	179	5	jcm12072621	jcm12072621	NOUN
easat-3872	179	6	.	.	PUNCT
easat-3872	180	1	[	[	X
easat-3872	180	2	13	13	NUM
easat-3872	180	3	]	]	PUNCT
easat-3872	180	4	k.	k.	PROPN
easat-3872	180	5	reddy	reddy	PROPN
easat-3872	180	6	,	,	PUNCT
easat-3872	180	7	a.	a.	NOUN
easat-3872	180	8	bekker	bekker	PROPN
easat-3872	180	9	,	,	PUNCT
easat-3872	180	10	a.	a.	PROPN
easat-3872	180	11	whitelaw	whitelaw	PROPN
easat-3872	180	12	,	,	PUNCT
easat-3872	180	13	t.	t.	NOUN
easat-3872	180	14	esterhuizen	esterhuizen	NOUN
easat-3872	180	15	,	,	PUNCT
easat-3872	180	16	and	and	CCONJ
easat-3872	180	17	a.	a.	NOUN
easat-3872	180	18	dramowski	dramowski	PROPN
easat-3872	180	19	,	,	PUNCT
easat-3872	180	20	"	"	PUNCT
easat-3872	180	21	a	a	DET
easat-3872	180	22	retrospective	retrospective	ADJ
easat-3872	180	23	analysis	analysis	NOUN
easat-3872	180	24	of	of	ADP
easat-3872	180	25	pathogen	pathogen	NOUN
easat-3872	180	26	profile	profile	NOUN
easat-3872	180	27	,	,	PUNCT
easat-3872	180	28	antimicrobial	antimicrobial	ADJ
easat-3872	180	29	resistance	resistance	NOUN
easat-3872	180	30	and	and	CCONJ
easat-3872	180	31	mortality	mortality	NOUN
easat-3872	180	32	in	in	ADP
easat-3872	180	33	neonatal	neonatal	ADJ
easat-3872	180	34	hospital	hospital	NOUN
easat-3872	180	35	-	-	PUNCT
easat-3872	180	36	acquired	acquire	VERB
easat-3872	180	37	bloodstream	bloodstream	NOUN
easat-3872	180	38	infections	infection	NOUN
easat-3872	180	39	,	,	PUNCT
easat-3872	180	40	"	"	PUNCT
easat-3872	180	41	plos	plos	PROPN
easat-3872	180	42	one	one	NUM
easat-3872	180	43	,	,	PUNCT
easat-3872	180	44	16	16	NUM
easat-3872	180	45	,	,	PUNCT
easat-3872	180	46	pp	pp	ADJ
easat-3872	180	47	.	.	PUNCT
easat-3872	180	48	,	,	PUNCT
easat-3872	180	49	2021	2021	NUM
easat-3872	180	50	.	.	PUNCT
easat-3872	181	1	doi	doi	NOUN
easat-3872	181	2	:	:	PUNCT
easat-3872	181	3	10.1371	10.1371	NUM
easat-3872	181	4	/	/	SYM
easat-3872	181	5	journal.pone.0245089	journal.pone.0245089	NOUN
easat-3872	181	6	.	.	PUNCT
easat-3872	182	1	[	[	X
easat-3872	182	2	14	14	NUM
easat-3872	182	3	]	]	X
easat-3872	182	4	e.	e.	PROPN
easat-3872	182	5	montella	montella	PROPN
easat-3872	182	6	,	,	PUNCT
easat-3872	182	7	a.	a.	NOUN
easat-3872	182	8	ferraro	ferraro	PROPN
easat-3872	182	9	,	,	PUNCT
easat-3872	182	10	g.	g.	PROPN
easat-3872	182	11	sperlí	sperlí	PROPN
easat-3872	182	12	,	,	PUNCT
easat-3872	182	13	et	et	PROPN
easat-3872	182	14	al	al	PROPN
easat-3872	182	15	.	.	PROPN
easat-3872	182	16	,	,	PUNCT
easat-3872	182	17	"	"	PUNCT
easat-3872	182	18	predictive	predictive	ADJ
easat-3872	182	19	analysis	analysis	NOUN
easat-3872	182	20	of	of	ADP
easat-3872	182	21	healthcare	healthcare	NOUN
easat-3872	182	22	-	-	PUNCT
easat-3872	182	23	associated	associate	VERB
easat-3872	182	24	blood	blood	NOUN
easat-3872	182	25	stream	stream	NOUN
easat-3872	182	26	infections	infection	NOUN
easat-3872	182	27	in	in	ADP
easat-3872	182	28	the	the	DET
easat-3872	182	29	neonatal	neonatal	ADJ
easat-3872	182	30	intensive	intensive	ADJ
easat-3872	182	31	care	care	NOUN
easat-3872	182	32	unit	unit	NOUN
easat-3872	182	33	using	use	VERB
easat-3872	182	34	artificial	artificial	ADJ
easat-3872	182	35	intelligence	intelligence	NOUN
easat-3872	182	36	:	:	PUNCT
easat-3872	182	37	a	a	DET
easat-3872	182	38	single	single	ADJ
easat-3872	182	39	center	center	NOUN
easat-3872	182	40	study	study	NOUN
easat-3872	182	41	,	,	PUNCT
easat-3872	182	42	"	"	PUNCT
easat-3872	182	43	international	international	ADJ
easat-3872	182	44	journal	journal	NOUN
easat-3872	182	45	of	of	ADP
easat-3872	182	46	environmental	environmental	ADJ
easat-3872	182	47	research	research	NOUN
easat-3872	182	48	and	and	CCONJ
easat-3872	182	49	public	public	ADJ
easat-3872	182	50	health	health	NOUN
easat-3872	182	51	,	,	PUNCT
easat-3872	182	52	19	19	NUM
easat-3872	182	53	,	,	PUNCT
easat-3872	182	54	pp	pp	ADJ
easat-3872	182	55	.	.	PUNCT
easat-3872	182	56	2498	2498	NUM
easat-3872	182	57	,	,	PUNCT
easat-3872	182	58	2022	2022	NUM
easat-3872	182	59	.	.	PUNCT
easat-3872	183	1	doi	doi	NOUN
easat-3872	183	2	:	:	PUNCT
easat-3872	183	3	10.3390	10.3390	NUM
easat-3872	183	4	/	/	SYM
easat-3872	183	5	ijerph19052498	ijerph19052498	NOUN
easat-3872	183	6	.	.	PUNCT
easat-3872	184	1	[	[	X
easat-3872	184	2	15	15	NUM
easat-3872	184	3	]	]	X
easat-3872	184	4	u.	u.	NOUN
easat-3872	184	5	okomo	okomo	PROPN
easat-3872	184	6	,	,	PUNCT
easat-3872	184	7	e.	e.	PROPN
easat-3872	184	8	akpalu	akpalu	PROPN
easat-3872	184	9	,	,	PUNCT
easat-3872	184	10	k.	k.	PROPN
easat-3872	184	11	le	le	PROPN
easat-3872	184	12	doare	doare	PROPN
easat-3872	184	13	,	,	PUNCT
easat-3872	184	14	et	et	PROPN
easat-3872	184	15	al	al	PROPN
easat-3872	184	16	.	.	PROPN
easat-3872	184	17	,	,	PUNCT
easat-3872	184	18	"	"	PUNCT
easat-3872	184	19	aetiology	aetiology	NOUN
easat-3872	184	20	of	of	ADP
easat-3872	184	21	invasive	invasive	ADJ
easat-3872	184	22	bacterial	bacterial	ADJ
easat-3872	184	23	infection	infection	NOUN
easat-3872	184	24	and	and	CCONJ
easat-3872	184	25	antimicrobial	antimicrobial	ADJ
easat-3872	184	26	resistance	resistance	NOUN
easat-3872	184	27	in	in	ADP
easat-3872	184	28	neonates	neonate	NOUN
easat-3872	184	29	in	in	ADP
easat-3872	184	30	sub	sub	ADJ
easat-3872	184	31	-	-	ADJ
easat-3872	184	32	saharan	saharan	ADJ
easat-3872	184	33	africa	africa	PROPN
easat-3872	184	34	,	,	PUNCT
easat-3872	184	35	"	"	PUNCT
easat-3872	184	36	the	the	DET
easat-3872	184	37	lancet	lancet	PROPN
easat-3872	184	38	.	.	PUNCT
easat-3872	185	1	infectious	infectious	ADJ
easat-3872	185	2	diseases	disease	NOUN
easat-3872	185	3	,	,	PUNCT
easat-3872	185	4	-	-	PUNCT
easat-3872	185	5	,	,	PUNCT
easat-3872	185	6	pp	pp	NOUN
easat-3872	185	7	.	.	PUNCT
easat-3872	186	1	-	-	PUNCT
easat-3872	186	2	,	,	PUNCT
easat-3872	186	3	2019	2019	NUM
easat-3872	186	4	.	.	PUNCT
easat-3872	187	1	doi	doi	NOUN
easat-3872	187	2	:	:	PUNCT
easat-3872	187	3	10.1016	10.1016	NUM
easat-3872	187	4	/	/	SYM
easat-3872	187	5	s1473	s1473	PROPN
easat-3872	187	6	-	-	PUNCT
easat-3872	187	7	3099(19)30414	3099(19)30414	NUM
easat-3872	187	8	-	-	SYM
easat-3872	187	9	1	1	NUM
easat-3872	187	10	.	.	PUNCT
easat-3872	188	1	[	[	X
easat-3872	188	2	16	16	NUM
easat-3872	188	3	]	]	X
easat-3872	188	4	g.	g.	PROPN
easat-3872	188	5	w.	w.	PROPN
easat-3872	188	6	jeon	jeon	PROPN
easat-3872	188	7	,	,	PUNCT
easat-3872	188	8	j.	j.	PROPN
easat-3872	188	9	h.	h.	PROPN
easat-3872	188	10	lee	lee	PROPN
easat-3872	188	11	,	,	PUNCT
easat-3872	188	12	m.	m.	NOUN
easat-3872	188	13	oh	oh	INTJ
easat-3872	188	14	,	,	PUNCT
easat-3872	188	15	and	and	CCONJ
easat-3872	188	16	y.	y.	PROPN
easat-3872	188	17	chang	chang	PROPN
easat-3872	188	18	,	,	PUNCT
easat-3872	188	19	"	"	PUNCT
easat-3872	188	20	serial	serial	ADJ
easat-3872	188	21	short	short	ADJ
easat-3872	188	22	-	-	PUNCT
easat-3872	188	23	term	term	NOUN
easat-3872	188	24	outcomes	outcome	NOUN
easat-3872	188	25	of	of	ADP
easat-3872	188	26	very	very	ADV
easat-3872	188	27	-	-	PUNCT
easat-3872	188	28	low	low	ADJ
easat-3872	188	29	-	-	PUNCT
easat-3872	188	30	birth	birth	NOUN
easat-3872	188	31	-	-	PUNCT
easat-3872	188	32	weight	weight	NOUN
easat-3872	188	33	infants	infant	NOUN
easat-3872	188	34	in	in	ADP
easat-3872	188	35	the	the	DET
easat-3872	188	36	korean	korean	ADJ
easat-3872	188	37	neonatal	neonatal	ADJ
easat-3872	188	38	network	network	NOUN
easat-3872	188	39	from	from	ADP
easat-3872	188	40	2013	2013	NUM
easat-3872	188	41	to	to	ADP
easat-3872	188	42	2020	2020	NUM
easat-3872	188	43	,	,	PUNCT
easat-3872	188	44	"	"	PUNCT
easat-3872	188	45	journal	journal	NOUN
easat-3872	188	46	of	of	ADP
easat-3872	188	47	korean	korean	PROPN
easat-3872	188	48	medical	medical	ADJ
easat-3872	188	49	science	science	NOUN
easat-3872	188	50	,	,	PUNCT
easat-3872	188	51	37	37	NUM
easat-3872	188	52	,	,	PUNCT
easat-3872	188	53	pp	pp	PROPN
easat-3872	188	54	.	.	PUNCT
easat-3872	188	55	-	-	PUNCT
easat-3872	188	56	,	,	PUNCT
easat-3872	188	57	2022	2022	NUM
easat-3872	188	58	.	.	PUNCT
easat-3872	189	1	doi	doi	NOUN
easat-3872	189	2	:	:	PUNCT
easat-3872	189	3	10.3346	10.3346	NUM
easat-3872	189	4	/	/	SYM
easat-3872	189	5	jkms.2022.37	jkms.2022.37	NOUN
easat-3872	189	6	.	.	PUNCT
easat-3872	190	1	e229	e229	PROPN
easat-3872	190	2	.	.	PROPN
easat-3872	190	3	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN